-
Notifications
You must be signed in to change notification settings - Fork 14
Drug_Code
Julien Guérin edited this page Jan 26, 2021
·
4 revisions
| Attribute | Value |
|---|---|
| ObjectClass | Drug |
| ObjectProperty | Code |
| DataElementConcept | Drug_Code |
| ObjectPropertyLabelEN | Code |
| ObjectPropertyLabelFR | Code molécule |
| DataElementConceptDefEN | Therapeutic classification code (5th level if possible) |
| DataElementConceptDefFR | Code de la classification thérapeutique (5ème niveau si possible) |
| Attribute | Value |
|---|---|
| FormatConceptualDomain | String |
| Required | mandatory if ObjectClass is set |
| Attribute | Value |
|---|---|
| Examples |
| ValueMeaning | LabelValueMeaning |
|---|---|
| ATC:A01A | Stomatological preparations |
| ATC:A01AA | Caries prophylactic agents |
| ATC:A01AA01 | Sodiumfluoride |
| ATC:A01AA02 | Sodiummonofluorophosphate |
| ATC:A01AA03 | Olaflur |
| ATC:A01AA04 | Stannousfluoride(Tin2fluoride) |
| ATC:A01AA30 | Cariesprophylacticagents,combinations |
| ATC:A01AA51 | Sodiumfluoride,combinations |
| ATC:A01AB | Anti-infectives and antiseptics for local oral treatment |
| ATC:A01AB02 | Hydrogenperoxide |
| ATC:A01AB03 | Chlorhexidine |
| ATC:A01AB04 | AmphotericinB |
| ATC:A01AB05 | Polynoxylin |
| ATC:A01AB06 | Domiphen |
| ATC:A01AB07 | Oxyquinoline(8-Hydroxyquinoline) |
| ATC:A01AB08 | Neomycin |
| ATC:A01AB09 | Miconazole |
| ATC:A01AB10 | Natamycin |
| ATC:A01AB11 | Anti-infectivesandantisepticsforlocaloraltreatment,various |
| ATC:A01AB12 | Hexetidine |
| ATC:A01AB13 | Tetracycline |
| ATC:A01AB14 | Benzoxoniumchloride |
| ATC:A01AB15 | Tibezoniumiodide |
| ATC:A01AB16 | Mepartricin |
| ATC:A01AB17 | Metronidazole |
| ATC:A01AB18 | Clotrimazole |
| ATC:A01AB19 | Sodiumperborate |
| ATC:A01AB21 | Chlortetracycline |
| ATC:A01AB22 | Doxycycline |
| ATC:A01AB23 | Minocycline |
| ATC:A01AC | Corticosteroids for local oral treatment |
| ATC:A01AC01 | Triamcinolone |
| ATC:A01AC02 | Dexamethasone |
| ATC:A01AC03 | Hydrocortisone(Cortisol) |
| ATC:A01AC54 | Prednisolone,combinations |
| ATC:A01AD | Other agents for local oral treatment |
| ATC:A01AD01 | Epinephrine |
| ATC:A01AD02 | Benzydamine |
| ATC:A01AD05 | Acetylsalicylicacid |
| ATC:A01AD06 | Adrenalone |
| ATC:A01AD07 | Amlexanox |
| ATC:A01AD08 | Becaplermin |
| ATC:A01AD11 | Otheragentsforlocaloraltreatment,Various |
| ATC:A02 | Drugs for acid related disorders |
| ATC:A02A | Antacid drugs (Stomach acid drugs) |
| ATC:A02AA | Magnesiumcompounds |
| ATC:A02AA01 | Magnesiumcarbonate |
| ATC:A02AA02 | Magnesiumoxide |
| ATC:A02AA03 | Magnesiumperoxide |
| ATC:A02AA04 | Magnesiumhydroxide |
| ATC:A02AA05 | Magnesiumsilicate |
| ATC:A02AA10 | Magnesiumcompounds,combinations |
| ATC:A02AB | Aluminiumcompounds |
| ATC:A02AB01 | Aluminiumhydroxide |
| ATC:A02AB02 | Algeldrate |
| ATC:A02AB03 | Aluminiumphosphate |
| ATC:A02AB04 | Dihydroxialuminisodiumcarbonate |
| ATC:A02AB05 | Aluminiumacetoacetate |
| ATC:A02AB06 | Aloglutamol |
| ATC:A02AB07 | Aluminiumglycinate |
| ATC:A02AB10 | Aluminiumcompounds,combinations |
| ATC:A02AC | Calciumcompoundslist |
| ATC:A02AC01 | Calciumcarbonate |
| ATC:A02AC02 | Calciumsilicate |
| ATC:A02AC10 | Calciumcompounds,combinations |
| ATC:A02AD | Combinationsandcomplexesofaluminium,calciumandmagnesiumcompounds |
| ATC:A02AD01 | Ordinarysaltcombinations |
| ATC:A02AD02 | Magaldrate |
| ATC:A02AD03 | Almagate |
| ATC:A02AD04 | Hydrotalcite |
| ATC:A02AD05 | Almasilate |
| ATC:A02AF | Antacidswithantiflatulents |
| ATC:A02AF01 | Magaldrateandantiflatulents |
| ATC:A02AF02 | Ordinarysaltcombinationsandantiflatulents |
| ATC:A02B | Drugs for peptic ulcer and gastro-oesophageal reflux disease |
| ATC:A02BA | H2-receptorantagonists |
| ATC:A02BA01 | Cimetidine |
| ATC:A02BA02 | Ranitidine |
| ATC:A02BA03 | Famotidine |
| ATC:A02BA04 | Nizatidine |
| ATC:A02BA05 | Niperotidine |
| ATC:A02BA06 | Roxatidine |
| ATC:A02BA07 | Ranitidinebismuthcitrate |
| ATC:A02BA08 | Lafutidine |
| ATC:A02BA51 | Cimetidine,combinations |
| ATC:A02BA53 | Famotidine,combinations |
| ATC:A02BB | Prostaglandins |
| ATC:A02BB01 | Misoprostol |
| ATC:A02BB02 | Enprostil |
| ATC:A02BC | Protonpumpinhibitors |
| ATC:A02BC01 | Omeprazole |
| ATC:A02BC02 | Pantoprazole |
| ATC:A02BC03 | Lansoprazole |
| ATC:A02BC04 | Rabeprazole |
| ATC:A02BC05 | Esomeprazole |
| ATC:A02BC06 | Dexlansoprazole |
| ATC:A02BC07 | Dexrabeprazole |
| ATC:A02BC53 | Lansoprazole,combinations |
| ATC:A02BC54 | Rabeprazole,combinations |
| ATC:A02BD | CombinationsforeradicationofHelicobacterpylori |
| ATC:A02BD01 | Omeprazole,amoxicillinandmetronidazole |
| ATC:A02BD02 | Lansoprazole,tetracyclineandmetronidazole |
| ATC:A02BD03 | Lansoprazole,amoxicillinandmetronidazole |
| ATC:A02BD04 | Pantoprazole,amoxicillinandclarithromycin |
| ATC:A02BD05 | Omeprazole,amoxicillinandclarithromycin |
| ATC:A02BD06 | Esomeprazole,amoxicillinandclarithromycin |
| ATC:A02BD07 | Lansoprazole,amoxicillinandclarithromycin |
| ATC:A02BD08 | Bismuthsubcitrate,tetracyclineandmetronidazole |
| ATC:A02BD09 | Lansoprazole,clarithromycinandtinidazole |
| ATC:A02BD10 | Lansoprazole,amoxicillinandlevofloxacin |
| ATC:A02BD11 | Pantoprazole,amoxicillin,clarithromycinandmetronidazole |
| ATC:A02BX | Otherdrugsforpepticulcerandgastro-oesophagealrefluxdisease(GORD/GERD) |
| ATC:A02BX01 | Carbenoxolone |
| ATC:A02BX02 | Sucralfate |
| ATC:A02BX03 | Pirenzepine |
| ATC:A02BX04 | Methiosulfoniumchloride |
| ATC:A02BX05 | Bismuthsubcitrate |
| ATC:A02BX06 | Proglumide |
| ATC:A02BX07 | Gefarnate |
| ATC:A02BX08 | Sulglicotide |
| ATC:A02BX09 | Acetoxolone |
| ATC:A02BX10 | Zolimidine |
| ATC:A02BX11 | Troxipide |
| ATC:A02BX12 | Bismuthsubnitrate |
| ATC:A02BX13 | Alginicacid |
| ATC:A02BX14 | Rebamipide |
| ATC:A02BX51 | Carbenoxolone,combinationsexcludingpsycholeptics |
| ATC:A02BX71 | Carbenoxolone,combinationswithpsycholeptics |
| ATC:A02BX77 | Gefarnate,combinationswithpsycholeptics |
| ATC:A02X | Otherdrugsforacidrelateddisorders |
| ATC:A03 | Drugs for functional gastrointestinal disorders |
| ATC:A03A | Drugs for functional bowel disorders |
| ATC:A03AA | Syntheticanticholinergics,esterswithtertiaryaminogroup |
| ATC:A03AA01 | Oxyphencyclimine |
| ATC:A03AA03 | Camylofin |
| ATC:A03AA04 | Mebeverine |
| ATC:A03AA05 | Trimebutine |
| ATC:A03AA06 | Rociverine |
| ATC:A03AA07 | Dicycloverine |
| ATC:A03AA08 | Dihexyverine |
| ATC:A03AA09 | Difemerine |
| ATC:A03AA30 | Piperidolate |
| ATC:A03AB | Syntheticanticholinergics,quaternaryammoniumcompounds |
| ATC:A03AB01 | Benzilone |
| ATC:A03AB02 | Glycopyrronium |
| ATC:A03AB03 | Oxyphenonium |
| ATC:A03AB04 | Penthienate |
| ATC:A03AB05 | Propantheline |
| ATC:A03AB06 | Otiloniumbromide |
| ATC:A03AB07 | Methantheline |
| ATC:A03AB08 | Tridihexethyl |
| ATC:A03AB09 | Isopropamide |
| ATC:A03AB10 | Hexocyclium |
| ATC:A03AB11 | Poldine |
| ATC:A03AB12 | Mepenzolate |
| ATC:A03AB13 | Bevonium |
| ATC:A03AB14 | Pipenzolate |
| ATC:A03AB15 | Diphemanil |
| ATC:A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammoniumiodide |
| ATC:A03AB17 | Tiemoniumiodide |
| ATC:A03AB18 | Prifiniumbromide |
| ATC:A03AB19 | Timepidiumbromide |
| ATC:A03AB21 | Fenpiverinium |
| ATC:A03AB53 | Oxyphenonium,combinations |
| ATC:A03AC | Syntheticantispasmodics,amideswithtertiaryamines |
| ATC:A03AC02 | Dimethylaminopropionylphenothiazine |
| ATC:A03AC04 | Nicofetamide |
| ATC:A03AC05 | Tiropramide |
| ATC:A03AD | Papaverineandderivatives |
| ATC:A03AD01 | Papaverine |
| ATC:A03AD02 | Drotaverine |
| ATC:A03AD30 | Moxaverine |
| ATC:A03AE | Serotoninreceptorantagonists |
| ATC:A03AE01 | Alosetron |
| ATC:A03AE03 | Cilansetron |
| ATC:A03AX | Otherdrugsforfunctionalgastrointestinaldisorders |
| ATC:A03AX01 | Fenpiprane |
| ATC:A03AX02 | Diisopromine |
| ATC:A03AX03 | Chlorbenzoxamine |
| ATC:A03AX04 | Pinaverium |
| ATC:A03AX05 | Fenoverine |
| ATC:A03AX06 | Idanpramine |
| ATC:A03AX07 | Proxazole |
| ATC:A03AX08 | Alverine |
| ATC:A03AX09 | Trepibutone |
| ATC:A03AX10 | Isometheptene |
| ATC:A03AX11 | Caroverine |
| ATC:A03AX12 | Phloroglucinol |
| ATC:A03AX13 | Silicones |
| ATC:A03AX14 | Valethamate |
| ATC:A03AX30 | Trimethyldiphenylpropylamine |
| ATC:A03AX58 | Alverine,combinations |
| ATC:A03B | Belladonna and derivatives, plain |
| ATC:A03C | Antispasmodics in combination with psycholeptics |
| ATC:A03D | Antispasmodics in combination with analgesics |
| ATC:A03E | Antispasmodics and anticholinergics in combination with other drugs |
| ATC:A03F | Propulsives |
| ATC:A04A | Antiemetics and antinauseants |
| ATC:A04AA | Serotonin (5-HT3) antagonists |
| ATC:A04AA01 | Ondansetron |
| ATC:A04AA02 | Granisetron |
| ATC:A04AA03 | Tropisetron |
| ATC:A04AA04 | Dolasetron |
| ATC:A04AA05 | Palonosetron |
| ATC:A04AA55 | Palonosetron,combinations |
| ATC:A04AD | Other antiemetics |
| ATC:A04AD01 | Scopolamine |
| ATC:A04AD02 | Ceriumoxalate |
| ATC:A04AD04 | Chlorobutanol |
| ATC:A04AD05 | Metopimazine |
| ATC:A04AD10 | Dronabinol |
| ATC:A04AD11 | Nabilone |
| ATC:A04AD12 | Aprepitant |
| ATC:A04AD13 | Casopitant |
| ATC:A04AD51 | Scopolamine,combinations |
| ATC:A04AD54 | Chlorobutanol,combinations |
| ATC:A05 | Bile and liver therapy |
| ATC:A05A | Bile therapy |
| ATC:A05AA | Bileacidpreparations |
| ATC:A05AA01 | Chenodeoxycholicacid |
| ATC:A05AA02 | Ursodeoxycholicacid |
| ATC:A05AA03 | Cholicacid |
| ATC:A05AA04 | Obeticholicacid |
| ATC:A05AB | Preparationsforbiliarytracttherapy |
| ATC:A05AB01 | Nicotinylmethylamide |
| ATC:A05AX | Otherdrugsforbiletherapy |
| ATC:A05AX01 | Piprozolin |
| ATC:A05AX02 | Hymecromone |
| ATC:A05AX03 | Cyclobutyrol |
| ATC:A05B | Liver therapy, lipotropics |
| ATC:A05BA | Livertherapy |
| ATC:A05BA01 | Arginineglutamate |
| ATC:A05BA03 | Silymarin |
| ATC:A05BA04 | Citiolone |
| ATC:A05BA05 | Epomediol |
| ATC:A05BA06 | Ornithineoxoglutarate |
| ATC:A05BA07 | Tidiacicarginine |
| ATC:A05BA08 | Glycyrrhizicacid(glycyrrhizin) |
| ATC:A05C | Drugs for bile therapy and lipotropics in combination |
| ATC:A06A | Drugs for constipation |
| ATC:A06AA | Softeners, emollients |
| ATC:A06AA01 | Liquidparaffin |
| ATC:A06AA02 | Docusatesodium |
| ATC:A06AA51 | Liquidparaffin,combinations |
| ATC:A06AB | Contact laxatives |
| ATC:A06AB01 | Oxyphenisatine |
| ATC:A06AB02 | Bisacodyl |
| ATC:A06AB03 | Dantron |
| ATC:A06AB04 | Phenolphthalein |
| ATC:A06AB05 | Castoroil |
| ATC:A06AB06 | Sennaglycosides |
| ATC:A06AB07 | Cascara |
| ATC:A06AB08 | Sodiumpicosulfate |
| ATC:A06AB09 | Bisoxatin |
| ATC:A06AB20 | Contactlaxativesincombination |
| ATC:A06AB30 | Contactlaxativesincombinationwithbelladonnaalkaloids |
| ATC:A06AB52 | Bisacodyl,combinations |
| ATC:A06AB53 | Dantron,combinations |
| ATC:A06AB56 | Sennaglycosides,combinations |
| ATC:A06AB57 | Cascara,combinations |
| ATC:A06AB58 | Sodiumpicosulfate,combinations |
| ATC:A06AC | Bulk-forming laxatives |
| ATC:A06AC01 | Ispaghula(psyllaseeds) |
| ATC:A06AC02 | Ethulose |
| ATC:A06AC03 | Sterculia |
| ATC:A06AC05 | Linseed |
| ATC:A06AC06 | Methylcellulose |
| ATC:A06AC07 | Triticum(wheatfibre) |
| ATC:A06AC08 | Polycarbophilcalcium |
| ATC:A06AC51 | Ispaghula,combinations |
| ATC:A06AC53 | Sterculia,combinations |
| ATC:A06AC55 | Linseed,combinations |
| ATC:A06AD | Osmotically acting laxatives |
| ATC:A06AD01 | Magnesiumcarbonate |
| ATC:A06AD02 | Magnesiumoxide |
| ATC:A06AD03 | Magnesiumperoxide |
| ATC:A06AD04 | Magnesiumsulfate |
| ATC:A06AD10 | Mineralsaltsincombination |
| ATC:A06AD11 | Lactulose |
| ATC:A06AD12 | Lactitol |
| ATC:A06AD13 | Sodiumsulfate |
| ATC:A06AD14 | Pentaerithrityl |
| ATC:A06AD15 | Macrogol |
| ATC:A06AD16 | Mannitol |
| ATC:A06AD17 | Sodiumphosphate |
| ATC:A06AD18 | Sorbitol |
| ATC:A06AD19 | Magnesiumcitrate |
| ATC:A06AD21 | Sodiumtartrate |
| ATC:A06AD61 | Lactulose,combinations |
| ATC:A06AD65 | Macrogol,combinations |
| ATC:A06AG | Enemas drugs |
| ATC:A06AG01 | Sodiumphosphate |
| ATC:A06AG02 | Bisacodyl |
| ATC:A06AG03 | Dantron,includingcombinations |
| ATC:A06AG04 | Glycerol |
| ATC:A06AG06 | Oil |
| ATC:A06AG07 | Sorbitol |
| ATC:A06AG10 | Docusatesodium,includingcombinations |
| ATC:A06AG11 | Laurilsulfate,includingcombinations |
| ATC:A06AG20 | Combinations |
| ATC:A06AH | Peripheral opioid receptor antagonists |
| ATC:A06AH01 | Methylnaltrexonebromide |
| ATC:A06AH02 | Alvimopan |
| ATC:A06AH03 | Naloxegol |
| ATC:A06AX | Other drugs for constipation |
| ATC:A06AX01 | Glycerol |
| ATC:A06AX02 | Carbondioxideproducingdrugs |
| ATC:A06AX03 | Lubiprostone |
| ATC:A06AX04 | Linaclotide |
| ATC:A06AX05 | Prucalopride |
| ATC:A06AX06 | Tegaserod |
| ATC:A06AX07 | Plecanatide |
| ATC:A07 | Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| ATC:A07A | Intestinal anti-infectives |
| ATC:A07AA | Antibiotics |
| ATC:A07AA01 | Neomycin |
| ATC:A07AA02 | Nystatin |
| ATC:A07AA03 | Natamycin |
| ATC:A07AA04 | Streptomycin |
| ATC:A07AA05 | PolymyxinB |
| ATC:A07AA06 | Paromomycin |
| ATC:A07AA07 | AmphotericinB |
| ATC:A07AA08 | Kanamycin |
| ATC:A07AA09 | Vancomycin |
| ATC:A07AA10 | Colistin |
| ATC:A07AA11 | Rifaximin |
| ATC:A07AA12 | Fidaxomicin |
| ATC:A07AA51 | Neomycin,combinations |
| ATC:A07AA54 | Streptomycin,combinations |
| ATC:A07AB | Sulfonamides |
| ATC:A07AB02 | Phthalylsulfathiazole |
| ATC:A07AB03 | Sulfaguanidine |
| ATC:A07AB04 | Succinylsulfathiazole |
| ATC:A07AC | Imidazolederivatives |
| ATC:A07AC01 | Miconazole |
| ATC:A07AX | Otherintestinalanti-infectives |
| ATC:A07AX01 | Broxyquinoline |
| ATC:A07AX02 | Acetarsol |
| ATC:A07AX03 | Nifuroxazide |
| ATC:A07AX04 | Nifurzide |
| ATC:A07B | Intestinal adsorbents |
| ATC:A07BA | Charcoalpreparations |
| ATC:A07BA01 | Medicinalcharcoal |
| ATC:A07BA51 | Medicinalcharcoal,combinations |
| ATC:A07BC | Otherintestinaladsorbents |
| ATC:A07BC01 | Pectin |
| ATC:A07BC02 | Kaolin |
| ATC:A07BC03 | Crospovidone |
| ATC:A07BC04 | Attapulgite |
| ATC:A07BC05 | Diosmectite |
| ATC:A07BC30 | Combinations |
| ATC:A07BC54 | Attapulgite,combinations |
| ATC:A07C | Electrolytes with carbohydrates |
| ATC:A07CA | Oralrehydrationsaltformulations |
| ATC:A07DA | Antipropulsives |
| ATC:A07DA01 | Diphenoxylate |
| ATC:A07DA02 | Opium |
| ATC:A07DA03 | Loperamide |
| ATC:A07DA04 | Difenoxin |
| ATC:A07DA05 | Loperamideoxide |
| ATC:A07DA06 | Eluxadoline |
| ATC:A07DA52 | Morphine,combinations |
| ATC:A07DA53 | Loperamide,combinations |
| ATC:A07E | Intestinal anti-inflammatory agents |
| ATC:A07EA | Corticosteroidsactinglocally |
| ATC:A07EA01 | Prednisolone |
| ATC:A07EA02 | Hydrocortisone |
| ATC:A07EA03 | Prednisone |
| ATC:A07EA04 | Betamethasone |
| ATC:A07EA05 | Tixocortol |
| ATC:A07EA06 | Budesonide |
| ATC:A07EA07 | Beclometasone |
| ATC:A07EB | Antiallergicagents,excludingcorticosteroids |
| ATC:A07EB01 | Cromoglicicacid |
| ATC:A07EC | Aminosalicylicacidandsimilaragents |
| ATC:A07EC01 | Sulfasalazine |
| ATC:A07EC02 | Mesalazine |
| ATC:A07EC03 | Olsalazine |
| ATC:A07EC04 | Balsalazide |
| ATC:A07FA | Antidiarrheal micro-organisms |
| ATC:A07FA01 | Lacticacidproducingorganisms |
| ATC:A07FA02 | Saccharomycesboulardii |
| ATC:A07FA51 | Lacticacidproducingorganisms,combinations |
| ATC:A07XA | Other antidiarrheals |
| ATC:A07XA01 | Albumintannate |
| ATC:A07XA02 | Ceratonia |
| ATC:A07XA03 | Calciumcompounds |
| ATC:A07XA04 | Racecadotril |
| ATC:A07XA51 | Albumintannate,combinations |
| ATC:A08 | Antiobesity preparations, excluding diet products |
| ATC:A08A | Anti obesity drugs list, excluding diet products |
| ATC:A08AA | Centrallyactingantiobesitydrugs |
| ATC:A08AA01 | Phentermine |
| ATC:A08AA02 | Fenfluramine |
| ATC:A08AA03 | Amfepramone |
| ATC:A08AA04 | Dexfenfluramine |
| ATC:A08AA05 | Mazindol |
| ATC:A08AA06 | Etilamfetamine |
| ATC:A08AA07 | Cathine |
| ATC:A08AA08 | Clobenzorex |
| ATC:A08AA09 | Mefenorex |
| ATC:A08AA10 | Sibutramine |
| ATC:A08AA11 | Lorcaserin |
| ATC:A08AA56 | Ephedrine,combinations |
| ATC:A08AA62 | Bupropionandnaltrexone |
| ATC:A08AB | Peripherallyactingantiobesitydrugs |
| ATC:A08AB01 | Orlistat |
| ATC:A08AX | Otherantiobesitydrugs |
| ATC:A08AX01 | Rimonabant |
| ATC:A09A | Digestives, including enzymes |
| ATC:A09AA | Enzyme preparations |
| ATC:A09AA01 | Diastase |
| ATC:A09AA02 | Multienzymes(lipase,protease,etc.) |
| ATC:A09AA03 | Pepsin |
| ATC:A09AA04 | Tilactase |
| ATC:A09AB | Acid preparations |
| ATC:A09AB01 | Glutamicacidhydrochloride |
| ATC:A09AB02 | Betainehydrochloride |
| ATC:A09AB03 | Hydrochloricacid |
| ATC:A09AB04 | Citricacid |
| ATC:A09AC | Enzyme and acid preparations, combinations |
| ATC:A09AC01 | Pepsinandacidpreparations |
| ATC:A09AC02 | Multienzymesandacidpreparations |
| ATC:A10 | Drugs used in diabetes |
| ATC:A10A | Insulins and analogues |
| ATC:A10AB | Insulinsandanaloguesforinjection,fast-acting |
| ATC:A10AB01 | Insulin(human) |
| ATC:A10AB02 | Insulin(beef) |
| ATC:A10AB03 | Insulin(pork) |
| ATC:A10AB04 | Insulinlispro |
| ATC:A10AB05 | Insulinaspart |
| ATC:A10AB06 | Insulinglulisine |
| ATC:A10AB30 | Combinations |
| ATC:A10AC | Insulinsandanaloguesforinjection,intermediate-acting |
| ATC:A10AC01 | Insulin(human) |
| ATC:A10AC02 | Insulin(beef) |
| ATC:A10AC03 | Insulin(pork) |
| ATC:A10AC04 | Insulinlispro |
| ATC:A10AC30 | Combinations |
| ATC:A10AD | Insulinsandanaloguesforinjection,intermediate-orlong-actingcombinedwithfast-acting |
| ATC:A10AD01 | Insulin(human) |
| ATC:A10AD02 | Insulin(beef) |
| ATC:A10AD03 | Insulin(pork) |
| ATC:A10AD04 | Insulinlispro |
| ATC:A10AD05 | Insulinaspart |
| ATC:A10AD06 | Insulindegludecandinsulinaspart |
| ATC:A10AD30 | Combinations |
| ATC:A10AE | Insulinsandanaloguesforinjection,long-acting |
| ATC:A10AE01 | Insulin(human) |
| ATC:A10AE02 | Insulin(beef) |
| ATC:A10AE03 | Insulin(pork) |
| ATC:A10AE04 | Insulinglargine |
| ATC:A10AE05 | Insulindetemir |
| ATC:A10AE06 | Insulindegludec |
| ATC:A10AE30 | Combinations |
| ATC:A10AE54 | Insulinglargineandlixisenatide |
| ATC:A10AE56 | Insulindegludecandliraglutide |
| ATC:A10AF | Insulinsandanaloguesforinhalation |
| ATC:A10AF01 | Insulin(human) |
| ATC:A10B | Blood glucose lowering drugs, excluding insulins |
| ATC:A10BA | Biguanides |
| ATC:A10BA01 | Phenformin |
| ATC:A10BA02 | Metformin |
| ATC:A10BA03 | Buformin |
| ATC:A10BB | Sulfonylureas |
| ATC:A10BB01 | Glibenclamide |
| ATC:A10BB02 | Chlorpropamide |
| ATC:A10BB03 | Tolbutamide |
| ATC:A10BB04 | Glibornuride |
| ATC:A10BB05 | Tolazamide |
| ATC:A10BB06 | Carbutamide |
| ATC:A10BB07 | Glipizide |
| ATC:A10BB08 | Gliquidone |
| ATC:A10BB09 | Gliclazide |
| ATC:A10BB10 | Metahexamide |
| ATC:A10BB11 | Glisoxepide |
| ATC:A10BB12 | Glimepiride |
| ATC:A10BB31 | Acetohexamide |
| ATC:A10BC | Sulfonamides(heterocyclic) |
| ATC:A10BC01 | Glymidine |
| ATC:A10BD | Combinationsoforalbloodglucoseloweringdrugs |
| ATC:A10BD01 | Phenforminandsulfonamides |
| ATC:A10BD02 | Metforminandsulfonamides |
| ATC:A10BD03 | Metforminandrosiglitazone |
| ATC:A10BD04 | Glimepirideandrosiglitazone |
| ATC:A10BD05 | Metforminandpioglitazone |
| ATC:A10BD06 | Glimepirideandpioglitazone |
| ATC:A10BD07 | Metforminandsitagliptin |
| ATC:A10BD08 | Metforminandvildagliptin |
| ATC:A10BD09 | Pioglitazoneandalogliptin |
| ATC:A10BD10 | Metforminandsaxagliptin |
| ATC:A10BD11 | Metforminandlinagliptin |
| ATC:A10BD12 | Pioglitazoneandsitagliptin |
| ATC:A10BD13 | Metforminandalogliptin |
| ATC:A10BD14 | Metforminandrepaglinide |
| ATC:A10BD15 | Metforminanddapagliflozin |
| ATC:A10BD16 | Metforminandcanagliflozin |
| ATC:A10BD17 | Metforminandacarbose |
| ATC:A10BD18 | Metforminandgemigliptin |
| ATC:A10BD19 | Linagliptinandempagliflozin |
| ATC:A10BD20 | Metforminandempagliflozin |
| ATC:A10BD21 | Saxagliptinanddapagliflozin |
| ATC:A10BD22 | Metforminandevogliptin |
| ATC:A10BF | Alphaglucosidaseinhibitors |
| ATC:A10BF01 | Acarbose |
| ATC:A10BF02 | Miglitol |
| ATC:A10BF03 | Voglibose |
| ATC:A10BG | Thiazolidinediones |
| ATC:A10BG01 | Troglitazone |
| ATC:A10BG02 | Rosiglitazone |
| ATC:A10BG03 | Pioglitazone |
| ATC:A10BH | Dipeptidylpeptidase4(DPP-4)inhibitors |
| ATC:A10BH01 | Sitagliptin |
| ATC:A10BH02 | Vildagliptin |
| ATC:A10BH03 | Saxagliptin |
| ATC:A10BH04 | Alogliptin |
| ATC:A10BH05 | Linagliptin |
| ATC:A10BH06 | Gemigliptin |
| ATC:A10BH07 | Evogliptin |
| ATC:A10BH51 | Sitagliptinandsimvastatin |
| ATC:A10BJ | Glucagon-likepeptide-1receptor(GLP-1)analogues |
| ATC:A10BJ01 | Exenatide |
| ATC:A10BJ02 | Liraglutide |
| ATC:A10BJ03 | Lixisenatide |
| ATC:A10BJ04 | Albiglutide |
| ATC:A10BJ05 | Dulaglutide |
| ATC:A10BJ06 | Semaglutide |
| ATC:A10BK | Sodium-glucoseco-transporter2(SGLT2)inhibitors |
| ATC:A10BX | Otherbloodglucoseloweringdrugs,excludinginsulins |
| ATC:A10BX01 | Guargum |
| ATC:A10BX02 | Repaglinide |
| ATC:A10BX03 | Nateglinide |
| ATC:A10BX05 | Pramlintide |
| ATC:A10BX06 | Benfluorex |
| ATC:A10BX08 | Mitiglinide |
| ATC:A10BX09 | Dapagliflozin |
| ATC:A10BX11 | Canagliflozin |
| ATC:A10BX12 | Empagliflozin |
| ATC:A10X | Other drugs used in diabetes |
| ATC:A10XA | Aldosereductaseinhibitors |
| ATC:A10XA01 | Tolrestat |
| ATC:A11 | Vitamins |
| ATC:A11A | Multivitamins, combinations |
| ATC:A11AA | Multivitaminswithminerals |
| ATC:A11AA01 | Multivitaminsandiron |
| ATC:A11AA02 | Multivitaminsandcalcium |
| ATC:A11AA03 | Multivitaminsandotherminerals,includingcombinations |
| ATC:A11AA04 | Multivitaminsandtraceelements |
| ATC:A11AB | Multivitamins,othercombinations |
| ATC:A11B | Multivitamins,plain |
| ATC:A11C | Vitamin A and D, including combinations of the two |
| ATC:A11CA | VitaminA,plain |
| ATC:A11CA01 | Retinol(vitaminA) |
| ATC:A11CA02 | Betacarotene |
| ATC:A11CB | VitaminAandDincombination |
| ATC:A11CC | VitaminDandanalogues |
| ATC:A11CC01 | Ergocalciferol |
| ATC:A11CC02 | Dihydrotachysterol |
| ATC:A11CC03 | Alfacalcidol |
| ATC:A11CC04 | Calcitriol |
| ATC:A11CC05 | Colecalciferol |
| ATC:A11CC06 | Calcifediol |
| ATC:A11CC20 | Combinations |
| ATC:A11CC55 | Colecalciferol,combinations |
| ATC:A11D | Vitamin B1, plain and in combination with vitamin B6 and B12 |
| ATC:A11DA | VitaminB1,plain |
| ATC:A11DA01 | Thiamine(vitaminB1) |
| ATC:A11DA02 | Sulbutiamine |
| ATC:A11DA03 | Benfotiamine |
| ATC:A11DB | VitaminB1incombinationwithvitaminB6and/orvitaminB12 |
| ATC:A11E | Vitamin B-complex, including combinations |
| ATC:A11EA | VitaminB-complex,plain |
| ATC:A11EB | VitaminB-complexwithvitaminC |
| ATC:A11EC | VitaminB-complexwithminerals |
| ATC:A11ED | VitaminB-complexwithanabolicsteroids |
| ATC:A11EX | VitaminB-complex,othercombinations |
| ATC:A11G | Ascorbic acid (vitamin C), including combinations |
| ATC:A11GA | Ascorbicacid(vitaminC),plain |
| ATC:A11GA01 | Ascorbicacid(vitaminC) |
| ATC:A11GB | Ascorbicacid(vitaminC),combinations |
| ATC:A11GB01 | Ascorbicacid(vitaminC)andcalcium |
| ATC:A11HA | Other plain vitamin preparations |
| ATC:A11HA01 | Nicotinamide |
| ATC:A11HA02 | Pyridoxine(vitaminB6) |
| ATC:A11HA03 | Tocopherol(vitaminE) |
| ATC:A11HA04 | Riboflavin(vitaminB2) |
| ATC:A11HA05 | Biotin |
| ATC:A11HA06 | Pyridoxalphosphate |
| ATC:A11HA07 | Inositol |
| ATC:A11HA08 | Tocofersolan |
| ATC:A11HA30 | Dexpanthenol |
| ATC:A11HA31 | Calciumpantothenate |
| ATC:A11HA32 | Pantethine |
| ATC:A11J | Other vitamin products, combinations |
| ATC:A11JA | Combinationsofvitamins |
| ATC:A11JB | Vitaminswithminerals |
| ATC:A11JC | Vitamins,othercombinations |
| ATC:A12 | Mineral supplements |
| ATC:A12A | Calcium |
| ATC:A12AA | Calcium |
| ATC:A12AA01 | Calciumphosphate |
| ATC:A12AA02 | Calciumglubionate |
| ATC:A12AA03 | Calciumgluconate |
| ATC:A12AA04 | Calciumcarbonate |
| ATC:A12AA05 | Calciumlactate |
| ATC:A12AA06 | Calciumlactategluconate |
| ATC:A12AA07 | Calciumchloride |
| ATC:A12AA08 | Calciumglycerylphosphate |
| ATC:A12AA09 | Calciumcitratelysinecomplex |
| ATC:A12AA10 | Calciumglucoheptonate |
| ATC:A12AA11 | Calciumpangamate |
| ATC:A12AA12 | Calciumacetateanhydrous |
| ATC:A12AA13 | Calciumcitrate |
| ATC:A12AA20 | Calcium(differentsaltsincombination) |
| ATC:A12AA30 | Calciumlaevulate |
| ATC:A12AX | Calcium,combinationswithvitaminDand/orotherdrugs |
| ATC:A12BA | Potassium |
| ATC:A12BA01 | Potassiumchloride |
| ATC:A12BA02 | Potassiumcitrate |
| ATC:A12BA03 | Potassiumhydrogentartrate |
| ATC:A12BA04 | Potassiumhydrogencarbonate |
| ATC:A12BA05 | Potassiumgluconate |
| ATC:A12BA30 | Combinations |
| ATC:A12BA51 | Potassiumchloride,combinations |
| ATC:A12C | Other mineral supplements |
| ATC:A12CA | Sodium |
| ATC:A12CA01 | Sodiumchloride |
| ATC:A12CA02 | Sodiumsulfate |
| ATC:A12CB | Zinc |
| ATC:A12CB01 | Zincsulfate |
| ATC:A12CB02 | Zincgluconate |
| ATC:A12CB03 | Zincproteincomplex |
| ATC:A12CC | Magnesium |
| ATC:A12CC01 | Magnesiumchloride |
| ATC:A12CC02 | Magnesiumsulfate |
| ATC:A12CC03 | Magnesiumgluconate |
| ATC:A12CC04 | Magnesiumcitrate |
| ATC:A12CC05 | Magnesiumaspartate |
| ATC:A12CC06 | Magnesiumlactate |
| ATC:A12CC07 | Magnesiumlevulinate |
| ATC:A12CC08 | Magnesiumpidolate |
| ATC:A12CC09 | Magnesiumorotate |
| ATC:A12CC10 | Magnesiumoxide |
| ATC:A12CC30 | Magnesium(differentsaltsincombination) |
| ATC:A12CD | Fluoride |
| ATC:A12CD01 | Sodiumfluoride |
| ATC:A12CD02 | Sodiummonofluorophosphate |
| ATC:A12CD51 | Fluoride,combinations |
| ATC:A12CE | Selenium |
| ATC:A12CE01 | Sodiumselenate |
| ATC:A12CE02 | Sodiumselenite |
| ATC:A12CX | Othermineralproducts |
| ATC:A13 | Tonics |
| ATC:A14 | Anabolic agents for systemic use |
| ATC:A14A | Anabolic steroids |
| ATC:A14AA | Androstanderivatives |
| ATC:A14AA01 | Androstanolone(Dihydrotestosterone) |
| ATC:A14AA02 | Stanozolol |
| ATC:A14AA03 | Methandrostenolone |
| ATC:A14AA04 | Metenolone |
| ATC:A14AA05 | Oxymetholone |
| ATC:A14AA06 | Quinbolone |
| ATC:A14AA07 | Dehydroepiandrosterone(Prasterone) |
| ATC:A14AA08 | Oxandrolone |
| ATC:A14AA09 | Norethandrolone |
| ATC:A14AB | Estrenderivatives |
| ATC:A14AB01 | Nandrolone |
| ATC:A14AB02 | Ethylestrenol |
| ATC:A14AB03 | Oxabolonecipionate |
| ATC:A14B | Otheranabolicagents |
| ATC:A15 | Appetitestimulants |
| ATC:A16A | Other alimentary tract and metabolism products |
| ATC:A16AA | Amino acids and derivatives |
| ATC:A16AA01 | Levocarnitine |
| ATC:A16AA02 | Ademetionine |
| ATC:A16AA03 | Levoglutamide |
| ATC:A16AA04 | Mercaptamine |
| ATC:A16AA05 | Carglumicacid |
| ATC:A16AA06 | Betaine |
| ATC:A16AA07 | Metreleptin |
| ATC:A16AB | Enzymes |
| ATC:A16AB01 | Alglucerase |
| ATC:A16AB02 | Imiglucerase |
| ATC:A16AB03 | Agalsidasealfa |
| ATC:A16AB04 | Agalsidasebeta |
| ATC:A16AB05 | Laronidase |
| ATC:A16AB06 | Sacrosidase |
| ATC:A16AB07 | Alglucosidasealfa |
| ATC:A16AB08 | Galsulfase |
| ATC:A16AB09 | Idursulfase |
| ATC:A16AB10 | Velaglucerasealfa |
| ATC:A16AB11 | Taliglucerasealfa |
| ATC:A16AB12 | Elosulfasealfa |
| ATC:A16AB13 | Asfotasealfa |
| ATC:A16AB14 | Sebelipasealfa |
| ATC:A16AB15 | Velmanasealfa |
| ATC:A16AB16 | Idursulfasebeta |
| ATC:A16AB17 | Cerliponasealfa |
| ATC:A16AB18 | Vestronidasealfa |
| ATC:A16AX | Various alimentary tract and metabolism products |
| ATC:A16AX01 | Thiocticacid |
| ATC:A16AX02 | Anetholetrithione |
| ATC:A16AX03 | Sodiumphenylbutyrate |
| ATC:A16AX04 | Nitisinone |
| ATC:A16AX05 | Zincacetate |
| ATC:A16AX06 | Miglustat |
| ATC:A16AX07 | Sapropterin |
| ATC:A16AX08 | Teduglutide |
| ATC:A16AX09 | Glycerolphenylbutyrate |
| ATC:A16AX10 | Eliglustat |
| ATC:A16AX11 | Sodiumbenzoate |
| ATC:A16AX12 | Trientine |
| ATC:A16AX13 | Uridinetriacetate |
| ATC:A16AX14 | Migalastat |
| ATC:B01A | Antithrombotic agents |
| ATC:B01AA | Vitamin K antagonists |
| ATC:B01AA01 | Dicoumarol |
| ATC:B01AA02 | Phenindione |
| ATC:B01AA03 | Warfarin |
| ATC:B01AA04 | Phenprocoumon |
| ATC:B01AA07 | Acenocoumarol |
| ATC:B01AA08 | Ethylbiscoumacetate |
| ATC:B01AA09 | Clorindione |
| ATC:B01AA10 | Diphenadione |
| ATC:B01AA11 | Tioclomarol |
| ATC:B01AA12 | Fluindione |
| ATC:B01AB | Heparin group |
| ATC:B01AB01 | Heparin |
| ATC:B01AB02 | AntithrombinIII |
| ATC:B01AB04 | Dalteparin |
| ATC:B01AB05 | Enoxaparin |
| ATC:B01AB06 | Nadroparin |
| ATC:B01AB07 | Parnaparin |
| ATC:B01AB08 | Reviparin |
| ATC:B01AB09 | Danaparoid |
| ATC:B01AB10 | Tinzaparin |
| ATC:B01AB11 | Sulodexide |
| ATC:B01AB12 | Bemiparin |
| ATC:B01AB51 | Heparin,combinations |
| ATC:B01AC | Platelet aggregation inhibitors excluding heparin |
| ATC:B01AC01 | Ditazole |
| ATC:B01AC02 | Cloricromen |
| ATC:B01AC03 | Picotamide |
| ATC:B01AC04 | Clopidogrel |
| ATC:B01AC05 | Ticlopidine |
| ATC:B01AC06 | Acetylsalicylicacid |
| ATC:B01AC07 | Dipyridamole |
| ATC:B01AC08 | Carbasalatecalcium |
| ATC:B01AC09 | Epoprostenol |
| ATC:B01AC10 | Indobufen |
| ATC:B01AC11 | Iloprost |
| ATC:B01AC13 | Abciximab |
| ATC:B01AC15 | Aloxiprin |
| ATC:B01AC16 | Eptifibatide |
| ATC:B01AC17 | Tirofiban |
| ATC:B01AC18 | Triflusal |
| ATC:B01AC19 | Beraprost |
| ATC:B01AC21 | Treprostinil |
| ATC:B01AC22 | Prasugrel |
| ATC:B01AC23 | Cilostazol |
| ATC:B01AC24 | Ticagrelor |
| ATC:B01AC25 | Cangrelor |
| ATC:B01AC26 | Vorapaxar |
| ATC:B01AC27 | Selexipag |
| ATC:B01AC30 | Combinations |
| ATC:B01AC56 | Acetylsalicylicacid,combinationswithprotonpumpinhibitors |
| ATC:B01AD | Enzymes |
| ATC:B01AD01 | Streptokinase |
| ATC:B01AD02 | Alteplase |
| ATC:B01AD03 | Anistreplase |
| ATC:B01AD04 | Urokinase |
| ATC:B01AD05 | Fibrinolysin |
| ATC:B01AD06 | Brinase |
| ATC:B01AD07 | Reteplase |
| ATC:B01AD08 | Saruplase |
| ATC:B01AD09 | Ancrod |
| ATC:B01AD10 | Drotrecoginalfa(activated) |
| ATC:B01AD11 | Tenecteplase |
| ATC:B01AD12 | ProteinC |
| ATC:B01AE | Direct thrombin inhibitors |
| ATC:B01AE01 | Desirudin |
| ATC:B01AE02 | Lepirudin |
| ATC:B01AE03 | Argatroban |
| ATC:B01AE04 | Melagatran |
| ATC:B01AE05 | Ximelagatran |
| ATC:B01AE06 | Bivalirudin |
| ATC:B01AE07 | Dabigatranetexilate |
| ATC:B01AF | Direct factor Xa inhibitors |
| ATC:B01AF01 | Rivaroxaban |
| ATC:B01AF02 | Apixaban |
| ATC:B01AF03 | Edoxaban |
| ATC:B01AX | Other antithrombotic agents |
| ATC:B01AX01 | Defibrotide |
| ATC:B01AX04 | Dermatansulfate |
| ATC:B01AX05 | Fondaparinux |
| ATC:B02 | Antihemorrhagic drugs |
| ATC:B02A | Antifibrinolytics |
| ATC:B02AA | Aminoacids |
| ATC:B02AA01 | Aminocaproicacid |
| ATC:B02AA02 | Tranexamicacid |
| ATC:B02AA03 | Aminomethylbenzoicacid |
| ATC:B02AB | Proteinaseinhibitors |
| ATC:B02AB01 | Aprotinin |
| ATC:B02AB02 | Alfa1antitrypsin |
| ATC:B02AB04 | Camostat |
| ATC:B02B | Vitamin K and other hemostatics |
| ATC:B02BA | VitaminK |
| ATC:B02BA01 | Phytomenadione |
| ATC:B02BA02 | Menadione |
| ATC:B02BB | Fibrinogen |
| ATC:B02BB01 | Humanfibrinogen |
| ATC:B02BC | Localhemostatics |
| ATC:B02BC01 | Absorbablegelatinsponge |
| ATC:B02BC02 | Oxidizedcellulose |
| ATC:B02BC03 | Tetragalacturonicacidhydroxymethylester |
| ATC:B02BC05 | Adrenalone |
| ATC:B02BC06 | Thrombin |
| ATC:B02BC07 | Collagen |
| ATC:B02BC08 | Calciumalginate |
| ATC:B02BC09 | Epinephrine |
| ATC:B02BC30 | Combinations |
| ATC:B02BD | Bloodcoagulationfactors |
| ATC:B02BD01 | CoagulationfactorIX,II,VIIandXincombination(Prothrombincomplexconcentrate) |
| ATC:B02BD02 | CoagulationfactorVIII |
| ATC:B02BD03 | FactorVIIIinhibitorbypassingactivity |
| ATC:B02BD04 | CoagulationfactorIX |
| ATC:B02BD05 | CoagulationfactorVII |
| ATC:B02BD06 | VonWillebrandfactorandcoagulationfactorVIIIincombination |
| ATC:B02BD07 | CoagulationfactorXIII |
| ATC:B02BD08 | Eptacogalfa(activated) |
| ATC:B02BD09 | Nonacogalfa |
| ATC:B02BD10 | vonWillebrandfactor |
| ATC:B02BD11 | Catridecacog |
| ATC:B02BD12 | Trenonacogalfa |
| ATC:B02BD13 | CoagulationfactorX |
| ATC:B02BD14 | Susoctocogalfa |
| ATC:B02BD30 | Thrombin |
| ATC:B02BX | Othersystemichemostatics |
| ATC:B02BX01 | Etamsylate |
| ATC:B02BX02 | Carbazochrome |
| ATC:B02BX03 | Batroxobin |
| ATC:B02BX04 | Romiplostim |
| ATC:B02BX05 | Eltrombopag |
| ATC:B03 | Antianemic drugs |
| ATC:B03A | Iron preparations |
| ATC:B03AA | Ironbivalent,oralpreparations |
| ATC:B03AA01 | Ferrousglycinesulfate |
| ATC:B03AA02 | Ferrousfumarate |
| ATC:B03AA03 | Ferrousgluconate |
| ATC:B03AA04 | Ferrouscarbonate |
| ATC:B03AA05 | Ferrouschloride |
| ATC:B03AA06 | Ferroussuccinate |
| ATC:B03AA07 | Ferroussulfate |
| ATC:B03AA08 | Ferroustartrate |
| ATC:B03AA09 | Ferrousaspartate |
| ATC:B03AA10 | Ferrousascorbate |
| ATC:B03AA11 | Ferrousiodine |
| ATC:B03AB | Irontrivalent,oralpreparations |
| ATC:B03AB01 | Ferricsodiumcitrate |
| ATC:B03AB02 | Saccharatedironoxide |
| ATC:B03AB03 | Sodiumferedetate |
| ATC:B03AB04 | Ferrichydroxide |
| ATC:B03AB05 | Ferricoxidepolymaltosecomplexes |
| ATC:B03AB06 | Ferriccitrate |
| ATC:B03AB07 | Chondroitinsulfate-ironcomplex |
| ATC:B03AB08 | Ferricacetyltransferrin |
| ATC:B03AB09 | Ferricproteinsuccinylate |
| ATC:B03AB10 | Ferricmaltol |
| ATC:B03AD | Ironincombinationwithfolicacid |
| ATC:B03AD01 | Ferrousaminoacidcomplex |
| ATC:B03AD02 | Ferrousfumarate |
| ATC:B03AD03 | Ferroussulfate |
| ATC:B03AD04 | Ferricoxidepolymaltosecomplexes |
| ATC:B03AE | Ironinothercombinations |
| ATC:B03AE01 | Iron,vitaminB12andfolicacid |
| ATC:B03AE02 | Iron,multivitaminsandfolicacid |
| ATC:B03AE03 | Ironandmultivitamins |
| ATC:B03AE04 | Iron,multivitaminsandminerals |
| ATC:B03AE10 | Variouscombinations |
| ATC:B03B | Vitamin B12 and folic acid |
| ATC:B03BA | VitaminB12(cyanocobalaminandanalogues) |
| ATC:B03BA01 | Cyanocobalamin |
| ATC:B03BA02 | Cyanocobalamintannincomplex |
| ATC:B03BA03 | Hydroxocobalamin |
| ATC:B03BA04 | Cobamamide |
| ATC:B03BA05 | Mecobalamin |
| ATC:B03BA51 | Cyanocobalamin,combinations |
| ATC:B03BA53 | Hydroxocobalamin,combinations |
| ATC:B03BB | Folicacidandderivatives |
| ATC:B03BB01 | Folicacid |
| ATC:B03BB51 | Folicacid,combinations |
| ATC:B03XA | Other antianemic preparations |
| ATC:B03XA01 | Erythropoietin |
| ATC:B03XA02 | Darbepoetinalfa |
| ATC:B03XA03 | Methoxypolyethyleneglycol-epoetinbeta |
| ATC:B03XA04 | Peginesatide |
| ATC:B05 | Blood substitutes and perfusion solutions |
| ATC:B05A | Blood and related products |
| ATC:B05AA | Bloodsubstitutesandplasmaproteinfractions |
| ATC:B05AA01 | Serumalbumin |
| ATC:B05AA02 | Otherplasmaproteinfractions |
| ATC:B05AA03 | Fluorocarbonbloodsubstitutes |
| ATC:B05AA05 | Dextran |
| ATC:B05AA06 | Gelatinagents |
| ATC:B05AA07 | Hydroxyethylstarch |
| ATC:B05AA08 | Hemoglobincrosfumaril |
| ATC:B05AA09 | Hemoglobinraffimer |
| ATC:B05AA10 | Hemoglobinglutamer(bovine) |
| ATC:B05AX | Otherbloodproducts |
| ATC:B05AX01 | Erythrocytes |
| ATC:B05AX02 | Thrombocytes |
| ATC:B05AX03 | Bloodplasma |
| ATC:B05AX04 | Stemcellsfromumbilicalcordblood |
| ATC:B05B | I.V. solutions |
| ATC:B05BA | Solutionsforparenteralnutrition |
| ATC:B05BA01 | Aminoacids |
| ATC:B05BA02 | Fatemulsions |
| ATC:B05BA03 | Carbohydrates |
| ATC:B05BA04 | Proteinhydrolysates |
| ATC:B05BA10 | Combinations |
| ATC:B05BB | Solutionsaffectingtheelectrolytebalance |
| ATC:B05BB01 | Electrolytes |
| ATC:B05BB02 | Electrolyteswithcarbohydrates |
| ATC:B05BB03 | Trometamol |
| ATC:B05BB04 | Electrolytesincombinationwithotherdrugs |
| ATC:B05BC | Solutionsproducingosmoticdiuresis |
| ATC:B05BC01 | Mannitol |
| ATC:B05BC02 | Carbamide |
| ATC:B05C | Irrigating solutions |
| ATC:B05CA | Antiinfectives |
| ATC:B05CA01 | Cetylpyridinium |
| ATC:B05CA02 | Chlorhexidine |
| ATC:B05CA03 | Nitrofural |
| ATC:B05CA04 | Sulfamethizole |
| ATC:B05CA05 | Taurolidine |
| ATC:B05CA06 | Mandelicacid |
| ATC:B05CA07 | Noxytiolin |
| ATC:B05CA08 | Ethacridinelactate |
| ATC:B05CA09 | Neomycin |
| ATC:B05CA10 | Combinations |
| ATC:B05CB | Saltsolutions |
| ATC:B05CB01 | Sodiumchloride |
| ATC:B05CB02 | Sodiumcitrate |
| ATC:B05CB03 | Magnesiumcitrate |
| ATC:B05CB04 | Sodiumbicarbonate |
| ATC:B05CB10 | Combinations |
| ATC:B05CX | Otherirrigatingsolutions |
| ATC:B05CX01 | Glucose |
| ATC:B05CX02 | Sorbitol |
| ATC:B05CX03 | Glycine |
| ATC:B05CX04 | Mannitol |
| ATC:B05CX10 | Combinations |
| ATC:B05X | I.V. solution additives |
| ATC:B05XA | Electrolytesolutions |
| ATC:B05XA01 | Potassiumchloride |
| ATC:B05XA02 | Sodiumbicarbonate |
| ATC:B05XA03 | Sodiumchloride |
| ATC:B05XA04 | Ammoniumchloride |
| ATC:B05XA05 | Magnesiumsulfate |
| ATC:B05XA06 | Potassiumphosphate,includingcombinationswithotherpotassiumsalts |
| ATC:B05XA07 | Calciumchloride |
| ATC:B05XA08 | Sodiumacetate |
| ATC:B05XA09 | Sodiumphosphate |
| ATC:B05XA10 | Magnesiumphosphate |
| ATC:B05XA11 | Magnesiumchloride |
| ATC:B05XA12 | Zincchloride |
| ATC:B05XA13 | Hydrochloricacid |
| ATC:B05XA14 | Sodiumglycerophosphate |
| ATC:B05XA15 | Potassiumlactate |
| ATC:B05XA16 | Cardioplegiasolutions |
| ATC:B05XA17 | Potassiumacetate |
| ATC:B05XA30 | Combinationsofelectrolytes |
| ATC:B05XA31 | Electrolytesincombinationwithotherdrugs |
| ATC:B05XB | Aminoacids |
| ATC:B05XB01 | Argininehydrochloride |
| ATC:B05XB02 | Alanylglutamine |
| ATC:B05XB03 | Lysine |
| ATC:B05XX | Otheri.v.solutionadditives |
| ATC:B05XX02 | Trometamol |
| ATC:B06A | Other hematologic drugs |
| ATC:B06AA | Enzymes |
| ATC:B06AA02 | Fibrinolysinanddesoxyribonuclease |
| ATC:B06AA03 | Hyaluronidase |
| ATC:B06AA04 | Chymotrypsin |
| ATC:B06AA07 | Trypsin |
| ATC:B06AA10 | Desoxyribonuclease |
| ATC:B06AA55 | Streptokinase,combinations |
| ATC:B06AB | Other hematological products |
| ATC:B06AB01 | Hematin |
| ATC:B06AC | Drugs used in hereditary angioedema |
| ATC:B06AC01 | C1-inhibitor,plasmaderived |
| ATC:B06AC02 | Icatibant |
| ATC:B06AC03 | Ecallantide |
| ATC:B06AC04 | Conestatalfa |
| ATC:C01 | Cardiac therapy |
| ATC:C01A | Cardiac glycosides list |
| ATC:C01AA | Digitalisglycosides |
| ATC:C01AA01 | Acetyldigitoxin |
| ATC:C01AA02 | Acetyldigoxin |
| ATC:C01AA03 | Digitalisleaves |
| ATC:C01AA04 | Digitoxin |
| ATC:C01AA05 | Digoxin |
| ATC:C01AA06 | LanatosideC |
| ATC:C01AA07 | Deslanoside |
| ATC:C01AA08 | Metildigoxin |
| ATC:C01AA09 | Gitoformate |
| ATC:C01AA52 | Acetyldigoxin,combinations |
| ATC:C01AB | Scillaglycosides |
| ATC:C01AB01 | Proscillaridin |
| ATC:C01AB51 | Proscillaridin,combinations |
| ATC:C01AC | Strophantusglycosides |
| ATC:C01AC01 | G-strophanthin |
| ATC:C01AC03 | Cymarin |
| ATC:C01AX | Othercardiacglycosides |
| ATC:C01AX02 | Peruvoside |
| ATC:C01B | Class 1 and 3 antiarrhythmic drugs |
| ATC:C01BA | Class1aantiarrhythmicdrugs |
| ATC:C01BA01 | Quinidine |
| ATC:C01BA02 | Procainamide |
| ATC:C01BA03 | Disopyramide |
| ATC:C01BA04 | Sparteine |
| ATC:C01BA05 | Ajmaline |
| ATC:C01BA08 | Prajmaline |
| ATC:C01BA12 | Lorajmine |
| ATC:C01BA51 | Quinidine,combinationsexcludingpsycholeptics |
| ATC:C01BA71 | Quinidine,combinationswithpsycholeptics |
| ATC:C01BB | Class1bantiarrhythmicdrugs |
| ATC:C01BB01 | Lidocaine |
| ATC:C01BB02 | Mexiletine |
| ATC:C01BB03 | Tocainide |
| ATC:C01BB04 | Aprindine |
| ATC:C01BC | Class1cantiarrhythmicdrugs |
| ATC:C01BC03 | Propafenone |
| ATC:C01BC04 | Flecainide |
| ATC:C01BC07 | Lorcainide |
| ATC:C01BC08 | Encainide |
| ATC:C01BC09 | Ethacizine |
| ATC:C01BD | Class3antiarrhythmicdrugs |
| ATC:C01BD01 | Amiodarone |
| ATC:C01BD02 | Bretyliumtosilate |
| ATC:C01BD03 | Bunaftine |
| ATC:C01BD04 | Dofetilide |
| ATC:C01BD05 | Ibutilide |
| ATC:C01BD06 | Tedisamil |
| ATC:C01BD07 | Dronedarone |
| ATC:C01BG | Class1and3antiarrhythmicdrugs |
| ATC:C01BG01 | Moracizine |
| ATC:C01BG07 | Cibenzoline |
| ATC:C01BG11 | Vernakalant |
| ATC:C01C | Cardiac stimulants excluding cardiac glycosides |
| ATC:C01CA | Adrenergicanddopaminergicagents |
| ATC:C01CA01 | Etilefrine |
| ATC:C01CA02 | Isoprenaline |
| ATC:C01CA03 | Norepinephrine |
| ATC:C01CA04 | Dopamine |
| ATC:C01CA05 | Norfenefrine |
| ATC:C01CA06 | Phenylephrine |
| ATC:C01CA07 | Dobutamine |
| ATC:C01CA08 | Oxedrine |
| ATC:C01CA09 | Metaraminol |
| ATC:C01CA10 | Methoxamine |
| ATC:C01CA11 | Mephentermine |
| ATC:C01CA12 | Dimetofrine |
| ATC:C01CA13 | Prenalterol |
| ATC:C01CA14 | Dopexamine |
| ATC:C01CA15 | Gepefrine |
| ATC:C01CA16 | Ibopamine |
| ATC:C01CA17 | Midodrine |
| ATC:C01CA18 | Octopamine |
| ATC:C01CA19 | Fenoldopam |
| ATC:C01CA21 | Cafedrine |
| ATC:C01CA22 | Arbutamine |
| ATC:C01CA23 | Theodrenaline |
| ATC:C01CA24 | Epinephrine |
| ATC:C01CA25 | Ameziniummetilsulfate |
| ATC:C01CA26 | Ephedrine |
| ATC:C01CA27 | Droxidopa |
| ATC:C01CA30 | Combinations |
| ATC:C01CA51 | Etilefrine,combinations |
| ATC:C01CE | Phosphodiesteraseinhibitorsdrugs |
| ATC:C01CE01 | Amrinone |
| ATC:C01CE02 | Milrinone |
| ATC:C01CE03 | Enoximone |
| ATC:C01CE04 | Bucladesine |
| ATC:C01CX | Othercardiacstimulantsdrugs |
| ATC:C01CX06 | Angiotensinamide |
| ATC:C01CX07 | Xamoterol |
| ATC:C01CX08 | Levosimendan |
| ATC:C01D | Vasodilators used in cardiac diseases |
| ATC:C01DA | Organicnitrates |
| ATC:C01DA02 | Glyceryltrinitrate |
| ATC:C01DA04 | Methylpropylpropanedioldinitrate |
| ATC:C01DA05 | Pentaerithrityltetranitrate |
| ATC:C01DA07 | Propatylnitrate |
| ATC:C01DA08 | Isosorbidedinitrate |
| ATC:C01DA09 | Trolnitrate |
| ATC:C01DA13 | Eritrityltetranitrate |
| ATC:C01DA14 | Isosorbidemononitrate |
| ATC:C01DA20 | Organicnitratesincombination |
| ATC:C01DA38 | Tenitramine |
| ATC:C01DA52 | Glyceryltrinitrate,combinations |
| ATC:C01DA54 | Methylpropylpropanedioldinitrate,combinations |
| ATC:C01DA55 | Pentaerithrityltetranitrate,combinations |
| ATC:C01DA57 | Propatylnitrate,combinations |
| ATC:C01DA58 | Isosorbidedinitrate,combinations |
| ATC:C01DA59 | Trolnitrate,combinations |
| ATC:C01DA63 | Eritrityltetranitrate,combinations |
| ATC:C01DA70 | Organicnitratesincombinationwithpsycholeptics |
| ATC:C01DB | Quinolonevasodilators |
| ATC:C01DB01 | Flosequinan |
| ATC:C01DX | Othervasodilatorsusedincardiacdiseases |
| ATC:C01DX01 | Itramintosilate |
| ATC:C01DX02 | Prenylamine |
| ATC:C01DX03 | Oxyfedrine |
| ATC:C01DX04 | Benziodarone |
| ATC:C01DX05 | Carbocromen |
| ATC:C01DX06 | Hexobendine |
| ATC:C01DX07 | Etafenone |
| ATC:C01DX08 | Heptaminol |
| ATC:C01DX09 | Imolamine |
| ATC:C01DX10 | Dilazep |
| ATC:C01DX11 | Trapidil |
| ATC:C01DX12 | Molsidomine |
| ATC:C01DX13 | Efloxate |
| ATC:C01DX14 | Cinepazet |
| ATC:C01DX15 | Cloridarol |
| ATC:C01DX16 | Nicorandil |
| ATC:C01DX18 | Linsidomine |
| ATC:C01DX19 | Nesiritide |
| ATC:C01DX21 | Serelaxin |
| ATC:C01DX51 | Itramintosilate,combinations |
| ATC:C01DX52 | Prenylamine,combinations |
| ATC:C01DX53 | Oxyfedrine,combinations |
| ATC:C01DX54 | Benziodarone,combinations |
| ATC:C01E | Other cardiac preparations |
| ATC:C01EA | Prostaglandins |
| ATC:C01EA01 | Alprostadil |
| ATC:C01EB | Othercardiacpreparations |
| ATC:C01EB02 | Camphor |
| ATC:C01EB03 | Indometacin |
| ATC:C01EB04 | Crataegusglycosides |
| ATC:C01EB05 | Creatinolfosfate |
| ATC:C01EB06 | Fosfocreatine |
| ATC:C01EB07 | Fructose1,6-diphosphate |
| ATC:C01EB09 | Ubidecarenone |
| ATC:C01EB10 | Adenosine |
| ATC:C01EB11 | Tiracizine |
| ATC:C01EB13 | Acadesine |
| ATC:C01EB15 | Trimetazidine |
| ATC:C01EB16 | Ibuprofen |
| ATC:C01EB17 | Ivabradine |
| ATC:C01EB18 | Ranolazine |
| ATC:C01EB21 | Regadenoson |
| ATC:C01EB22 | Meldonium |
| ATC:C01EB23 | Tiazoticacid |
| ATC:C02 | Antihypertensive drugs |
| ATC:C02A | Antiadrenergic agents, centrally acting |
| ATC:C02AA | Rauvolfiaalkaloids |
| ATC:C02AA01 | Rescinnamine |
| ATC:C02AA02 | Reserpine |
| ATC:C02AA03 | Combinationsofrauwolfiaalkaloids |
| ATC:C02AA04 | Rauwolfiaalkaloids,wholeroot |
| ATC:C02AA05 | Deserpidine |
| ATC:C02AA06 | Methoserpidine |
| ATC:C02AA07 | Bietaserpine |
| ATC:C02AA52 | Reserpine,combinations |
| ATC:C02AA53 | Combinationsofrauwolfiaalkoloids,combinations |
| ATC:C02AA57 | Bietaserpine,combinations |
| ATC:C02AB | Methyldopa |
| ATC:C02AB01 | Methyldopa(levorotatory) |
| ATC:C02AB02 | Methyldopa(racemic) |
| ATC:C02AC | Imidazolinereceptoragonists |
| ATC:C02AC01 | Clonidine |
| ATC:C02AC02 | Guanfacine |
| ATC:C02AC04 | Tolonidine |
| ATC:C02AC05 | Moxonidine |
| ATC:C02AC06 | Rilmenidine |
| ATC:C02B | Antiadrenergic agents, ganglion-blocking |
| ATC:C02BA | Sulfoniumderivatives |
| ATC:C02BA01 | Trimetaphan |
| ATC:C02BB | Secondaryandtertiaryamines |
| ATC:C02BB01 | Mecamylamine |
| ATC:C02C | Antiadrenergic agents, peripherally acting |
| ATC:C02CA | Alpha-adrenoreceptorantagonists |
| ATC:C02CA01 | Prazosin |
| ATC:C02CA02 | Indoramin |
| ATC:C02CA03 | Trimazosin |
| ATC:C02CA04 | Doxazosin |
| ATC:C02CA06 | Urapidil |
| ATC:C02CC | Guanidinederivatives |
| ATC:C02CC01 | Betanidine |
| ATC:C02CC02 | Guanethidine |
| ATC:C02CC03 | Guanoxan |
| ATC:C02CC04 | Debrisoquine |
| ATC:C02CC05 | Guanoclor |
| ATC:C02CC06 | Guanazodine |
| ATC:C02CC07 | Guanoxabenz |
| ATC:C02D | Arteriolar smooth muscle, agents acting on |
| ATC:C02DA | Thiazidederivatives |
| ATC:C02DA01 | Diazoxide |
| ATC:C02DB | Hydrazinophthalazinederivatives |
| ATC:C02DB01 | Dihydralazine |
| ATC:C02DB02 | Hydralazine |
| ATC:C02DB03 | Endralazine |
| ATC:C02DB04 | Cadralazine |
| ATC:C02DC | Pyrimidinederivatives |
| ATC:C02DC01 | Minoxidil |
| ATC:C02DD | Nitroferricyanidederivatives |
| ATC:C02DD01 | Nitroprusside |
| ATC:C02DG | Guanidinederivatives |
| ATC:C02DG01 | Pinacidil |
| ATC:C02K | Other antihypertensives |
| ATC:C02KA | Alkaloids,excludingrauwolfia |
| ATC:C02KA01 | Veratrum |
| ATC:C02KB | Tyrosinehydroxylaseinhibitors |
| ATC:C02KB01 | Metirosine |
| ATC:C02KC | MAOinhibitors |
| ATC:C02KC01 | Pargyline |
| ATC:C02KD | Serotoninantagonists |
| ATC:C02KD01 | Ketanserin |
| ATC:C02KX | Antihypertensivesforpulmonaryarterialhypertension |
| ATC:C02KX01 | Bosentan |
| ATC:C02KX02 | Ambrisentan |
| ATC:C02KX03 | Sitaxentan |
| ATC:C02KX04 | Macitentan |
| ATC:C02KX05 | Riociguat |
| ATC:C02L | Antihypertensives and diuretics in combination |
| ATC:C02LA | Rauwolfiaalkaloidsanddiureticsincombination |
| ATC:C02LA01 | Reserpineanddiuretics |
| ATC:C02LA02 | Rescinnamineanddiuretics |
| ATC:C02LA03 | Deserpidineanddiuretics |
| ATC:C02LA04 | Methoserpidineanddiuretics |
| ATC:C02LA07 | Bietaserpineanddiuretics |
| ATC:C02LA08 | Rauwolfiaalkaloids,wholerootanddiuretics |
| ATC:C02LA09 | Syrosingopineanddiuretics |
| ATC:C02LA50 | Combinationsofrauwolfiaalkaloidsanddiureticsincludingothercombinations |
| ATC:C02LA51 | Reserpineanddiuretics,combinationswithotherdrugs |
| ATC:C02LA52 | Rescinnamineanddiuretics,combinationswithotherdrugs |
| ATC:C02LA71 | Reserpineanddiuretics,combinationswithpsycholeptics |
| ATC:C02LB | Methyldopaanddiureticsincombination |
| ATC:C02LB01 | Methyldopa(levorotatory)anddiuretics |
| ATC:C02LC | Imidazolinereceptoragonistsincombinationwithdiuretics |
| ATC:C02LC01 | Clonidineanddiuretics |
| ATC:C02LC05 | Moxonidineanddiuretics |
| ATC:C02LC51 | Clonidineanddiuretics,combinationswithotherdrugs |
| ATC:C02LE | Alpha-adrenoreceptorantagonistsanddiuretics |
| ATC:C02LE01 | Prazosinanddiuretics |
| ATC:C02LF | Guanidinederivativesanddiuretics |
| ATC:C02LF01 | Guanethidineanddiuretics |
| ATC:C02LG | Hydrazinophthalazinederivativesanddiuretics |
| ATC:C02LG01 | Dihydralazineanddiuretics |
| ATC:C02LG02 | Hydralazineanddiuretics |
| ATC:C02LG03 | Picodralazineanddiuretics |
| ATC:C02LG51 | Dihydralazineanddiuretics,combinationswithotherdrugs |
| ATC:C02LG73 | Picodralazineanddiuretics,combinationswithpsycholeptics |
| ATC:C02LK | Alkaloids,excludingrauwolfia,incombinationwithdiuretics |
| ATC:C02LK01 | Veratrumanddiuretics |
| ATC:C02LL | MAOinhibitorsanddiuretics |
| ATC:C02LL01 | Pargylineanddiuretics |
| ATC:C02LX | Otherantihypertensivesanddiuretics |
| ATC:C02LX01 | Pinacidilanddiuretics |
| ATC:C03 | Diuretic drugs |
| ATC:C03A | Low-ceiling diuretics, thiazides |
| ATC:C03AA | Thiazides,plain |
| ATC:C03AA01 | Bendroflumethiazide |
| ATC:C03AA02 | Hydroflumethiazide |
| ATC:C03AA03 | Hydrochlorothiazide |
| ATC:C03AA04 | Chlorothiazide |
| ATC:C03AA05 | Polythiazide |
| ATC:C03AA06 | Trichlormethiazide |
| ATC:C03AA07 | Cyclopenthiazide |
| ATC:C03AA08 | Methyclothiazide |
| ATC:C03AA09 | Cyclothiazide |
| ATC:C03AA13 | Mebutizide |
| ATC:C03AB | Thiazidesandpotassiumincombination |
| ATC:C03AB01 | Bendroflumethiazideandpotassium |
| ATC:C03AB02 | Hydroflumethiazideandpotassium |
| ATC:C03AB03 | Hydrochlorothiazideandpotassium |
| ATC:C03AB04 | Chlorothiazideandpotassium |
| ATC:C03AB05 | Polythiazideandpotassium |
| ATC:C03AB06 | Trichlormethiazideandpotassium |
| ATC:C03AB07 | Cyclopenthiazideandpotassium |
| ATC:C03AB08 | Methyclothiazideandpotassium |
| ATC:C03AB09 | Cyclothiazideandpotassium |
| ATC:C03AH | Thiazides,combinationswithpsycholepticsand/oranalgesics |
| ATC:C03AH01 | Chlorothiazide,combinations |
| ATC:C03AH02 | Hydroflumethiazide,combinations |
| ATC:C03AX | Thiazides,combinationswithotherdrugs |
| ATC:C03AX01 | Hydrochlorothiazide,combinations |
| ATC:C03B | Low-ceiling diuretics, excluding thiazides |
| ATC:C03BA | Sulfonamides,plain |
| ATC:C03BA02 | Quinethazone |
| ATC:C03BA03 | Clopamide |
| ATC:C03BA04 | Chlortalidone |
| ATC:C03BA05 | Mefruside |
| ATC:C03BA07 | Clofenamide |
| ATC:C03BA08 | Metolazone |
| ATC:C03BA09 | Meticrane |
| ATC:C03BA10 | Xipamide |
| ATC:C03BA11 | Indapamide |
| ATC:C03BA12 | Clorexolone |
| ATC:C03BA13 | Fenquizone |
| ATC:C03BA82 | Clorexolone,combinationswithpsycholeptics |
| ATC:C03BB | Sulfonamidesandpotassiumincombination |
| ATC:C03BB02 | Quinethazoneandpotassium |
| ATC:C03BB03 | Clopamideandpotassium |
| ATC:C03BB04 | Chlortalidoneandpotassium |
| ATC:C03BB05 | Mefrusideandpotassium |
| ATC:C03BB07 | Clofenamideandpotassium |
| ATC:C03BC | Mercurialdiuretics |
| ATC:C03BC01 | Mersalyl |
| ATC:C03BD | Xanthinederivatives |
| ATC:C03BD01 | Theobromine |
| ATC:C03BX | Otherlow-ceilingdiuretics |
| ATC:C03BX03 | Cicletanine |
| ATC:C03C | High-ceiling diuretics |
| ATC:C03CA | Sulfonamides,plain |
| ATC:C03CA01 | Furosemide |
| ATC:C03CA02 | Bumetanide |
| ATC:C03CA03 | Piretanide |
| ATC:C03CA04 | Torasemide |
| ATC:C03CB | Sulfonamidesandpotassiumincombination |
| ATC:C03CB01 | Furosemideandpotassium |
| ATC:C03CB02 | Bumetanideandpotassium |
| ATC:C03CC | Aryloxyaceticacidderivatives |
| ATC:C03CC01 | Etacrynicacid |
| ATC:C03CC02 | Tienilicacid |
| ATC:C03CD | Pyrazolonederivatives |
| ATC:C03CD01 | Muzolimine |
| ATC:C03CX | Otherhigh-ceilingdiuretics |
| ATC:C03CX01 | Etozolin |
| ATC:C03D | Potassium-sparing agents |
| ATC:C03DA | Aldosteroneantagonists |
| ATC:C03DA01 | Spironolactone |
| ATC:C03DA02 | Potassiumcanrenoate |
| ATC:C03DA03 | Canrenone |
| ATC:C03DA04 | Eplerenone |
| ATC:C03DB | Otherpotassium-sparingagents |
| ATC:C03DB01 | Amiloride |
| ATC:C03DB02 | Triamterene |
| ATC:C03E | Diuretics and potassium-sparing agents in combination |
| ATC:C03EA | Low-ceilingdiureticsandpotassium-sparingagents |
| ATC:C03EA01 | Hydrochlorothiazideandpotassium-sparingagents |
| ATC:C03EA02 | Trichlormethiazideandpotassium-sparingagents |
| ATC:C03EA03 | Epitizideandpotassium-sparingagents |
| ATC:C03EA04 | Altizideandpotassium-sparingagents |
| ATC:C03EA05 | Mebutizideandpotassium-sparingagents |
| ATC:C03EA06 | Chlortalidoneandpotassium-sparingagents |
| ATC:C03EA07 | Cyclopenthiazideandpotassium-sparingagents |
| ATC:C03EA12 | Metolazoneandpotassium-sparingagents |
| ATC:C03EA13 | Bendroflumethiazideandpotassium-sparingagents |
| ATC:C03EA14 | Butizideandpotassium-sparingagents |
| ATC:C03EB | High-ceilingdiureticsandpotassium-sparingagents |
| ATC:C03EB01 | Furosemideandpotassium-sparingagents |
| ATC:C03EB02 | Bumetanideandpotassium-sparingagents |
| ATC:C03X | Other diuretics |
| ATC:C03XA | Vasopressinantagonists |
| ATC:C03XA01 | Tolvaptan |
| ATC:C03XA02 | Conivaptan |
| ATC:C04 | Peripheral vasodilators |
| ATC:C04A | Peripheral vasodilators |
| ATC:C04AA | 2-amino-1-phenylethanolderivatives |
| ATC:C04AA01 | Isoxsuprine |
| ATC:C04AA02 | Buphenine |
| ATC:C04AA31 | Bamethan |
| ATC:C04AB | Imidazolinederivatives |
| ATC:C04AB01 | Phentolamine |
| ATC:C04AB02 | Tolazoline |
| ATC:C04AC | Nicotinicacidandderivatives |
| ATC:C04AC01 | Nicotinicacid |
| ATC:C04AC02 | Nicotinylalcohol(pyridylcarbinol) |
| ATC:C04AC03 | Inositolnicotinate |
| ATC:C04AC07 | Ciclonicate |
| ATC:C04AD | Purinederivatives |
| ATC:C04AD01 | Pentifylline |
| ATC:C04AD02 | Xantinolnicotinate |
| ATC:C04AD03 | Pentoxifylline |
| ATC:C04AD04 | Etofyllinenicotinate |
| ATC:C04AE | Ergotalkaloids |
| ATC:C04AE01 | Ergoloidmesylates |
| ATC:C04AE02 | Nicergoline |
| ATC:C04AE04 | Dihydroergocristine |
| ATC:C04AE51 | Ergoloidmesylates,combinations |
| ATC:C04AE54 | Dihydroergocristine,combinations |
| ATC:C04AF | Enzymes |
| ATC:C04AF01 | Kallidinogenase |
| ATC:C04AX | Otherperipheralvasodilators |
| ATC:C04AX01 | Cyclandelate |
| ATC:C04AX02 | Phenoxybenzamine |
| ATC:C04AX07 | Vincamine |
| ATC:C04AX10 | Moxisylyte |
| ATC:C04AX11 | Bencyclane |
| ATC:C04AX17 | Vinburnine |
| ATC:C04AX19 | Sulcotidil |
| ATC:C04AX20 | Buflomedil |
| ATC:C04AX21 | Naftidrofuryl |
| ATC:C04AX23 | Butalamine |
| ATC:C04AX24 | Visnadine |
| ATC:C04AX26 | Cetiedil |
| ATC:C04AX27 | Cinepazide |
| ATC:C04AX28 | Ifenprodil |
| ATC:C04AX30 | Azapetine |
| ATC:C04AX32 | Fasudil |
| ATC:C05 | Vasoprotective drugs |
| ATC:C05A | Agents for treatment of hemorrhoids and anal fissures for topical use |
| ATC:C05AA | Corticosteroids |
| ATC:C05AA01 | Hydrocortisone |
| ATC:C05AA04 | Prednisolone |
| ATC:C05AA05 | Betamethasone |
| ATC:C05AA06 | Fluorometholone |
| ATC:C05AA08 | Fluocortolone |
| ATC:C05AA09 | Dexamethasone |
| ATC:C05AA10 | Fluocinoloneacetonide |
| ATC:C05AA11 | Fluocinonide |
| ATC:C05AA12 | Triamcinolone |
| ATC:C05AD | Localanesthetics |
| ATC:C05AD01 | Lidocaine |
| ATC:C05AD02 | Tetracaine |
| ATC:C05AD03 | Benzocaine |
| ATC:C05AD04 | Cinchocaine |
| ATC:C05AD05 | Procaine |
| ATC:C05AD06 | Oxetacaine |
| ATC:C05AD07 | Pramocaine |
| ATC:C05AE | Musclerelaxants |
| ATC:C05AE01 | Glyceryltrinitrate |
| ATC:C05AE02 | Isosorbidedinitrate |
| ATC:C05AE03 | Diltiazem |
| ATC:C05AX | Otheragentsfortreatmentofhemorrhoidsandanalfissuresfortopicaluse |
| ATC:C05AX01 | Aluminiumpreparations |
| ATC:C05AX02 | Bismuthpreparations,combinations |
| ATC:C05AX03 | Otherpreparations,combinations |
| ATC:C05AX04 | Zincpreparations |
| ATC:C05AX05 | Tribenoside |
| ATC:C05B | Antivaricose therapy |
| ATC:C05BA | Heparinsorheparinoidsfortopicaluse |
| ATC:C05BA01 | Organo-heparinoid |
| ATC:C05BA02 | Sodiumapolate |
| ATC:C05BA03 | Heparin |
| ATC:C05BA04 | Pentosanpolysulfatesodium |
| ATC:C05BA51 | Heparinoid,combinations |
| ATC:C05BA53 | Heparin,combinations |
| ATC:C05BB | Sclerosingagentsforlocalinjection |
| ATC:C05BB01 | Monoethanolamineoleate |
| ATC:C05BB02 | Polidocanol |
| ATC:C05BB03 | Invertsugar |
| ATC:C05BB04 | Sodiumtetradecylsulfate |
| ATC:C05BB05 | Phenol |
| ATC:C05BB56 | Glucose,combinations |
| ATC:C05BX | Othersclerosingagents |
| ATC:C05BX01 | Calciumdobesilate |
| ATC:C05BX51 | Calciumdobesilate,combinations |
| ATC:C05C | Capillary stabilising agents |
| ATC:C05CA | Bioflavonoids |
| ATC:C05CA01 | Rutoside |
| ATC:C05CA02 | Monoxerutin |
| ATC:C05CA03 | Diosmin |
| ATC:C05CA04 | Troxerutin |
| ATC:C05CA05 | Hidrosmin |
| ATC:C05CA51 | Rutoside,combinations |
| ATC:C05CA53 | Diosmin,combinations |
| ATC:C05CA54 | Troxerutin,combinations |
| ATC:C05CX | Othercapillarystabilisingagents |
| ATC:C05CX01 | Tribenoside |
| ATC:C05CX02 | Naftazone |
| ATC:C05CX03 | Hippocastanisemen |
| ATC:C07 | Beta blocking agents |
| ATC:C07A | Beta blocking agents |
| ATC:C07AA | Betablockingagents,non-selective |
| ATC:C07AA01 | Alprenolol |
| ATC:C07AA02 | Oxprenolol |
| ATC:C07AA03 | Pindolol |
| ATC:C07AA05 | Propranolol |
| ATC:C07AA06 | Timolol |
| ATC:C07AA07 | Sotalol |
| ATC:C07AA12 | Nadolol |
| ATC:C07AA14 | Mepindolol |
| ATC:C07AA15 | Carteolol |
| ATC:C07AA16 | Tertatolol |
| ATC:C07AA17 | Bopindolol |
| ATC:C07AA19 | Bupranolol |
| ATC:C07AA23 | Penbutolol |
| ATC:C07AA27 | Cloranolol |
| ATC:C07AA57 | Sotalol,combinations |
| ATC:C07AB | Betablockingagents,selective |
| ATC:C07AB01 | Practolol |
| ATC:C07AB02 | Metoprolol |
| ATC:C07AB03 | Atenolol |
| ATC:C07AB04 | Acebutolol |
| ATC:C07AB05 | Betaxolol |
| ATC:C07AB06 | Bevantolol |
| ATC:C07AB07 | Bisoprolol |
| ATC:C07AB08 | Celiprolol |
| ATC:C07AB09 | Esmolol |
| ATC:C07AB10 | Epanolol |
| ATC:C07AB11 | S-atenolol |
| ATC:C07AB12 | Nebivolol |
| ATC:C07AB13 | Talinolol |
| ATC:C07AB14 | Landiolol |
| ATC:C07AB52 | Metoprolol,combinations |
| ATC:C07AB57 | Bisoprolol,combinations |
| ATC:C07AG | Alphaandbetablockingagents |
| ATC:C07AG01 | Labetalol |
| ATC:C07AG02 | Carvedilol |
| ATC:C07B | Beta blocking agents and thiazides |
| ATC:C07BA | Betablockingagents,non-selective,andthiazides |
| ATC:C07BA02 | Oxprenololandthiazides |
| ATC:C07BA05 | Propranololandthiazides |
| ATC:C07BA06 | Timololandthiazides |
| ATC:C07BA07 | Sotalolandthiazides |
| ATC:C07BA12 | Nadololandthiazides |
| ATC:C07BA68 | Metipranololandthiazides,combinations |
| ATC:C07BB | Betablockingagents,selective,andthiazides |
| ATC:C07BB02 | Metoprololandthiazides |
| ATC:C07BB03 | Atenololandthiazides |
| ATC:C07BB04 | Acebutololandthiazides |
| ATC:C07BB06 | Bevantololandthiazides |
| ATC:C07BB07 | Bisoprololandthiazides |
| ATC:C07BB12 | Nebivololandthiazides |
| ATC:C07BB52 | Metoprololandthiazides,combinations |
| ATC:C07BG | Alphaandbetablockingagentsandthiazides |
| ATC:C07BG01 | Labetalolandthiazides |
| ATC:C07C | Beta blocking agents and other diuretics |
| ATC:C07CA | Betablockingagents,non-selective,andotherdiuretics |
| ATC:C07CA02 | Oxprenololandotherdiuretics |
| ATC:C07CA03 | Pindololandotherdiuretics |
| ATC:C07CA17 | Bopindololandotherdiuretics |
| ATC:C07CA23 | Penbutololandotherdiuretics |
| ATC:C07CB | Betablockingagents,selective,andotherdiuretics |
| ATC:C07CB02 | Metoprololandotherdiuretics |
| ATC:C07CB03 | Atenololandotherdiuretics |
| ATC:C07CB53 | Atenololandotherdiuretics,combinations |
| ATC:C07CG | Alphaandbetablockingagentsandotherdiuretics |
| ATC:C07CG01 | Labetalolandotherdiuretics |
| ATC:C07D | Beta blocking agents, thiazides and other diuretics |
| ATC:C07DA | Betablockingagents,non-selective,thiazidesandotherdiuretics |
| ATC:C07DA06 | Timolol,thiazidesandotherdiuretics |
| ATC:C07DB | Betablockingagents,selective,thiazidesandotherdiuretics |
| ATC:C07DB01 | Atenolol,thiazidesandotherdiuretics |
| ATC:C07F | Beta blocking agents and other antihypertensives |
| ATC:C07FA | Betablockingagents,non-selective,andotherantihypertensives |
| ATC:C07FA05 | Propranololandotherantihypertensives |
| ATC:C07FB | Betablockingagents,selective,andotherantihypertensives |
| ATC:C07FB02 | Metoprololandotherantihypertensives |
| ATC:C07FB03 | Atenololandotherantihypertensives |
| ATC:C07FB07 | Bisoprololandotherantihypertensives |
| ATC:C07FB12 | Nebivololandotherantihypertensives |
| ATC:C07FX | Betablockingagents,othercombinations |
| ATC:C07FX05 | MetoprololandIvabradine |
| ATC:C07FX06 | CarvedilolandIvabradine |
| ATC:C08 | Calcium channel blockers |
| ATC:C08C | Selective calcium channel blockers with mainly vascular effects |
| ATC:C08CA | Dihydropyridinederivatives |
| ATC:C08CA01 | Amlodipine |
| ATC:C08CA02 | Felodipine |
| ATC:C08CA03 | Isradipine |
| ATC:C08CA04 | Nicardipine |
| ATC:C08CA05 | Nifedipine |
| ATC:C08CA06 | Nimodipine |
| ATC:C08CA07 | Nisoldipine |
| ATC:C08CA08 | Nitrendipine |
| ATC:C08CA09 | Lacidipine |
| ATC:C08CA10 | Nilvadipine |
| ATC:C08CA11 | Manidipine |
| ATC:C08CA12 | Barnidipine |
| ATC:C08CA13 | Lercanidipine |
| ATC:C08CA14 | Cilnidipine |
| ATC:C08CA15 | Benidipine |
| ATC:C08CA16 | Clevidipine |
| ATC:C08CA55 | Nifedipine,combinations |
| ATC:C08CX | Otherselectivecalciumchannelblockerswithmainlyvasculareffects |
| ATC:C08CX01 | Mibefradil |
| ATC:C08D | Selective calcium channel blockers with direct cardiac effects |
| ATC:C08DA | Phenylalkylaminederivatives |
| ATC:C08DA01 | Verapamil |
| ATC:C08DA02 | Gallopamil |
| ATC:C08DA51 | Verapamil,combinations |
| ATC:C08DB | Benzothiazepinederivatives |
| ATC:C08DB01 | Diltiazem |
| ATC:C08E | Non-selective calcium channel blockers |
| ATC:C08EA | Phenylalkylaminederivatives |
| ATC:C08EA01 | Fendiline |
| ATC:C08EA02 | Bepridil |
| ATC:C08EX | Othernon-selectivecalciumchannelblockers |
| ATC:C08EX01 | Lidoflazine |
| ATC:C08EX02 | Perhexiline |
| ATC:C08GA | Calcium channel blockers and diuretics |
| ATC:C08GA01 | Nifedipineanddiuretics |
| ATC:C08GA02 | Amlodipineanddiuretics |
| ATC:C09 | Agents acting on the renin-angiotensin system |
| ATC:C09AA | ACE inhibitors, plain |
| ATC:C09AA01 | Captopril |
| ATC:C09AA02 | Enalapril |
| ATC:C09AA03 | Lisinopril |
| ATC:C09AA04 | Perindopril |
| ATC:C09AA05 | Ramipril |
| ATC:C09AA06 | Quinapril |
| ATC:C09AA07 | Benazepril |
| ATC:C09AA08 | Cilazapril |
| ATC:C09AA09 | Fosinopril |
| ATC:C09AA10 | Trandolapril |
| ATC:C09AA11 | Spirapril |
| ATC:C09AA12 | Delapril |
| ATC:C09AA13 | Moexipril |
| ATC:C09AA14 | Temocapril |
| ATC:C09AA15 | Zofenopril |
| ATC:C09AA16 | Imidapril |
| ATC:C09B | ACE inhibitors, combinations |
| ATC:C09BA | ACEinhibitorsanddiuretics |
| ATC:C09BA01 | Captoprilanddiuretics |
| ATC:C09BA02 | Enalaprilanddiuretics |
| ATC:C09BA03 | Lisinoprilanddiuretics |
| ATC:C09BA04 | Perindoprilanddiuretics |
| ATC:C09BA05 | Ramiprilanddiuretics |
| ATC:C09BA06 | Quinaprilanddiuretics |
| ATC:C09BA07 | Benazeprilanddiuretics |
| ATC:C09BA08 | Cilazaprilanddiuretics |
| ATC:C09BA09 | Fosinoprilanddiuretics |
| ATC:C09BA12 | Delaprilanddiuretics |
| ATC:C09BA13 | Moexiprilanddiuretics |
| ATC:C09BA15 | Zofenoprilanddiuretics |
| ATC:C09BB | ACEinhibitorsandcalciumchannelblockers |
| ATC:C09BB02 | Enalaprilandlercanidipine |
| ATC:C09BB03 | Lisinoprilandamlodipine |
| ATC:C09BB04 | Perindoprilandamlodipine |
| ATC:C09BB05 | Ramiprilandfelodipine |
| ATC:C09BB06 | Enalaprilandnitrendipine |
| ATC:C09BB07 | Ramiprilandamlodipine |
| ATC:C09BB10 | Trandolaprilandverapamil |
| ATC:C09BB12 | Delaprilandmanidipine |
| ATC:C09BX | ACEinhibitors,othercombinations |
| ATC:C09BX01 | Perindopril,amlodipineandindapamide |
| ATC:C09BX02 | Perindoprilandbisoprolol |
| ATC:C09CA | Angiotensin II antagonists, plain |
| ATC:C09CA01 | Losartan |
| ATC:C09CA02 | Eprosartan |
| ATC:C09CA03 | Valsartan |
| ATC:C09CA04 | Irbesartan |
| ATC:C09CA05 | Tasosartan |
| ATC:C09CA06 | Candesartan |
| ATC:C09CA07 | Telmisartan |
| ATC:C09CA08 | Olmesartanmedoxomil |
| ATC:C09CA09 | Azilsartanmedoxomil |
| ATC:C09CA10 | Fimasartan |
| ATC:C09D | Angiotensin II antagonists, combinations |
| ATC:C09DA | AngiotensinIIantagonistsanddiuretics |
| ATC:C09DA01 | Losartananddiuretics |
| ATC:C09DA02 | Eprosartananddiuretics |
| ATC:C09DA03 | Valsartananddiuretics |
| ATC:C09DA04 | Irbesartananddiuretics |
| ATC:C09DA06 | Candesartananddiuretics |
| ATC:C09DA07 | Telmisartananddiuretics |
| ATC:C09DA08 | Olmesartanmedoxomilanddiuretics |
| ATC:C09DA09 | Azilsartanmedoxomilanddiuretics |
| ATC:C09DB | AngiotensinIIantagonistsandcalciumchannelblockers |
| ATC:C09DB01 | Valsartanandamlodipine |
| ATC:C09DB02 | Olmesartanmedoxomilandamlodipine |
| ATC:C09DB04 | Telmisartanandamlodipine |
| ATC:C09DB05 | Irbesartanandamlodipine |
| ATC:C09DB06 | Losartanandamlodipine |
| ATC:C09DB07 | Candesartanandamlodipine |
| ATC:C09DB08 | Valsartanandlercanidipine |
| ATC:C09DX | AngiotensinIIantagonists,othercombinations |
| ATC:C09DX01 | Valsartan,amlodipineandhydrochlorothiazide |
| ATC:C09DX02 | Valsartanandaliskiren |
| ATC:C09DX03 | Olmesartanmedoxomil,amlodipineandhydrochlorothiazide |
| ATC:C09DX04 | Valsartanandsacubitril |
| ATC:C09X | Other agents acting on the renin-angiotensin system |
| ATC:C09XA | Renin-inhibitors |
| ATC:C09XA01 | Remikiren |
| ATC:C09XA02 | Aliskiren |
| ATC:C09XA52 | Aliskirenandhydrochlorothiazide |
| ATC:C09XA53 | Aliskirenandamlodipine |
| ATC:C09XA54 | Aliskiren,amlodipineandhydrochlorothiazide |
| ATC:C10 | Lipid modifying agents |
| ATC:C10A | Lipid modifying agents, plain |
| ATC:C10AA | HMGCoAreductaseinhibitors |
| ATC:C10AA01 | Simvastatin |
| ATC:C10AA02 | Lovastatin |
| ATC:C10AA03 | Pravastatin |
| ATC:C10AA04 | Fluvastatin |
| ATC:C10AA05 | Atorvastatin |
| ATC:C10AA06 | Cerivastatin |
| ATC:C10AA07 | Rosuvastatin |
| ATC:C10AA08 | Pitavastatin |
| ATC:C10AB | Fibrates |
| ATC:C10AB01 | Clofibrate |
| ATC:C10AB02 | Bezafibrate |
| ATC:C10AB03 | Aluminiumclofibrate |
| ATC:C10AB04 | Gemfibrozil |
| ATC:C10AB05 | Fenofibrate |
| ATC:C10AB06 | Simfibrate |
| ATC:C10AB07 | Ronifibrate |
| ATC:C10AB08 | Ciprofibrate |
| ATC:C10AB09 | Etofibrate |
| ATC:C10AB10 | Clofibride |
| ATC:C10AB11 | Cholinefenofibrate |
| ATC:C10AC | Bileacidsequestrants |
| ATC:C10AC01 | Colestyramine |
| ATC:C10AC02 | Colestipol |
| ATC:C10AC03 | Colextran |
| ATC:C10AC04 | Colesevelam |
| ATC:C10AD | Nicotinicacidandderivatives |
| ATC:C10AD01 | Niceritrol |
| ATC:C10AD02 | Nicotinicacid |
| ATC:C10AD03 | Nicofuranose |
| ATC:C10AD04 | Aluminiumnicotinate |
| ATC:C10AD05 | Nicotinylalcohol(pyridylcarbinol) |
| ATC:C10AD06 | Acipimox |
| ATC:C10AD52 | Nicotinicacid,combinations |
| ATC:C10AX | Otherlipidmodifyingagents |
| ATC:C10AX01 | Dextrothyroxine |
| ATC:C10AX02 | Probucol |
| ATC:C10AX03 | Tiadenol |
| ATC:C10AX05 | Meglutol |
| ATC:C10AX06 | Omega-3-triglycerides |
| ATC:C10AX07 | Magnesiumpyridoxal5-phosphateglutamate |
| ATC:C10AX08 | Policosanol |
| ATC:C10AX09 | Ezetimibe |
| ATC:C10AX10 | Alipogenetiparvovec |
| ATC:C10AX11 | Mipomersen |
| ATC:C10AX12 | Lomitapide |
| ATC:C10AX13 | Evolocumab |
| ATC:C10AX14 | Alirocumab |
| ATC:C10B | Lipid modifying agents, combinations |
| ATC:C10BA | HMGCoAreductaseinhibitorsincombinationwithotherlipidmodifyingagents |
| ATC:C10BA01 | Lovastatinandnicotinicacid |
| ATC:C10BA02 | Simvastatinandezetimibe |
| ATC:C10BA03 | Pravastatinandfenofibrate |
| ATC:C10BA04 | Simvastatinandfenofibrate |
| ATC:C10BA05 | Atorvastatinandezetimibe |
| ATC:C10BA06 | Rosuvastatinandezetimibe |
| ATC:C10BX | HMGCoAreductaseinhibitors,othercombinations |
| ATC:C10BX01 | Simvastatinandacetylsalicylicacid |
| ATC:C10BX02 | Pravastatinandacetylsalicylicacid |
| ATC:C10BX03 | Atorvastatinandamlodipine |
| ATC:C10BX04 | Simvastatin,acetylsalicylicacidandramipril |
| ATC:C10BX05 | Rosuvastatinandacetylsalisylicacid |
| ATC:C10BX06 | Atorvastatin,acetylsalicylicacidandramipril |
| ATC:C10BX07 | Rosuvastatin,amlodipineandlisinopril |
| ATC:C10BX08 | Atorvastatinandacetylsalicylicacid |
| ATC:C10BX09 | Rosuvastatinandamlodipine |
| ATC:C10BX10 | Rosuvastatinandvalsartan |
| ATC:C10BX11 | Atorvastatin,amlodipineandperindopril |
| ATC:D01 | Antifungals for dermatological use |
| ATC:D01A | Antifungals for topical use |
| ATC:D01AA | Antibiotics |
| ATC:D01AA01 | Nystatin |
| ATC:D01AA02 | Natamycin |
| ATC:D01AA03 | Hachimycin |
| ATC:D01AA04 | Pecilocin |
| ATC:D01AA06 | Mepartricin |
| ATC:D01AA07 | Pyrrolnitrin |
| ATC:D01AA08 | Griseofulvin |
| ATC:D01AA20 | Combinations |
| ATC:D01AC | Imidazoleandtriazolederivatives |
| ATC:D01AC01 | Clotrimazole |
| ATC:D01AC02 | Miconazole |
| ATC:D01AC03 | Econazole |
| ATC:D01AC04 | Clomidazole |
| ATC:D01AC05 | Isoconazole |
| ATC:D01AC06 | Tiabendazole |
| ATC:D01AC07 | Tioconazole |
| ATC:D01AC08 | Ketoconazole |
| ATC:D01AC09 | Sulconazole |
| ATC:D01AC10 | Bifonazole |
| ATC:D01AC11 | Oxiconazole |
| ATC:D01AC12 | Fenticonazole |
| ATC:D01AC13 | Omoconazole |
| ATC:D01AC14 | Sertaconazole |
| ATC:D01AC15 | Fluconazole |
| ATC:D01AC16 | Flutrimazole |
| ATC:D01AC17 | Eberconazole |
| ATC:D01AC18 | Luliconazole |
| ATC:D01AC19 | Efinaconazole |
| ATC:D01AC20 | Combinations |
| ATC:D01AC52 | Miconazole,combinations |
| ATC:D01AC60 | Bifonazole,combinations |
| ATC:D01AE | Otherantifungalsfortopicaluse |
| ATC:D01AE01 | Bromochlorosalicylanilide |
| ATC:D01AE02 | Methylrosaniline |
| ATC:D01AE03 | Tribromometacresol |
| ATC:D01AE04 | Undecylenicacid |
| ATC:D01AE05 | Polynoxylin |
| ATC:D01AE06 | 2-(4-chlorphenoxy)-ethanol |
| ATC:D01AE07 | Chlorphenesin |
| ATC:D01AE08 | Ticlatone |
| ATC:D01AE09 | Sulbentine |
| ATC:D01AE10 | Ethylhydroxybenzoate |
| ATC:D01AE11 | Haloprogin |
| ATC:D01AE12 | Salicylicacid |
| ATC:D01AE13 | Seleniumsulfide |
| ATC:D01AE14 | Ciclopirox |
| ATC:D01AE15 | Terbinafine |
| ATC:D01AE16 | Amorolfine |
| ATC:D01AE17 | Dimazole |
| ATC:D01AE18 | Tolnaftate |
| ATC:D01AE19 | Tolciclate |
| ATC:D01AE20 | Combinations |
| ATC:D01AE21 | Flucytosine |
| ATC:D01AE22 | Naftifine |
| ATC:D01AE23 | Butenafine |
| ATC:D01AE54 | Undecylenicacid,combinations |
| ATC:D01BA | Antifungals for systemic use |
| ATC:D01BA01 | Griseofulvin |
| ATC:D01BA02 | Terbinafine |
| ATC:D02 | Emollients and protectants |
| ATC:D02A | Emollients and protectives |
| ATC:D02AE | Carbamideproducts |
| ATC:D02AE01 | Carbamide |
| ATC:D02AE51 | Carbamide,combinations |
| ATC:D02B | Protectives against UV-radiation |
| ATC:D02BA | ProtectivesagainstUV-radiationfortopicaluse |
| ATC:D02BA01 | Aminobenzoicacid |
| ATC:D02BA02 | Octinoxate |
| ATC:D02BB | ProtectivesagainstUV-radiationforsystemicuse |
| ATC:D02BB01 | Betacarotene |
| ATC:D02BB02 | Afamelanotide |
| ATC:D03 | Treatment of wounds and ulcers |
| ATC:D03A | Cicatrizants |
| ATC:D03AA | Cod-liveroilointments |
| ATC:D03AX | Othercicatrizants |
| ATC:D03AX01 | Cadexomeriodine |
| ATC:D03AX02 | Dextranomer |
| ATC:D03AX03 | Dexpanthenol |
| ATC:D03AX04 | Calciumpantothenate |
| ATC:D03AX05 | Hyaluronicacid |
| ATC:D03AX06 | Becaplermin |
| ATC:D03AX09 | Crilanomer |
| ATC:D03AX10 | Enoxolone |
| ATC:D03AX11 | Sodiumchlorite(tetrachlorodecaoxide) |
| ATC:D03AX12 | Trolamine |
| ATC:D03B | Enzymes |
| ATC:D03BA | Proteolyticenzymes |
| ATC:D03BA01 | Trypsin |
| ATC:D03BA02 | Clostridiopeptidase |
| ATC:D03BA03 | Bromelains |
| ATC:D03BA52 | Clostridiopeptidase,combinations |
| ATC:D04 | Antipyretics drugs |
| ATC:D04A | Antipruritics, including antihistamines, anesthetics, etc. |
| ATC:D04AA | Topicalantihistamines |
| ATC:D04AA01 | Thonzylamine |
| ATC:D04AA02 | Mepyramine |
| ATC:D04AA03 | Thenalidine |
| ATC:D04AA04 | Tripelennamine |
| ATC:D04AA09 | Chloropyramine |
| ATC:D04AA10 | Promethazine |
| ATC:D04AA12 | Tolpropamine |
| ATC:D04AA13 | Dimetindene |
| ATC:D04AA14 | Clemastine |
| ATC:D04AA15 | Bamipine |
| ATC:D04AA16 | Pheniramine |
| ATC:D04AA22 | Isothipendyl |
| ATC:D04AA32 | Diphenhydramine |
| ATC:D04AA33 | Diphenhydraminemethylbromide |
| ATC:D04AA34 | Chlorphenoxamine |
| ATC:D04AB | Topicalanesthetics |
| ATC:D04AB01 | Lidocaine |
| ATC:D04AB02 | Cinchocaine |
| ATC:D04AB03 | Oxybuprocaine |
| ATC:D04AB04 | Benzocaine |
| ATC:D04AB05 | Quinisocaine |
| ATC:D04AB06 | Tetracaine |
| ATC:D04AB07 | Pramocaine |
| ATC:D05 | Antipsoriatic drugs |
| ATC:D05A | Antipsoriatics for topical use |
| ATC:D05AC | Antracenderivatives |
| ATC:D05AC01 | Dithranol |
| ATC:D05AC51 | Dithranol,combinations |
| ATC:D05AD | Psoralensfortopicaluse |
| ATC:D05AD01 | Trioxysalen |
| ATC:D05AD02 | Methoxsalen |
| ATC:D05AX | Otherantipsoriaticsfortopicaluse |
| ATC:D05AX01 | Fumaricacid |
| ATC:D05AX02 | Calcipotriol |
| ATC:D05AX03 | Calcitriol |
| ATC:D05AX04 | Tacalcitol |
| ATC:D05AX05 | Tazarotene |
| ATC:D05AX52 | Calcipotriol,combinations |
| ATC:D05B | Antipsoriatics for systemic use |
| ATC:D05BA | Psoralensforsystemicuse |
| ATC:D05BA01 | Trioxysalen |
| ATC:D05BA02 | Methoxsalen |
| ATC:D05BA03 | Bergapten |
| ATC:D05BB | Retinoidsfortreatmentofpsoriasis |
| ATC:D05BB01 | Etretinate |
| ATC:D05BB02 | Acitretin |
| ATC:D05BX | Otherantipsoriaticsforsystemicuse |
| ATC:D05BX51 | Fumaricacidderivatives,combinations |
| ATC:D06 | Antibiotics and chemotherapeutics for dermatological use |
| ATC:D06A | Antibiotics for topical use |
| ATC:D06AA | Tetracyclineandderivatives |
| ATC:D06AA01 | Demeclocycline |
| ATC:D06AA02 | Chlortetracycline |
| ATC:D06AA03 | Oxytetracycline |
| ATC:D06AA04 | Tetracycline |
| ATC:D06AX | Otherantibioticsfortopicaluse |
| ATC:D06AX01 | Fusidicacid |
| ATC:D06AX02 | Chloramphenicol |
| ATC:D06AX04 | Neomycin |
| ATC:D06AX05 | Bacitracin |
| ATC:D06AX07 | Gentamicin |
| ATC:D06AX08 | Tyrothricin |
| ATC:D06AX09 | Mupirocin |
| ATC:D06AX10 | Virginiamycin |
| ATC:D06AX11 | Rifaximin |
| ATC:D06AX12 | Amikacin |
| ATC:D06AX13 | Retapamulin |
| ATC:D06B | Chemotherapeutics for topical use |
| ATC:D06BA | Sulfonamides |
| ATC:D06BA01 | Silversulfadiazine |
| ATC:D06BA02 | Sulfathiazole |
| ATC:D06BA03 | Mafenide |
| ATC:D06BA04 | Sulfamethizole |
| ATC:D06BA05 | Sulfanilamide |
| ATC:D06BA06 | Sulfamerazine |
| ATC:D06BA51 | Silversulfadiazine,combinations |
| ATC:D06BB | Antivirals |
| ATC:D06BB01 | Idoxuridine |
| ATC:D06BB02 | Tromantadine |
| ATC:D06BB03 | Aciclovir |
| ATC:D06BB04 | Podophyllotoxin |
| ATC:D06BB05 | Inosine |
| ATC:D06BB06 | Penciclovir |
| ATC:D06BB07 | Lysozyme |
| ATC:D06BB08 | Ibacitabine |
| ATC:D06BB09 | Edoxudine |
| ATC:D06BB10 | Imiquimod |
| ATC:D06BB11 | Docosanol |
| ATC:D06BB12 | Sinecatechins |
| ATC:D06BB53 | Aciclovir,combinations |
| ATC:D06BX | Otherchemotherapeutics |
| ATC:D06BX01 | Metronidazole |
| ATC:D06BX02 | Ingenolmebutate |
| ATC:D07 | Topical dermatological corticosteroids |
| ATC:D07A | Corticosteroids, plain |
| ATC:D07AA | Corticosteroids,weak(groupI) |
| ATC:D07AA01 | Methylprednisolone |
| ATC:D07AA02 | Hydrocortisone |
| ATC:D07AA03 | Prednisolone |
| ATC:D07AB | Corticosteroids,moderatelypotent(groupII) |
| ATC:D07AB01 | Clobetasone |
| ATC:D07AB02 | Hydrocortisonebutyrate |
| ATC:D07AB03 | Flumetasone |
| ATC:D07AB04 | Fluocortin |
| ATC:D07AB05 | Fluperolone |
| ATC:D07AB06 | Fluorometholone |
| ATC:D07AB07 | Fluprednidene |
| ATC:D07AB08 | Desonide |
| ATC:D07AB09 | Triamcinolone |
| ATC:D07AB10 | Alclometasone |
| ATC:D07AB11 | Hydrocortisonebuteprate |
| ATC:D07AB19 | Dexamethasone |
| ATC:D07AB21 | Clocortolone |
| ATC:D07AB30 | Combinationsofcorticosteroids |
| ATC:D07AC | Corticosteroids,potent(groupIII) |
| ATC:D07AC01 | Betamethasone |
| ATC:D07AC02 | Fluclorolone |
| ATC:D07AC03 | Desoximetasone |
| ATC:D07AC04 | Fluocinoloneacetonide |
| ATC:D07AC05 | Fluocortolone |
| ATC:D07AC06 | Diflucortolone |
| ATC:D07AC07 | Fludroxycortide |
| ATC:D07AC08 | Fluocinonide |
| ATC:D07AC09 | Budesonide |
| ATC:D07AC10 | Diflorasone |
| ATC:D07AC11 | Amcinonide |
| ATC:D07AC12 | Halometasone |
| ATC:D07AC13 | Mometasonefuroate |
| ATC:D07AC14 | Methylprednisoloneaceponate |
| ATC:D07AC15 | Beclometasone |
| ATC:D07AC16 | Hydrocortisoneaceponate |
| ATC:D07AC17 | Fluticasone |
| ATC:D07AC18 | Prednicarbate |
| ATC:D07AC19 | Difluprednate |
| ATC:D07AC21 | Ulobetasol |
| ATC:D07AD | Corticosteroids,verypotent(groupIV) |
| ATC:D07AD01 | Clobetasol |
| ATC:D07AD02 | Halcinonide |
| ATC:D07B | Corticosteroids, combinations with antiseptics |
| ATC:D07BA | Corticosteroids,weak,combinationswithantiseptics |
| ATC:D07BA01 | Prednisoloneandantiseptics |
| ATC:D07BA04 | Hydrocortisoneandantiseptics |
| ATC:D07BB | Corticosteroids,moderatelypotent,combinationswithantiseptics |
| ATC:D07BB01 | Flumetasoneandantiseptics |
| ATC:D07BB02 | Desonideandantiseptics |
| ATC:D07BB03 | Triamcinoloneandantiseptics |
| ATC:D07BB04 | Hydrocortisonebutyrateandantiseptics |
| ATC:D07BC | Corticosteroids,potent,combinationswithantiseptics |
| ATC:D07BC01 | Betamethasoneandantiseptics |
| ATC:D07BC02 | Fluocinoloneacetonideandantiseptics |
| ATC:D07BC03 | Fluocortoloneandantiseptics |
| ATC:D07BC04 | Diflucortoloneandantiseptics |
| ATC:D07C | Corticosteroids, combinations with antibiotics |
| ATC:D07CA | Corticosteroids,weak,combinationswithantibiotics |
| ATC:D07CA01 | Hydrocortisoneandantibiotics |
| ATC:D07CA02 | Methylprednisoloneandantibiotics |
| ATC:D07CA03 | Prednisoloneandantibiotics |
| ATC:D07CB | Corticosteroids,moderatelypotent,combinationswithantibiotics |
| ATC:D07CB01 | Triamcinoloneandantibiotics |
| ATC:D07CB02 | Fluprednideneandantibiotics |
| ATC:D07CB03 | Fluorometholoneandantibiotics |
| ATC:D07CB04 | Dexamethasoneandantibiotics |
| ATC:D07CB05 | Flumetasoneandantibiotics |
| ATC:D07CC | Corticosteroids,potent,combinationswithantibiotics |
| ATC:D07CC01 | Betamethasoneandantibiotics |
| ATC:D07CC02 | Fluocinoloneacetonideandantibiotics |
| ATC:D07CC03 | Fludroxycortideandantibiotics |
| ATC:D07CC04 | Beclometasoneandantibiotics |
| ATC:D07CC05 | Fluocinonideandantibiotics |
| ATC:D07CC06 | Fluocortoloneandantibiotics |
| ATC:D07CD | Corticosteroids,verypotent,combinationswithantibiotics |
| ATC:D07CD01 | Clobetasolandantibiotics |
| ATC:D07X | Corticosteroids, other combinations |
| ATC:D07XA | Corticosteroids,weak,othercombinations |
| ATC:D07XA01 | Hydrocortisone |
| ATC:D07XA02 | Prednisolone |
| ATC:D07XB | Corticosteroids,moderatelypotent,othercombinations |
| ATC:D07XB01 | Flumetasone |
| ATC:D07XB02 | Triamcinolone |
| ATC:D07XB03 | Fluprednidene |
| ATC:D07XB04 | Fluorometholone |
| ATC:D07XB05 | Dexamethasone |
| ATC:D07XB30 | Combinationsofcorticosteroids |
| ATC:D07XC | Corticosteroids,potent,othercombinations |
| ATC:D07XC01 | Betamethasone |
| ATC:D07XC02 | Desoximetasone |
| ATC:D07XC03 | Mometasone |
| ATC:D07XC04 | Diflucortolone |
| ATC:D07XC05 | Fluocortolone |
| ATC:D08 | Antiseptics and disinfectants drugs |
| ATC:D08A | Antiseptics and disinfectants |
| ATC:D08AA | Acridinederivatives |
| ATC:D08AA01 | Ethacridinelactate |
| ATC:D08AA02 | Aminoacridine |
| ATC:D08AA03 | Euflavine |
| ATC:D08AC | Biguanidesandamidines |
| ATC:D08AC01 | Dibrompropamidine |
| ATC:D08AC02 | Chlorhexidine |
| ATC:D08AC03 | Propamidine |
| ATC:D08AC04 | Hexamidine |
| ATC:D08AC05 | Polihexanide |
| ATC:D08AC52 | Chlorhexidine,combinations |
| ATC:D08AE | Phenolandderivatives |
| ATC:D08AE01 | Hexachlorophene |
| ATC:D08AE02 | Policresulen |
| ATC:D08AE03 | Phenol |
| ATC:D08AE04 | Triclosan |
| ATC:D08AE05 | Chloroxylenol |
| ATC:D08AE06 | Biphenylol |
| ATC:D08AF | Nitrofuranderivatives |
| ATC:D08AF01 | Nitrofural |
| ATC:D08AG | Iodineproducts |
| ATC:D08AG01 | Iodine/octylphenoxypolyglycolether |
| ATC:D08AG02 | Povidone-iodine |
| ATC:D08AG03 | Iodine |
| ATC:D08AG04 | Diiodohydroxypropane |
| ATC:D08AH | Quinolinederivatives |
| ATC:D08AH01 | Dequalinium |
| ATC:D08AH02 | Chlorquinaldol |
| ATC:D08AH03 | Oxyquinoline |
| ATC:D08AH30 | Clioquinol |
| ATC:D08AJ | Quaternaryammoniumcompounds |
| ATC:D08AJ01 | Benzalkonium |
| ATC:D08AJ02 | Cetrimonium |
| ATC:D08AJ03 | Cetylpyridinium |
| ATC:D08AJ04 | Cetrimide |
| ATC:D08AJ05 | Benzoxoniumchloride |
| ATC:D08AJ06 | Didecyldimethylammoniumchloride |
| ATC:D08AJ08 | Benzethoniumchloride |
| ATC:D08AJ10 | Decamethoxine |
| ATC:D08AJ57 | Octenidine,combinations |
| ATC:D08AJ58 | Benzethoniumchloride,combinations |
| ATC:D08AJ59 | Dodecloniumbromide,combinations |
| ATC:D08AK | Mercurialproducts |
| ATC:D08AK01 | Mercuricamidochloride |
| ATC:D08AK02 | Phenylmercuricborate |
| ATC:D08AK03 | Mercuricchloride |
| ATC:D08AK04 | Mercurochrome |
| ATC:D08AK05 | Mercury,metallic |
| ATC:D08AK06 | Thiomersal |
| ATC:D08AK30 | Mercuriciodide |
| ATC:D08AL | Silvercompounds |
| ATC:D08AL01 | Silvernitrate |
| ATC:D08AL30 | Silver |
| ATC:D08AX | Otherantisepticsanddisinfectants |
| ATC:D08AX01 | Hydrogenperoxide |
| ATC:D08AX02 | Eosin |
| ATC:D08AX03 | Propanol |
| ATC:D08AX04 | Tosylchloramidesodium |
| ATC:D08AX05 | Isopropanol |
| ATC:D08AX06 | Potassiumpermanganate |
| ATC:D08AX07 | Sodiumhypochlorite |
| ATC:D08AX08 | Ethanol |
| ATC:D08AX53 | Propanol,combinations |
| ATC:D09 | Medicated dressings |
| ATC:D09A | Medicated dressings |
| ATC:D09AA | Medicateddressingswithantiinfectives |
| ATC:D09AA01 | Framycetin |
| ATC:D09AA02 | Fusidicacid |
| ATC:D09AA03 | Nitrofural |
| ATC:D09AA04 | Phenylmercuricnitrate |
| ATC:D09AA05 | Benzododecinium |
| ATC:D09AA06 | Triclosan |
| ATC:D09AA07 | Cetylpyridinium |
| ATC:D09AA08 | Aluminiumchlorohydrate |
| ATC:D09AA09 | Povidone-iodine |
| ATC:D09AA10 | Clioquinol |
| ATC:D09AA11 | Benzalkonium |
| ATC:D09AA12 | Chlorhexidine |
| ATC:D09AA13 | Iodoform |
| ATC:D09AB | Zincbandages |
| ATC:D09AB01 | Zincbandagewithoutsupplements |
| ATC:D09AB02 | Zincbandagewithsupplements |
| ATC:D09AX | Softparaffindressings |
| ATC:D10 | Acne drugs |
| ATC:D10A | Topical acne drugs |
| ATC:D10AA | Corticosteroids,combinationsfortreatmentofacne |
| ATC:D10AA01 | Fluorometholone |
| ATC:D10AA02 | Methylprednisolone |
| ATC:D10AA03 | Dexamethasone |
| ATC:D10AB | Preparationscontainingsulfur |
| ATC:D10AB01 | Bithionol |
| ATC:D10AB02 | Sulfur |
| ATC:D10AB03 | Tioxolone |
| ATC:D10AB05 | Mesulfen |
| ATC:D10AD | Retinoidsfortopicaluseinacne |
| ATC:D10AD01 | Tretinoin |
| ATC:D10AD02 | Retinol |
| ATC:D10AD03 | Adapalene |
| ATC:D10AD04 | Isotretinoin |
| ATC:D10AD05 | Motretinide |
| ATC:D10AD51 | Tretinoin,combinations |
| ATC:D10AD53 | Adapalene,combinations |
| ATC:D10AD54 | Isotretinoin,combinations |
| ATC:D10AE | Peroxides |
| ATC:D10AE01 | Benzoylperoxide |
| ATC:D10AE51 | Benzoylperoxide,combinations |
| ATC:D10AF | Anti-infectivesfortreatmentofacne |
| ATC:D10AF01 | Clindamycin |
| ATC:D10AF02 | Erythromycin |
| ATC:D10AF03 | Chloramphenicol |
| ATC:D10AF04 | Meclocycline |
| ATC:D10AF05 | Nadifloxacin |
| ATC:D10AF06 | Sulfacetamide |
| ATC:D10AF51 | Clindamycin,combinations |
| ATC:D10AF52 | Erythromycin,combinations |
| ATC:D10AX | Otheranti-acnepreparationsfortopicaluse |
| ATC:D10AX01 | Aluminiumchloride |
| ATC:D10AX02 | Resorcinol |
| ATC:D10AX03 | Azelaicacid |
| ATC:D10AX04 | Aluminiumoxide |
| ATC:D10AX05 | Dapsone |
| ATC:D10AX30 | Variouscombinations |
| ATC:D10B | Anti-acne preparations for systemic use |
| ATC:D10BA | Retinoidsfortreatmentofacne |
| ATC:D10BA01 | Isotretinoin |
| ATC:D10BX | Otheranti-acnepreparationsforsystemicuse |
| ATC:D10BX01 | Ichtasol |
| ATC:D11 | Other dermatological drugs |
| ATC:D11A | Other dermatological preparations |
| ATC:D11AC | Medicatedshampoos |
| ATC:D11AC01 | Cetrimide |
| ATC:D11AC02 | Cadmiumcompounds |
| ATC:D11AC03 | Seleniumcompounds |
| ATC:D11AC06 | Povidone-iodine |
| ATC:D11AC08 | Sulfurcompounds |
| ATC:D11AC09 | Xenysalate |
| ATC:D11AC30 | Others |
| ATC:D11AE | Androgensfortopicaluse |
| ATC:D11AE01 | Metandienone |
| ATC:D11AH | Agentsfordermatitis,excludingcorticosteroids |
| ATC:D11AH01 | Tacrolimus |
| ATC:D11AH02 | Pimecrolimus |
| ATC:D11AH03 | Cromoglicicacid |
| ATC:D11AH04 | Alitretinoin |
| ATC:D11AX | Otherdermatologicals |
| ATC:D11AX01 | Minoxidil |
| ATC:D11AX02 | Gamolenicacid |
| ATC:D11AX03 | Calciumgluconate |
| ATC:D11AX04 | Lithiumsuccinate |
| ATC:D11AX05 | Magnesiumsulfate |
| ATC:D11AX06 | Mequinol |
| ATC:D11AX08 | Tiratricol |
| ATC:D11AX09 | Oxaceprol |
| ATC:D11AX10 | Finasteride |
| ATC:D11AX11 | Hydroquinone |
| ATC:D11AX12 | Pyrithionezinc |
| ATC:D11AX13 | Monobenzone |
| ATC:D11AX16 | Eflornithine |
| ATC:D11AX18 | Diclofenac |
| ATC:D11AX21 | Brimonidine |
| ATC:D11AX22 | Ivermectin |
| ATC:D11AX23 | Aminobenzoatepotassium |
| ATC:D11AX24 | Deoxycholicacid |
| ATC:D11AX52 | Gamolenicacid,combinations |
| ATC:D11AX57 | Collagen,combinations |
| ATC:G01 | Gynecological anti-infectives and antiseptics |
| ATC:G01A | Anti infectives and antiseptics, excluding combinations with corticosteroids |
| ATC:G01AA | Antibiotics |
| ATC:G01AA01 | Nystatin |
| ATC:G01AA02 | Natamycin |
| ATC:G01AA03 | AmphotericinB |
| ATC:G01AA04 | Candicidin |
| ATC:G01AA05 | Chloramphenicol |
| ATC:G01AA06 | Hachimycin |
| ATC:G01AA07 | Oxytetracycline |
| ATC:G01AA08 | Carfecillin |
| ATC:G01AA09 | Mepartricin |
| ATC:G01AA10 | Clindamycin |
| ATC:G01AA11 | Pentamycin |
| ATC:G01AA51 | Nystatin,combinations |
| ATC:G01AB | Arseniccompounds |
| ATC:G01AB01 | Acetarsol |
| ATC:G01AC | Quinolinederivatives |
| ATC:G01AC01 | Diiodohydroxyquinoline |
| ATC:G01AC02 | Clioquinol |
| ATC:G01AC03 | Chlorquinaldol |
| ATC:G01AC05 | Dequalinium |
| ATC:G01AC06 | Broxyquinoline |
| ATC:G01AC30 | Oxyquinoline |
| ATC:G01AD | Organicacids |
| ATC:G01AD01 | Lacticacid |
| ATC:G01AD02 | Aceticacid |
| ATC:G01AD03 | Ascorbicacid |
| ATC:G01AE | Sulfonamides |
| ATC:G01AE01 | Sulfatolamide |
| ATC:G01AE10 | Combinationsofsulfonamides |
| ATC:G01AF | Imidazolederivatives |
| ATC:G01AF01 | Metronidazole |
| ATC:G01AF02 | Clotrimazole |
| ATC:G01AF04 | Miconazole |
| ATC:G01AF05 | Econazole |
| ATC:G01AF06 | Ornidazole |
| ATC:G01AF07 | Isoconazole |
| ATC:G01AF08 | Tioconazole |
| ATC:G01AF11 | Ketoconazole |
| ATC:G01AF12 | Fenticonazole |
| ATC:G01AF13 | Azanidazole |
| ATC:G01AF14 | Propenidazole |
| ATC:G01AF15 | Butoconazole |
| ATC:G01AF16 | Omoconazole |
| ATC:G01AF17 | Oxiconazole |
| ATC:G01AF18 | Flutrimazole |
| ATC:G01AF19 | Sertaconazole |
| ATC:G01AF20 | Combinationsofimidazolederivatives |
| ATC:G01AG | Triazolederivatives |
| ATC:G01AG02 | Terconazole |
| ATC:G01AX | Otheranti-infectivesandantiseptics |
| ATC:G01AX01 | Clodantoin |
| ATC:G01AX02 | Inosine |
| ATC:G01AX03 | Policresulen |
| ATC:G01AX05 | Nifuratel |
| ATC:G01AX06 | Furazolidone |
| ATC:G01AX09 | Methylrosaniline |
| ATC:G01AX11 | Povidone-iodine |
| ATC:G01AX12 | Ciclopirox |
| ATC:G01AX13 | Protiofate |
| ATC:G01AX14 | Lactobacillusfermentum |
| ATC:G01AX15 | Copperusnate |
| ATC:G01AX16 | Hexetidine |
| ATC:G01AX66 | Octenidine,combinations |
| ATC:G02 | Other gynecological drugs |
| ATC:G02A | Uterotonics |
| ATC:G02AB | Ergotalkaloids |
| ATC:G02AB01 | Methylergometrine |
| ATC:G02AB02 | Ergotalkaloids |
| ATC:G02AB03 | Ergometrine |
| ATC:G02AC | Ergotalkaloidsandoxytocinincludinganalogues,incombination |
| ATC:G02AC01 | Methylergometrineandoxytocin |
| ATC:G02AD | Prostaglandins |
| ATC:G02AD01 | Dinoprost |
| ATC:G02AD02 | Dinoprostone |
| ATC:G02AD03 | Gemeprost |
| ATC:G02AD04 | Carboprost |
| ATC:G02AD05 | Sulprostone |
| ATC:G02AD06 | Misoprostol |
| ATC:G02B | Contraceptives for topical use |
| ATC:G02BA | Intrauterinecontraceptives |
| ATC:G02BA01 | PlasticIUD |
| ATC:G02BA02 | PlasticIUDwithcopper |
| ATC:G02BA03 | PlasticIUDwithprogestogen |
| ATC:G02BB | Intravaginalcontraceptives |
| ATC:G02BB01 | Vaginalringwithprogestogenandestrogen |
| ATC:G02C | Other gynecologicals |
| ATC:G02CA | Sympathomimetics,labourrepressants |
| ATC:G02CA01 | Ritodrine |
| ATC:G02CA02 | Buphenine |
| ATC:G02CA03 | Fenoterol |
| ATC:G02CB | Prolactininhibitors |
| ATC:G02CB01 | Bromocriptine |
| ATC:G02CB02 | Lisuride |
| ATC:G02CB03 | Cabergoline |
| ATC:G02CB04 | Quinagolide |
| ATC:G02CB05 | Metergoline |
| ATC:G02CB06 | Terguride |
| ATC:G02CC | Anti-inflammatoryproductsforvaginaladministration |
| ATC:G02CC01 | Ibuprofen |
| ATC:G02CC02 | Naproxen |
| ATC:G02CC03 | Benzydamine |
| ATC:G02CC04 | Flunoxaprofen |
| ATC:G02CX | Othergynecologicals |
| ATC:G02CX01 | Atosiban |
| ATC:G02CX03 | Agnicastifructus |
| ATC:G02CX04 | Cimicifugaerhizoma |
| ATC:G03 | Sex hormones and modulators of the genital system |
| ATC:G03A | Hormonal contraceptives for systemic use |
| ATC:G03AA | Progestogensandestrogens,fixedcombinations |
| ATC:G03AA01 | Etynodiolandethinylestradiol |
| ATC:G03AA02 | Quingestanolandethinylestradiol |
| ATC:G03AA03 | Lynestrenolandethinylestradiol |
| ATC:G03AA04 | Megestrolandethinylestradiol |
| ATC:G03AA05 | Norethisteroneandethinylestradiol |
| ATC:G03AA06 | Norgestrelandethinylestradiol |
| ATC:G03AA07 | Levonorgestrelandethinylestradiol |
| ATC:G03AA08 | Medroxyprogesteroneandethinylestradiol |
| ATC:G03AA09 | Desogestrelandethinylestradiol |
| ATC:G03AA10 | Gestodeneandethinylestradiol |
| ATC:G03AA11 | Norgestimateandethinylestradiol |
| ATC:G03AA12 | Drospirenoneandethinylestradiol |
| ATC:G03AA13 | Norelgestrominandethinylestradiol |
| ATC:G03AA14 | Nomegestrolandestradiol |
| ATC:G03AA15 | Chlormadinoneandethinylestradiol |
| ATC:G03AA16 | Dienogestandethinylestradiol |
| ATC:G03AB | Progestogensandestrogens,sequentialpreparations |
| ATC:G03AB01 | Megestrolandethinylestradiol |
| ATC:G03AB02 | Lynestrenolandethinylestradiol |
| ATC:G03AB03 | Levonorgestrelandethinylestradiol |
| ATC:G03AB04 | Norethisteroneandethinylestradiol |
| ATC:G03AB05 | Desogestrelandethinylestradiol |
| ATC:G03AB06 | Gestodeneandethinylestradiol |
| ATC:G03AB07 | Chlormadinoneandethinylestradiol |
| ATC:G03AB08 | Dienogestandestradiol |
| ATC:G03AC | Progestogens |
| ATC:G03AC01 | Norethisterone |
| ATC:G03AC02 | Lynestrenol |
| ATC:G03AC03 | Levonorgestrel |
| ATC:G03AC04 | Quingestanol |
| ATC:G03AC05 | Megestrol |
| ATC:G03AC06 | Medroxyprogesterone |
| ATC:G03AC07 | Norgestrienone |
| ATC:G03AC08 | Etonogestrel |
| ATC:G03AC09 | Desogestrel |
| ATC:G03AC10 | Drospirenone |
| ATC:G03AD | Emergencycontraceptives |
| ATC:G03AD01 | Levonorgestrel |
| ATC:G03AD02 | Ulipristal |
| ATC:G03B | Androgens |
| ATC:G03BA | 3-oxoandrosten-(4)derivatives |
| ATC:G03BA01 | Fluoxymesterone |
| ATC:G03BA02 | Methyltestosterone |
| ATC:G03BA03 | Testosterone |
| ATC:G03BB | 5-androstanon-(3)derivatives |
| ATC:G03BB01 | Mesterolone |
| ATC:G03BB02 | Androstanolone |
| ATC:G03C | Estrogens |
| ATC:G03CA | Naturalandsemisyntheticestrogens,plain |
| ATC:G03CA01 | Ethinylestradiol |
| ATC:G03CA03 | Estradiol |
| ATC:G03CA04 | Estriol |
| ATC:G03CA06 | Chlorotrianisene |
| ATC:G03CA07 | Estrone |
| ATC:G03CA09 | Promestriene |
| ATC:G03CA53 | Estradiol,combinations |
| ATC:G03CA57 | Conjugatedestrogens |
| ATC:G03CB | Syntheticestrogens,plain |
| ATC:G03CB01 | Dienestrol |
| ATC:G03CB02 | Diethylstilbestrol |
| ATC:G03CB03 | Methallenestril |
| ATC:G03CB04 | Moxestrol |
| ATC:G03CC | Estrogens,combinationswithotherdrugs |
| ATC:G03CC02 | Dienestrol |
| ATC:G03CC03 | Methallenestril |
| ATC:G03CC04 | Estrone |
| ATC:G03CC05 | Diethylstilbestrol |
| ATC:G03CC06 | Estriol |
| ATC:G03CC07 | Conjugatedestrogensandbazedoxifene |
| ATC:G03CX | Otherestrogens |
| ATC:G03CX01 | Tibolone |
| ATC:G03D | Progestogens |
| ATC:G03DA | Pregnen-(4)derivatives |
| ATC:G03DA01 | Gestonorone |
| ATC:G03DA02 | Medroxyprogesterone |
| ATC:G03DA03 | Hydroxyprogesterone |
| ATC:G03DA04 | Progesterone |
| ATC:G03DB | Pregnadienderivatives |
| ATC:G03DB01 | Dydrogesterone |
| ATC:G03DB02 | Megestrol |
| ATC:G03DB03 | Medrogestone |
| ATC:G03DB04 | Nomegestrol |
| ATC:G03DB05 | Demegestone |
| ATC:G03DB06 | Chlormadinone |
| ATC:G03DB07 | Promegestone |
| ATC:G03DB08 | Dienogest |
| ATC:G03DC | Estrenderivatives |
| ATC:G03DC01 | Allylestrenol |
| ATC:G03DC02 | Norethisterone |
| ATC:G03DC03 | Lynestrenol |
| ATC:G03DC04 | Ethisterone |
| ATC:G03DC06 | Etynodiol |
| ATC:G03DC31 | Methylestrenolone |
| ATC:G03E | Androgens and female sex hormones in combination |
| ATC:G03EA | Androgensandestrogens |
| ATC:G03EA01 | Methyltestosteroneandestrogen |
| ATC:G03EA02 | Testosteroneandestrogen |
| ATC:G03EA03 | Prasteroneandestrogen |
| ATC:G03EK | Androgensandfemalesexhormonesincombinationwithotherdrugs |
| ATC:G03EK01 | Methyltestosterone |
| ATC:G03F | Progestogens and estrogens in combination |
| ATC:G03FA | Progestogensandestrogens,fixedcombinations |
| ATC:G03FA01 | Norethisteroneandestrogen |
| ATC:G03FA02 | Hydroxyprogesteroneandestrogen |
| ATC:G03FA03 | Ethisteroneandestrogen |
| ATC:G03FA04 | Progesteroneandestrogen |
| ATC:G03FA05 | Methylnortestosteroneandestrogen |
| ATC:G03FA06 | Etynodiolandestrogen |
| ATC:G03FA07 | Lynestrenolandestrogen |
| ATC:G03FA08 | Megestrolandestrogen |
| ATC:G03FA09 | Noretynodrelandestrogen |
| ATC:G03FA10 | Norgestrelandestrogen |
| ATC:G03FA11 | Levonorgestrelandestrogen |
| ATC:G03FA12 | Medroxyprogesteroneandestrogen |
| ATC:G03FA13 | Norgestimateandestrogen |
| ATC:G03FA14 | Dydrogesteroneandestrogen |
| ATC:G03FA15 | Dienogestandestrogen |
| ATC:G03FA16 | Trimegestoneandestrogen |
| ATC:G03FA17 | Drospirenoneandestrogen |
| ATC:G03FB | Progestogensandestrogens,sequentialpreparations |
| ATC:G03FB01 | Norgestrelandestrogen |
| ATC:G03FB02 | Lynestrenolandestrogen |
| ATC:G03FB03 | Chlormadinoneandestrogen |
| ATC:G03FB04 | Megestrolandestrogen |
| ATC:G03FB05 | Norethisteroneandestrogen |
| ATC:G03FB06 | Medroxyprogesteroneandestrogen |
| ATC:G03FB07 | Medrogestoneandestrogen |
| ATC:G03FB08 | Dydrogesteroneandestrogen |
| ATC:G03FB09 | Levonorgestrelandestrogen |
| ATC:G03FB10 | Desogestrelandestrogen |
| ATC:G03FB11 | Trimegestoneandestrogen |
| ATC:G03FB12 | Nomegestrolandestrogen |
| ATC:G03G | Gonadotropins and other ovulation stimulants |
| ATC:G03GA | Gonadotropins |
| ATC:G03GA01 | Humanchorionicgonadotropin |
| ATC:G03GA02 | Humanmenopausalgonadotropin |
| ATC:G03GA03 | Serumgonadotropin |
| ATC:G03GA04 | Urofollitropin |
| ATC:G03GA05 | Follitropinalfa |
| ATC:G03GA06 | Follitropinbeta |
| ATC:G03GA07 | Lutropinalfa |
| ATC:G03GA08 | Choriogonadotropinalfa |
| ATC:G03GA09 | Corifollitropinalfa |
| ATC:G03GA10 | Follitropindelta |
| ATC:G03GA30 | Combinations |
| ATC:G03GB | Ovulationstimulants,synthetic |
| ATC:G03GB01 | Cyclofenil |
| ATC:G03GB02 | Clomifene |
| ATC:G03GB03 | Epimestrol |
| ATC:G03H | Antiandrogens |
| ATC:G03HA | Antiandrogens,plain |
| ATC:G03HA01 | Cyproterone |
| ATC:G03HB | Antiandrogensandestrogens |
| ATC:G03HB01 | Cyproteroneandestrogen |
| ATC:G03X | Other sex hormones and modulators of the genital system |
| ATC:G03XA | Antigonadotropinsandsimilaragents |
| ATC:G03XA01 | Danazol |
| ATC:G03XA02 | Gestrinone |
| ATC:G03XB | Progesteronereceptormodulators |
| ATC:G03XB01 | Mifepristone |
| ATC:G03XB02 | Ulipristal |
| ATC:G03XB51 | Mifepristone,combinations |
| ATC:G03XC | Selectiveestrogenreceptormodulators |
| ATC:G03XC01 | Raloxifene |
| ATC:G03XC02 | Bazedoxifene |
| ATC:G03XC03 | Lasofoxifene |
| ATC:G03XC04 | Ormeloxifene |
| ATC:G03XC05 | Ospemifene |
| ATC:G04 | Urological drugs |
| ATC:G04B | Urologicals |
| ATC:G04BA | Acidifiers |
| ATC:G04BA01 | Ammoniumchloride |
| ATC:G04BA03 | Calciumchloride |
| ATC:G04BC | Urinaryconcrementsolvents |
| ATC:G04BD | Drugsforurinaryfrequencyandincontinence |
| ATC:G04BD01 | Emepronium |
| ATC:G04BD02 | Flavoxate |
| ATC:G04BD03 | Meladrazine |
| ATC:G04BD04 | Oxybutynin |
| ATC:G04BD05 | Terodiline |
| ATC:G04BD06 | Propiverine |
| ATC:G04BD07 | Tolterodine |
| ATC:G04BD08 | Solifenacin |
| ATC:G04BD09 | Trospium |
| ATC:G04BD10 | Darifenacin |
| ATC:G04BD11 | Fesoterodine |
| ATC:G04BD12 | Mirabegron |
| ATC:G04BD13 | Desfesoterodine |
| ATC:G04BE | Drugsusedinerectiledysfunction |
| ATC:G04BE01 | Alprostadil |
| ATC:G04BE02 | Papaverine |
| ATC:G04BE03 | Sildenafil |
| ATC:G04BE04 | Yohimbin |
| ATC:G04BE06 | Moxisylyte |
| ATC:G04BE07 | Apomorphine |
| ATC:G04BE08 | Tadalafil |
| ATC:G04BE09 | Vardenafil |
| ATC:G04BE10 | Avanafil |
| ATC:G04BE11 | Udenafil |
| ATC:G04BE30 | Combinations |
| ATC:G04BE52 | Papaverine,combinations |
| ATC:G04BX | Otherurologicals |
| ATC:G04BX01 | Magnesiumhydroxide |
| ATC:G04BX03 | Acetohydroxamicacid |
| ATC:G04BX06 | Phenazopyridine |
| ATC:G04BX10 | Succinimide |
| ATC:G04BX11 | Collagen |
| ATC:G04BX12 | Phenylsalicylate |
| ATC:G04BX13 | Dimethylsulfoxide |
| ATC:G04BX14 | Dapoxetine |
| ATC:G04BX15 | Pentosanpolysulfatesodium |
| ATC:G04C | Drugs used in benign prostatic hypertrophy |
| ATC:G04CA | Alpha-adrenoreceptorantagonists |
| ATC:G04CA01 | Alfuzosin |
| ATC:G04CA02 | Tamsulosin |
| ATC:G04CA03 | Terazosin |
| ATC:G04CA04 | Silodosin |
| ATC:G04CA05 | Doxazosin |
| ATC:G04CA51 | Alfuzosinandfinasteride |
| ATC:G04CA52 | Tamsulosinanddutasteride |
| ATC:G04CA53 | Tamsulosinandsolifenacin |
| ATC:G04CB | Testosterone-5-alphareductaseinhibitors |
| ATC:G04CB01 | Finasteride |
| ATC:G04CB02 | Dutasteride |
| ATC:G04CX | Otherdrugsusedinbenignprostatichypertrophy |
| ATC:G04CX01 | Prunusafricanaecortex |
| ATC:G04CX02 | Sabalisserrulataefructus |
| ATC:G04CX03 | Mepartricin |
| ATC:H01 | Pituitary and hypothalamic hormones and analogues |
| ATC:H01A | Anterior pituitary lobe hormones and analogues |
| ATC:H01AA | Adrenocorticotropichormone |
| ATC:H01AA01 | Corticotropin |
| ATC:H01AA02 | Tetracosactide |
| ATC:H01AB | Thyrotropin |
| ATC:H01AB01 | Thyrotropinalfa |
| ATC:H01AC | Somatropinandsomatropinagonists |
| ATC:H01AC01 | Somatropin |
| ATC:H01AC02 | Somatrem |
| ATC:H01AC03 | Mecasermin |
| ATC:H01AC04 | Sermorelin |
| ATC:H01AC05 | Mecaserminrinfabate |
| ATC:H01AC06 | Tesamorelin |
| ATC:H01AX | Otheranteriorpituitarylobehormonesandanalogues |
| ATC:H01AX01 | Pegvisomant |
| ATC:H01B | Posterior pituitary lobe hormones |
| ATC:H01BA | Vasopressinandanalogues |
| ATC:H01BA01 | Vasopressin |
| ATC:H01BA02 | Desmopressin |
| ATC:H01BA03 | Lypressin |
| ATC:H01BA04 | Terlipressin |
| ATC:H01BA05 | Ornipressin |
| ATC:H01BA06 | Argipressin |
| ATC:H01BB | Oxytocinandanalogues |
| ATC:H01BB01 | Demoxytocin |
| ATC:H01BB02 | Oxytocin |
| ATC:H01BB03 | Carbetocin |
| ATC:H01C | Hypothalamic hormones |
| ATC:H01CA | Gonadotropin-releasinghormones |
| ATC:H01CA01 | Gonadorelin |
| ATC:H01CA02 | Nafarelin |
| ATC:H01CB | Somatostatinandanalogues |
| ATC:H01CB01 | Somatostatin |
| ATC:H01CB02 | Octreotide |
| ATC:H01CB03 | Lanreotide |
| ATC:H01CB04 | Vapreotide |
| ATC:H01CB05 | Pasireotide |
| ATC:H01CC | Anti-gonadotropin-releasinghormones |
| ATC:H01CC01 | Ganirelix |
| ATC:H01CC02 | Cetrorelix |
| ATC:H02 | Corticosteroids systemic |
| ATC:H02A | Corticosteroids for systemic use, plain |
| ATC:H02AA | Mineralocorticoids |
| ATC:H02AA01 | Aldosterone |
| ATC:H02AA02 | Fludrocortisone |
| ATC:H02AA03 | Desoxycortone |
| ATC:H02AB | Glucocorticoids |
| ATC:H02AB01 | Betamethasone |
| ATC:H02AB02 | Dexamethasone |
| ATC:H02AB03 | Fluocortolone |
| ATC:H02AB04 | Methylprednisolone |
| ATC:H02AB05 | Paramethasone |
| ATC:H02AB06 | Prednisolone |
| ATC:H02AB07 | Prednisone |
| ATC:H02AB08 | Triamcinolone |
| ATC:H02AB09 | Hydrocortisone |
| ATC:H02AB10 | Cortisone |
| ATC:H02AB11 | Prednylidene |
| ATC:H02AB12 | Rimexolone |
| ATC:H02AB13 | Deflazacort |
| ATC:H02AB14 | Cloprednol |
| ATC:H02AB15 | Meprednisone |
| ATC:H02AB17 | Cortivazol |
| ATC:H02BX | Corticosteroids for systemic use, combinations |
| ATC:H02BX01 | Methylprednisolone,combinations |
| ATC:H03 | Thyroid therapy |
| ATC:H03A | Thyroid preparations |
| ATC:H03AA | Thyroidhormones |
| ATC:H03AA01 | Levothyroxinesodium |
| ATC:H03AA02 | Liothyroninesodium |
| ATC:H03AA03 | Combinationsoflevothyroxineandliothyronine |
| ATC:H03AA04 | Tiratricol |
| ATC:H03AA05 | Thyroidglandpreparations |
| ATC:H03B | Antithyroid preparations |
| ATC:H03BA | Thiouracils |
| ATC:H03BA01 | Methylthiouracil |
| ATC:H03BA02 | Propylthiouracil |
| ATC:H03BA03 | Benzylthiouracil |
| ATC:H03BB | Sulphur-containingimidazolederivatives |
| ATC:H03BB01 | Carbimazole |
| ATC:H03BB02 | Thiamazole |
| ATC:H03BB52 | Thiamazole,combinations |
| ATC:H03BC | Perchlorates |
| ATC:H03BC01 | Potassiumperchlorate |
| ATC:H03BX | Otherantithyroidpreparations |
| ATC:H03BX01 | Diiodotyrosine |
| ATC:H03BX02 | Dibromotyrosine |
| ATC:H04 | Pancreatic hormones |
| ATC:H04AA | Glycogenolytic hormones |
| ATC:H04AA01 | Glucagon |
| ATC:H05 | Calcium homeostasis |
| ATC:H05AA | Parathyroid hormones and analogues |
| ATC:H05AA01 | Parathyroidglandextract |
| ATC:H05AA02 | Teriparatide |
| ATC:H05AA03 | Parathyroidhormone |
| ATC:H05B | Anti-parathyroid agents |
| ATC:H05BA | Calcitoninpreparations |
| ATC:H05BA01 | Calcitonin(salmonsynthetic) |
| ATC:H05BA02 | Calcitonin(porknatural) |
| ATC:H05BA03 | Calcitonin(humansynthetic) |
| ATC:H05BA04 | Elcatonin |
| ATC:H05BX | Otheranti-parathyroidagents |
| ATC:H05BX01 | Cinacalcet |
| ATC:H05BX02 | Paricalcitol |
| ATC:H05BX03 | Doxercalciferol |
| ATC:H05BX04 | Etelcalcetide |
| ATC:J01 | Antibacterial drugs |
| ATC:J01AA | Tetracyclines |
| ATC:J01AA01 | Demeclocycline |
| ATC:J01AA02 | Doxycycline |
| ATC:J01AA03 | Chlortetracycline |
| ATC:J01AA04 | Lymecycline |
| ATC:J01AA05 | Metacycline |
| ATC:J01AA06 | Oxytetracycline |
| ATC:J01AA07 | Tetracycline |
| ATC:J01AA08 | Minocycline |
| ATC:J01AA09 | Rolitetracycline |
| ATC:J01AA10 | Penimepicycline |
| ATC:J01AA11 | Clomocycline |
| ATC:J01AA12 | Tigecycline |
| ATC:J01AA20 | Tetracyclines,combinations |
| ATC:J01AA56 | Oxytetracycline,combinations |
| ATC:J01BA | Amphenicols |
| ATC:J01BA01 | Chloramphenicol |
| ATC:J01BA02 | Thiamphenicol |
| ATC:J01BA52 | Thiamphenicol,combinations |
| ATC:J01C | Beta lactam antibiotics, penicillins |
| ATC:J01CA | Penicillins,Extended-Spectrum |
| ATC:J01CA01 | Ampicillin |
| ATC:J01CA02 | Pivampicillin |
| ATC:J01CA03 | Carbenicillin |
| ATC:J01CA04 | Amoxicillin |
| ATC:J01CA05 | Carindacillin |
| ATC:J01CA06 | Bacampicillin |
| ATC:J01CA07 | Epicillin |
| ATC:J01CA08 | Pivmecillinam |
| ATC:J01CA09 | Azlocillin |
| ATC:J01CA10 | Mezlocillin |
| ATC:J01CA11 | Mecillinam |
| ATC:J01CA12 | Piperacillin |
| ATC:J01CA13 | Ticarcillin |
| ATC:J01CA14 | Metampicillin |
| ATC:J01CA15 | Talampicillin |
| ATC:J01CA16 | Sulbenicillin |
| ATC:J01CA17 | Temocillin |
| ATC:J01CA18 | Hetacillin |
| ATC:J01CA19 | Aspoxicillin |
| ATC:J01CA20 | Penicillinswithextendedspectrum,combinations |
| ATC:J01CA51 | Ampicillin,combinations |
| ATC:J01CE | Beta-lactamasesensitivepenicillins |
| ATC:J01CE01 | Benzylpenicillin |
| ATC:J01CE02 | Phenoxymethylpenicillin |
| ATC:J01CE03 | Propicillin |
| ATC:J01CE04 | Azidocillin |
| ATC:J01CE05 | Pheneticillin |
| ATC:J01CE06 | Penamecillin |
| ATC:J01CE07 | Clometocillin |
| ATC:J01CE08 | Benzathinebenzylpenicillin |
| ATC:J01CE09 | Procainebenzylpenicillin |
| ATC:J01CE10 | Benzathinephenoxymethylpenicillin |
| ATC:J01CE30 | Beta-lactamasesensitivepenicillins,combinations |
| ATC:J01CF | Beta-lactamaseresistantpenicillins |
| ATC:J01CF01 | Dicloxacillin |
| ATC:J01CF02 | Cloxacillin |
| ATC:J01CF03 | Meticillin |
| ATC:J01CF04 | Oxacillin |
| ATC:J01CF05 | Flucloxacillin |
| ATC:J01CF06 | Nafcillin |
| ATC:J01CG | Beta-lactamaseinhibitors |
| ATC:J01CG01 | Sulbactam |
| ATC:J01CG02 | Tazobactam |
| ATC:J01CR | Combinationsofpenicillins,includingbeta-lactamaseinhibitors |
| ATC:J01CR01 | Ampicillinandenzymeinhibitor |
| ATC:J01CR02 | Amoxicillinandenzymeinhibitor |
| ATC:J01CR03 | Ticarcillinandenzymeinhibitor |
| ATC:J01CR04 | Sultamicillin |
| ATC:J01CR05 | Piperacillinandenzymeinhibitor |
| ATC:J01CR50 | Combinationsofpenicillins |
| ATC:J01D | Other beta-lactam antibacterials |
| ATC:J01DB | Firstgenerationcephalosporinslist |
| ATC:J01DB01 | Cefalexin |
| ATC:J01DB02 | Cefaloridine |
| ATC:J01DB03 | Cefalotin |
| ATC:J01DB04 | Cefazolin |
| ATC:J01DB05 | Cefadroxil |
| ATC:J01DB06 | Cefazedone |
| ATC:J01DB07 | Cefatrizine |
| ATC:J01DB08 | Cefapirin |
| ATC:J01DB09 | Cefradine |
| ATC:J01DB10 | Cefacetrile |
| ATC:J01DB11 | Cefroxadine |
| ATC:J01DB12 | Ceftezole |
| ATC:J01DC | Secondgenerationcephalosporinslist |
| ATC:J01DC01 | Cefoxitin |
| ATC:J01DC02 | Cefuroxime |
| ATC:J01DC03 | Cefamandole |
| ATC:J01DC04 | Cefaclor |
| ATC:J01DC05 | Cefotetan |
| ATC:J01DC06 | Cefonicide |
| ATC:J01DC07 | Cefotiam |
| ATC:J01DC08 | Loracarbef |
| ATC:J01DC09 | Cefmetazole |
| ATC:J01DC10 | Cefprozil |
| ATC:J01DC11 | Ceforanide |
| ATC:J01DC12 | Cefminox |
| ATC:J01DC13 | Cefbuperazone |
| ATC:J01DC14 | Flomoxef |
| ATC:J01DD | Third-generationcephalosporins |
| ATC:J01DD01 | Cefotaxime |
| ATC:J01DD02 | Ceftazidime |
| ATC:J01DD03 | Cefsulodin |
| ATC:J01DD04 | Ceftriaxone |
| ATC:J01DD05 | Cefmenoxime |
| ATC:J01DD06 | Latamoxef |
| ATC:J01DD07 | Ceftizoxime |
| ATC:J01DD08 | Cefixime |
| ATC:J01DD09 | Cefodizime |
| ATC:J01DD10 | Cefetamet |
| ATC:J01DD11 | Cefpiramide |
| ATC:J01DD12 | Cefoperazone |
| ATC:J01DD13 | Cefpodoxime |
| ATC:J01DD14 | Ceftibuten |
| ATC:J01DD15 | Cefdinir |
| ATC:J01DD16 | Cefditoren |
| ATC:J01DD17 | Cefcapene |
| ATC:J01DD51 | Cefotaxime,combinations |
| ATC:J01DD52 | Ceftazidime,combinations |
| ATC:J01DD54 | Ceftriaxone,combinations |
| ATC:J01DD62 | Cefoperazone,combinations |
| ATC:J01DE | Fourth-generationcephalosporins |
| ATC:J01DE01 | Cefepime |
| ATC:J01DE02 | Cefpirome |
| ATC:J01DE03 | Cefozopran |
| ATC:J01DF | Monobactams |
| ATC:J01DF01 | Aztreonam |
| ATC:J01DF02 | Carumonam |
| ATC:J01DH | Carbapenems |
| ATC:J01DH02 | Meropenem |
| ATC:J01DH03 | Ertapenem |
| ATC:J01DH04 | Doripenem |
| ATC:J01DH05 | Biapenem |
| ATC:J01DH51 | Imipenemandenzymeinhibitor |
| ATC:J01DH55 | Panipenemandbetamipron |
| ATC:J01DI | Othercephalosporinsandpenems |
| ATC:J01DI01 | Ceftobiprolemedocaril |
| ATC:J01DI02 | Ceftarolinefosamil |
| ATC:J01DI03 | Faropenem |
| ATC:J01DI54 | Ceftolozaneandenzymeinhibitor |
| ATC:J01E | Sulfonamides and trimethoprim |
| ATC:J01EA | Trimethoprimandderivatives |
| ATC:J01EA01 | Trimethoprim |
| ATC:J01EA02 | Brodimoprim |
| ATC:J01EA03 | Iclaprim |
| ATC:J01EB | Short-actingsulfonamides |
| ATC:J01EB01 | Sulfaisodimidine |
| ATC:J01EB02 | Sulfamethizole |
| ATC:J01EB03 | Sulfadimidine |
| ATC:J01EB04 | Sulfapyridine |
| ATC:J01EB05 | Sulfafurazole |
| ATC:J01EB06 | Sulfanilamide |
| ATC:J01EB07 | Sulfathiazole |
| ATC:J01EB08 | Sulfathiourea |
| ATC:J01EB20 | Combinations |
| ATC:J01EC | Intermediate-actingsulfonamides |
| ATC:J01EC01 | Sulfamethoxazole |
| ATC:J01EC02 | Sulfadiazine |
| ATC:J01EC03 | Sulfamoxole |
| ATC:J01EC20 | Combinations |
| ATC:J01ED | Long-actingsulfonamides |
| ATC:J01ED01 | Sulfadimethoxine |
| ATC:J01ED02 | Sulfalene |
| ATC:J01ED03 | Sulfametomidine |
| ATC:J01ED04 | Sulfametoxydiazine |
| ATC:J01ED05 | Sulfamethoxypyridazine |
| ATC:J01ED06 | Sulfaperin |
| ATC:J01ED07 | Sulfamerazine |
| ATC:J01ED08 | Sulfaphenazole |
| ATC:J01ED09 | Sulfamazon |
| ATC:J01ED20 | Combinations |
| ATC:J01EE | Combinationsofsulfonamidesandtrimethoprim,includingderivatives |
| ATC:J01EE01 | Sulfamethoxazoleandtrimethoprim |
| ATC:J01EE02 | Sulfadiazineandtrimethoprim |
| ATC:J01EE03 | Sulfametroleandtrimethoprim |
| ATC:J01EE04 | Sulfamoxoleandtrimethoprim |
| ATC:J01EE05 | Sulfadimidineandtrimethoprim |
| ATC:J01EE06 | Sulfadiazineandtetroxoprim |
| ATC:J01EE07 | Sulfamerazineandtrimethoprim |
| ATC:J01F | Macrolides, lincosamides and streptogramins |
| ATC:J01FA | Macrolideantibiotics |
| ATC:J01FA01 | Erythromycin |
| ATC:J01FA02 | Spiramycin |
| ATC:J01FA03 | Midecamycin |
| ATC:J01FA05 | Oleandomycin |
| ATC:J01FA06 | Roxithromycin |
| ATC:J01FA07 | Josamycin |
| ATC:J01FA08 | Troleandomycin |
| ATC:J01FA09 | Clarithromycin |
| ATC:J01FA10 | Azithromycin |
| ATC:J01FA11 | Miocamycin |
| ATC:J01FA12 | Rokitamycin |
| ATC:J01FA13 | Dirithromycin |
| ATC:J01FA14 | Flurithromycin |
| ATC:J01FA15 | Telithromycin |
| ATC:J01FF | Lincosamideantibiotics |
| ATC:J01FF01 | Clindamycin |
| ATC:J01FF02 | Lincomycin |
| ATC:J01FG | Streptograminantibiotics |
| ATC:J01FG01 | Pristinamycin |
| ATC:J01FG02 | Quinupristin/dalfopristin |
| ATC:J01G | Aminoglycoside antibacterials |
| ATC:J01GA | Streptomycins |
| ATC:J01GA01 | Streptomycin |
| ATC:J01GA02 | Streptoduocin |
| ATC:J01GB | Otheraminoglycosides |
| ATC:J01GB01 | Tobramycin |
| ATC:J01GB03 | Gentamicin |
| ATC:J01GB04 | Kanamycin |
| ATC:J01GB05 | Neomycin |
| ATC:J01GB06 | Amikacin |
| ATC:J01GB07 | Netilmicin |
| ATC:J01GB08 | Sisomicin |
| ATC:J01GB09 | Dibekacin |
| ATC:J01GB10 | Ribostamycin |
| ATC:J01GB11 | Isepamicin |
| ATC:J01GB12 | Arbekacin |
| ATC:J01GB13 | Bekanamycin |
| ATC:J01M | Quinolone antibacterials |
| ATC:J01MA | Fluoroquinolones |
| ATC:J01MA01 | Ofloxacin |
| ATC:J01MA02 | Ciprofloxacin |
| ATC:J01MA03 | Pefloxacin |
| ATC:J01MA04 | Enoxacin |
| ATC:J01MA05 | Temafloxacin |
| ATC:J01MA06 | Norfloxacin |
| ATC:J01MA07 | Lomefloxacin |
| ATC:J01MA08 | Fleroxacin |
| ATC:J01MA09 | Sparfloxacin |
| ATC:J01MA10 | Rufloxacin |
| ATC:J01MA11 | Grepafloxacin |
| ATC:J01MA12 | Levofloxacin |
| ATC:J01MA13 | Trovafloxacin |
| ATC:J01MA14 | Moxifloxacin |
| ATC:J01MA15 | Gemifloxacin |
| ATC:J01MA16 | Gatifloxacin |
| ATC:J01MA17 | Prulifloxacin |
| ATC:J01MA18 | Pazufloxacin |
| ATC:J01MA19 | Garenoxacin |
| ATC:J01MA21 | Sitafloxacin |
| ATC:J01MB | Otherquinolones |
| ATC:J01MB01 | Rosoxacin |
| ATC:J01MB02 | Nalidixicacid |
| ATC:J01MB03 | Piromidicacid |
| ATC:J01MB04 | Pipemidicacid |
| ATC:J01MB05 | Oxolinicacid |
| ATC:J01MB06 | Cinoxacin |
| ATC:J01MB07 | Flumequine |
| ATC:J01MB08 | Nemonoxacin |
| ATC:J01RA | Combinations of antibacterials |
| ATC:J01RA01 | Penicillins,combinationswithotherantibacterials |
| ATC:J01RA02 | Sulfonamides,combinationswithotherantibacterials(excludingtrimethoprim) |
| ATC:J01RA03 | Cefuroximeandmetronidazole |
| ATC:J01RA04 | Spiramycinandmetronidazole |
| ATC:J01RA05 | Levofloxacinandornidazole |
| ATC:J01RA06 | Cefepimeandamikacin |
| ATC:J01RA07 | Azithromycin,fluconazoleandsecnidazole |
| ATC:J01RA08 | Tetracyclineandoleandomycin |
| ATC:J01RA09 | Ofloxacinandornidazole |
| ATC:J01RA10 | Ciprofloxacinandmetronidazole |
| ATC:J01RA11 | Ciprofloxacinandtinidazole |
| ATC:J01RA12 | Ciprofloxacinandornidazole |
| ATC:J01RA13 | Norfloxacinandtinidazole |
| ATC:J01X | Other antibacterial drugs |
| ATC:J01XA | Glycopeptideantibacterials |
| ATC:J01XA01 | Vancomycin |
| ATC:J01XA02 | Teicoplanin |
| ATC:J01XA03 | Telavancin |
| ATC:J01XA04 | Dalbavancin |
| ATC:J01XA05 | Oritavancin |
| ATC:J01XB | Polymyxins |
| ATC:J01XB01 | Colistin |
| ATC:J01XB02 | PolymyxinB |
| ATC:J01XC | Steroidantibacterials |
| ATC:J01XC01 | Fusidicacid |
| ATC:J01XD | Imidazolederivatives |
| ATC:J01XD01 | Metronidazole |
| ATC:J01XD02 | Tinidazole |
| ATC:J01XD03 | Ornidazole |
| ATC:J01XE | Nitrofuranderivatives |
| ATC:J01XE01 | Nitrofurantoin |
| ATC:J01XE02 | Nifurtoinol |
| ATC:J01XE03 | Furazidin |
| ATC:J01XE51 | Nitrofurantoincombinations |
| ATC:J01XX | Otherantibacterials |
| ATC:J01XX01 | Fosfomycin |
| ATC:J01XX02 | Xibornol |
| ATC:J01XX03 | Clofoctol |
| ATC:J01XX04 | Spectinomycin |
| ATC:J01XX05 | Methenamine |
| ATC:J01XX06 | Mandelicacid |
| ATC:J01XX07 | Nitroxoline |
| ATC:J01XX08 | Linezolid |
| ATC:J01XX09 | Daptomycin |
| ATC:J01XX10 | Bacitracin |
| ATC:J01XX11 | Tedizolid |
| ATC:J02 | Antimycotic drugs |
| ATC:J02A | Antimycotics for systemic use |
| ATC:J02AA | Antibiotics |
| ATC:J02AA01 | AmphotericinB |
| ATC:J02AA02 | Hachimycin |
| ATC:J02AB | Imidazolederivatives |
| ATC:J02AB01 | Miconazole |
| ATC:J02AB02 | Ketoconazole |
| ATC:J02AC | Triazolederivatives |
| ATC:J02AC01 | Fluconazole |
| ATC:J02AC02 | Itraconazole |
| ATC:J02AC03 | Voriconazole |
| ATC:J02AC04 | Posaconazole |
| ATC:J02AC05 | Isavuconazole |
| ATC:J02AX | Otherantimycoticsforsystemicuse |
| ATC:J02AX01 | Flucytosine |
| ATC:J02AX04 | Caspofungin |
| ATC:J02AX05 | Micafungin |
| ATC:J02AX06 | Anidulafungin |
| ATC:J04 | Antimycobacterials |
| ATC:J04A | Drugs for treatment of tuberculosis |
| ATC:J04AA | Aminosalicylicacidandderivatives |
| ATC:J04AA01 | Aminosalicylicacid |
| ATC:J04AA02 | Sodiumaminosalicylate |
| ATC:J04AA03 | Calciumaminosalicylate |
| ATC:J04AB | Antibiotics |
| ATC:J04AB01 | Cycloserine |
| ATC:J04AB02 | Rifampicin |
| ATC:J04AB03 | Rifamycin |
| ATC:J04AB04 | Rifabutin |
| ATC:J04AB05 | Rifapentin |
| ATC:J04AB30 | Capreomycin |
| ATC:J04AC | Hydrazides |
| ATC:J04AC01 | Isoniazid |
| ATC:J04AC51 | Isoniazid,combinations |
| ATC:J04AD | Thiocarbamidederivatives |
| ATC:J04AD01 | Protionamide |
| ATC:J04AD02 | Tiocarlide |
| ATC:J04AD03 | Ethionamide |
| ATC:J04AK | Otherdrugsfortreatmentoftuberculosis |
| ATC:J04AK01 | Pyrazinamide |
| ATC:J04AK02 | Ethambutol |
| ATC:J04AK03 | Terizidone |
| ATC:J04AK04 | Morinamide |
| ATC:J04AK05 | Bedaquiline |
| ATC:J04AK06 | Delamanid |
| ATC:J04AK07 | Thioacetazone |
| ATC:J04AM | Combinationsofdrugsfortreatmentoftuberculosis |
| ATC:J04AM01 | Streptomycinandisoniazid |
| ATC:J04AM02 | Rifampicinandisoniazid |
| ATC:J04AM03 | Ethambutolandisoniazid |
| ATC:J04AM04 | Thioacetazoneandisoniazid |
| ATC:J04AM05 | Rifampicin,pyrazinamideandisoniazid |
| ATC:J04AM06 | Rifampicin,pyrazinamide,ethambutolandisoniazid |
| ATC:J04BA | Drugs for treatment of lepra |
| ATC:J04BA01 | Clofazimine |
| ATC:J04BA02 | Dapsone |
| ATC:J04BA03 | Aldesulfonesodium |
| ATC:J05 | Antiviral drugs |
| ATC:J05A | Direct acting antiviral drugs |
| ATC:J05AA | Thiosemicarbazones |
| ATC:J05AA01 | Metisazone |
| ATC:J05AB | Nucleosidesandnucleotidesexcludingreversetranscriptaseinhibitors |
| ATC:J05AB01 | Aciclovir |
| ATC:J05AB02 | Idoxuridine |
| ATC:J05AB03 | Vidarabine |
| ATC:J05AB04 | Ribavirin |
| ATC:J05AB06 | Ganciclovir |
| ATC:J05AB09 | Famciclovir |
| ATC:J05AB11 | Valaciclovir |
| ATC:J05AB12 | Cidofovir |
| ATC:J05AB13 | Penciclovir |
| ATC:J05AB14 | Valganciclovir |
| ATC:J05AB15 | Brivudine |
| ATC:J05AB54 | Ribavirin,combinations |
| ATC:J05AC | Cyclicamines |
| ATC:J05AC02 | Rimantadine |
| ATC:J05AC03 | Tromantadine |
| ATC:J05AD | Phosphonicacidderivatives |
| ATC:J05AD01 | Foscarnet |
| ATC:J05AD02 | Fosfonet |
| ATC:J05AE | Proteaseinhibitors |
| ATC:J05AE01 | Saquinavir |
| ATC:J05AE02 | Indinavir |
| ATC:J05AE03 | Ritonavir |
| ATC:J05AE04 | Nelfinavir |
| ATC:J05AE05 | Amprenavir |
| ATC:J05AE07 | Fosamprenavir |
| ATC:J05AE08 | Atazanavir |
| ATC:J05AE09 | Tipranavir |
| ATC:J05AE10 | Darunavir |
| ATC:J05AE11 | Telaprevir |
| ATC:J05AE12 | Boceprevir |
| ATC:J05AE13 | Faldaprevir |
| ATC:J05AE14 | Simeprevir |
| ATC:J05AE15 | Asunaprevir |
| ATC:J05AF | Nucleosideandnucleotidereversetranscriptaseinhibitors |
| ATC:J05AF01 | Zidovudine |
| ATC:J05AF02 | Didanosine |
| ATC:J05AF03 | Zalcitabine |
| ATC:J05AF04 | Stavudine |
| ATC:J05AF05 | Lamivudine |
| ATC:J05AF06 | Abacavir |
| ATC:J05AF07 | Tenofovirdisoproxil |
| ATC:J05AF08 | Adefovirdipivoxil |
| ATC:J05AF09 | Emtricitabine |
| ATC:J05AF10 | Entecavir |
| ATC:J05AF11 | Telbivudine |
| ATC:J05AF12 | Clevudine |
| ATC:J05AG | Non-nucleosidereversetranscriptaseinhibitors |
| ATC:J05AG01 | Nevirapine |
| ATC:J05AG02 | Delavirdine |
| ATC:J05AG03 | Efavirenz |
| ATC:J05AG04 | Etravirine |
| ATC:J05AG05 | Rilpivirine |
| ATC:J05AH | Neuraminidaseinhibitors |
| ATC:J05AH01 | Zanamivir |
| ATC:J05AH02 | Oseltamivir |
| ATC:J05AP | AntiviralsfortreatmentofHCVinfections |
| ATC:J05AP56 | Sofosbuvir,velpatasvirandvoxilaprevir |
| ATC:J05AR | AntiviralsfortreatmentofHIVinfections,combinations |
| ATC:J05AR01 | Zidovudineandlamivudine |
| ATC:J05AR02 | Lamivudineandabacavir |
| ATC:J05AR03 | Tenofovirdisoproxilandemtricitabine |
| ATC:J05AR04 | Zidovudine,lamivudineandabacavir |
| ATC:J05AR05 | Zidovudine,lamivudineandnevirapine |
| ATC:J05AR06 | Emtricitabine,tenofovirdisoproxilandefavirenz |
| ATC:J05AR07 | Stavudine,lamivudineandnevirapine |
| ATC:J05AR08 | Emtricitabine,tenofovirdisoproxilandrilpivirine |
| ATC:J05AR09 | Emtricitabine,tenofovirdisoproxil,elvitegravirandcobicistat |
| ATC:J05AR10 | Lopinavirandritonavir |
| ATC:J05AR11 | Lamivudine,tenofovirdisoproxilandefavirenz |
| ATC:J05AR12 | Lamivudineandtenofovirdisoproxil |
| ATC:J05AR13 | Lamivudine,abacaviranddolutegravir |
| ATC:J05AR14 | Darunavirandcobicistat |
| ATC:J05AX | Otherantivirals |
| ATC:J05AX01 | Moroxydine |
| ATC:J05AX02 | Lysozyme |
| ATC:J05AX05 | Inosinepranobex |
| ATC:J05AX06 | Pleconaril |
| ATC:J05AX07 | Enfuvirtide |
| ATC:J05AX08 | Raltegravir |
| ATC:J05AX09 | Maraviroc |
| ATC:J05AX10 | Maribavir |
| ATC:J05AX11 | Elvitegravir |
| ATC:J05AX12 | Dolutegravir |
| ATC:J05AX13 | Umifenovir |
| ATC:J05AX14 | Daclatasvir |
| ATC:J05AX15 | Sofosbuvir |
| ATC:J05AX68 | ElbasvirandGrazoprevir |
| ATC:J06 | Immune sera and immunoglobulins |
| ATC:J06AA | Immune sera |
| ATC:J06AA01 | Diphtheriaantitoxin |
| ATC:J06AA02 | Tetanusantitoxin |
| ATC:J06AA03 | Snakevenomantiserum |
| ATC:J06AA04 | Botulinumantitoxin |
| ATC:J06AA05 | Gas-gangrenesera |
| ATC:J06AA06 | Rabiesserum |
| ATC:J06B | Immunoglobulins |
| ATC:J06BA | Immunoglobulins,normalhuman |
| ATC:J06BA01 | Immunoglobulins,normalhuman,forextravascularadministration |
| ATC:J06BA02 | Immunoglobulins,normalhuman,forintravascularadministration |
| ATC:J06BB | Specificimmunoglobulins |
| ATC:J06BB01 | Anti-D(rh)immunoglobulin |
| ATC:J06BB02 | Tetanusimmunoglobulin |
| ATC:J06BB03 | Varicella/zosterimmunoglobulin |
| ATC:J06BB04 | HepatitisBimmunoglobulin |
| ATC:J06BB05 | Rabiesimmunoglobulin |
| ATC:J06BB06 | Rubellaimmunoglobulin |
| ATC:J06BB07 | Vacciniaimmunoglobulin |
| ATC:J06BB08 | Staphylococcusimmunoglobulin |
| ATC:J06BB09 | Cytomegalovirusimmunoglobulin |
| ATC:J06BB10 | Diphtheriaimmunoglobulin |
| ATC:J06BB11 | HepatitisAimmunoglobulin |
| ATC:J06BB12 | Encephalitis,tickborneimmunoglobulin |
| ATC:J06BB13 | Pertussisimmunoglobulin |
| ATC:J06BB14 | Morbilliimmunoglobulin |
| ATC:J06BB15 | Parotitisimmunoglobulin |
| ATC:J06BB16 | Palivizumab |
| ATC:J06BB17 | Motavizumab |
| ATC:J06BB18 | Raxibacumab |
| ATC:J06BB19 | Anthraximmunoglobulin |
| ATC:J06BB30 | Combinations |
| ATC:J06BC | Otherimmunoglobulins |
| ATC:J06BC01 | Nebacumab |
| ATC:J07 | Vaccines |
| ATC:J07A | Bacterial vaccines |
| ATC:J07AC | Anthraxvaccines |
| ATC:J07AC01 | Anthraxantigen |
| ATC:J07AD | Brucellosisvaccines |
| ATC:J07AD01 | Brucellaantigen |
| ATC:J07AE | Choleravaccines |
| ATC:J07AE01 | Cholera,inactivated,wholecell |
| ATC:J07AE02 | Cholera,liveattenuated |
| ATC:J07AE51 | Cholera,combinationswithtyphoidvaccine,inactivated,wholecell |
| ATC:J07AF | Diphtheriavaccines |
| ATC:J07AF01 | Diphtheriatoxoid |
| ATC:J07AG | HaemophilusinfluenzaeBvaccine |
| ATC:J07AG01 | Hib,purifiedantigenconjugated |
| ATC:J07AG51 | Hib,combinationswithtoxoids |
| ATC:J07AG52 | Hib,combinationswithpertussisandtoxoids |
| ATC:J07AG53 | Hib,combinationswithmeningococcusC,conjugated |
| ATC:J07AH | Meningococcalvaccines |
| ATC:J07AH01 | MeningococcusA,purifiedpolysaccharidesantigen |
| ATC:J07AH02 | Othermeningococcalmonovalentpurifiedpolysaccharidesantigen |
| ATC:J07AH03 | MeningococcusA,C,bivalentpurifiedpolysaccharidesantigen |
| ATC:J07AH04 | MeningococcusA,C,Y,W-135,tetravalentpurifiedpolysaccharidesantigen |
| ATC:J07AH05 | Othermeningococcalpolyvalentpurifiedpolysaccharidesantigen |
| ATC:J07AH06 | MeningococcusB,outermembranevesiclevaccine |
| ATC:J07AH07 | MeningococcusC,purifiedpolysaccharidesantigenconjugated |
| ATC:J07AH08 | MeningococcusA,C,Y,W-135,tetravalentpurifiedpolysaccharidesantigenconjugated |
| ATC:J07AH09 | MeningococcusB,multicomponentvaccine |
| ATC:J07AH10 | MeningococcusA,purifiedpolysaccharidesantigenconjugated |
| ATC:J07AJ | Pertussisvaccines |
| ATC:J07AJ01 | Pertussis,inactivated,wholecell |
| ATC:J07AJ02 | Pertussis,purifiedantigen |
| ATC:J07AJ51 | Pertussis,inactivated,wholecell,combinationswithtoxoids |
| ATC:J07AJ52 | Pertussis,purifiedantigen,combinationswithtoxoids |
| ATC:J07AK | Plaguevaccines |
| ATC:J07AK01 | Plague,inactivated,wholecell |
| ATC:J07AL | Pneumococcalvaccines |
| ATC:J07AL01 | Pneumococcus,purifiedpolysaccharidesantigen |
| ATC:J07AL02 | Pneumococcus,purifiedpolysaccharidesantigenconjugated |
| ATC:J07AL52 | PneumococcuspurifiedpolysaccharidesantigenandHaemophilusinfluenzae,conjugated |
| ATC:J07AM | Tetanusvaccines |
| ATC:J07AM01 | Tetanustoxoid |
| ATC:J07AM51 | Tetanustoxoid,combinationswithdiphtheriatoxoid |
| ATC:J07AM52 | Tetanustoxoid,combinationswithtetanusimmunoglobulin |
| ATC:J07AN | Tuberculosisvaccines |
| ATC:J07AN01 | Tuberculosis,liveattenuated |
| ATC:J07AP | Typhoidvaccines |
| ATC:J07AP01 | Typhoid,oral,liveattenuated |
| ATC:J07AP02 | Typhoid,inactivated,wholecell |
| ATC:J07AP03 | Typhoid,purifiedpolysaccharideantigen |
| ATC:J07AP10 | Typhoid,combinationswithparatyphitypes |
| ATC:J07AR | Typhus(exanthematicus)vaccines |
| ATC:J07AR01 | Typhusexanthematicus,inactivated,wholecell |
| ATC:J07B | Viral vaccines |
| ATC:J07BA | Encephalitisvaccines |
| ATC:J07BA01 | Encephalitis,tickborne,inactivated,wholevirus |
| ATC:J07BA02 | Encephalitis,Japanese,inactivated,wholevirus |
| ATC:J07BA03 | Encephalitis,Japanese,liveattenuated |
| ATC:J07BB | Influenzavaccines |
| ATC:J07BB01 | Influenza,inactivated,wholevirus |
| ATC:J07BB02 | Influenza,purifiedantigen |
| ATC:J07BB03 | Influenza,liveattenuated |
| ATC:J07BC | Hepatitisvaccines |
| ATC:J07BC01 | HepatitisB,purifiedantigen |
| ATC:J07BC02 | HepatitisA,inactivated,wholevirus |
| ATC:J07BC20 | Combinations |
| ATC:J07BD | Measlesvaccines |
| ATC:J07BD01 | Measles,liveattenuated |
| ATC:J07BD51 | Measles,combinationswithmumps,liveattenuated |
| ATC:J07BD52 | Measles,combinationswithmumpsandrubella,liveattenuated |
| ATC:J07BD53 | Measles,combinationswithrubella,liveattenuated |
| ATC:J07BD54 | Measles,combinationswithmumps,rubellaandvaricella,liveattenuated |
| ATC:J07BE | Mumpsvaccines |
| ATC:J07BE01 | Mumps,liveattenuated |
| ATC:J07BF | Poliomyelitisvaccines |
| ATC:J07BF01 | Poliomyelitisoral,monovalentliveattenuated |
| ATC:J07BF02 | Poliomyelitisoral,trivalent,liveattenuated |
| ATC:J07BF03 | Poliomyelitis,trivalent,inactivated,wholevirus |
| ATC:J07BF04 | Poliomyelitisoral,bivalent,liveattenuated |
| ATC:J07BG | Rabiesvaccines |
| ATC:J07BG01 | Rabies,inactivated,wholevirus |
| ATC:J07BH | Rotavirusdiarrheavaccines |
| ATC:J07BH01 | Rotavirus,liveattenuated |
| ATC:J07BH02 | Rotavirus,pentavalent,live,reassorted |
| ATC:J07BJ | Rubellavaccines |
| ATC:J07BJ01 | Rubella,liveattenuated |
| ATC:J07BJ51 | Rubella,combinationswithmumps,liveattenuated |
| ATC:J07BK | Varicellazostervaccines |
| ATC:J07BK01 | Varicella,liveattenuated |
| ATC:J07BK02 | Zoster,liveattenuated |
| ATC:J07BL | Yellowfevervaccines |
| ATC:J07BL01 | Yellowfever,liveattenuated |
| ATC:J07BM | Papillomavirusvaccines |
| ATC:J07BM01 | Papillomavirus(humantypes6,11,16,18) |
| ATC:J07BM02 | Papillomavirus(humantypes16,18) |
| ATC:J07BM03 | Papillomavirus(humantypes6,11,16,18,31,33,45,52,58) |
| ATC:J07BX | Otherviralvaccines |
| ATC:J07BX01 | Smallpox,liveattenuated |
| ATC:J07CA | Bacterial and viral vaccines |
| ATC:J07CA01 | Diphtheria-poliomyelitis-tetanus |
| ATC:J07CA02 | Diphtheria-pertussis-poliomyelitis-tetanus |
| ATC:J07CA03 | Diphtheria-rubella-tetanus |
| ATC:J07CA04 | HemophilusinfluenzaeBandpoliomyelitis |
| ATC:J07CA05 | Diphtheria-hepatitisB-pertussis-tetanus |
| ATC:J07CA06 | Diphtheria-hemophilusinfluenzaeB-pertussis-poliomyelitis-tetanus |
| ATC:J07CA07 | Diphtheria-hepatitisB-tetanus |
| ATC:J07CA08 | HemophilusinfluenzaeBandhepatitisB |
| ATC:J07CA09 | Diphtheria-hemophilusinfluenzaeB-pertussis-poliomyelitis-tetanus-hepatitisB |
| ATC:J07CA10 | Typhoid-hepatitisA |
| ATC:J07CA11 | Diphtheria-HemophilusinfluenzaeB-pertussis-tetanus-hepatitisB |
| ATC:J07CA12 | Diphtheria-pertussis-poliomyelitis-tetanus-hepatitisB |
| ATC:J07CA13 | Diphtheria-hemophilusinfluenzaeB-pertussis-tetanus-hepatitisB-meningococcusA+C |
| ATC:L01 | Antineoplastic drugs |
| ATC:L01A | Alkylating agents list |
| ATC:L01AA | Nitrogenmustardanalogues |
| ATC:L01AA01 | Cyclophosphamide |
| ATC:L01AA02 | Chlorambucil |
| ATC:L01AA03 | Melphalan |
| ATC:L01AA05 | Chlormethine |
| ATC:L01AA06 | Ifosfamide |
| ATC:L01AA07 | Trofosfamide |
| ATC:L01AA08 | Prednimustine |
| ATC:L01AA09 | Bendamustine |
| ATC:L01AB | Alkylsulfonates |
| ATC:L01AB01 | Busulfan |
| ATC:L01AB02 | Treosulfan |
| ATC:L01AB03 | Mannosulfan |
| ATC:L01AC | Ethyleneimines |
| ATC:L01AC01 | Thiotepa |
| ATC:L01AC02 | Triaziquone |
| ATC:L01AC03 | Carboquone |
| ATC:L01AD | Nitrosoureas |
| ATC:L01AD01 | Carmustine |
| ATC:L01AD02 | Lomustine |
| ATC:L01AD03 | Semustine |
| ATC:L01AD04 | Streptozocin |
| ATC:L01AD05 | Fotemustine |
| ATC:L01AD06 | Nimustine |
| ATC:L01AD07 | Ranimustine |
| ATC:L01AG | Epoxides |
| ATC:L01AG01 | Etoglucid |
| ATC:L01AX | Otheralkylatingagents |
| ATC:L01AX01 | Mitobronitol |
| ATC:L01AX02 | Pipobroman |
| ATC:L01AX03 | Temozolomide |
| ATC:L01AX04 | Dacarbazine |
| ATC:L01B | Antimetabolites |
| ATC:L01BA | Folicacidanalogues |
| ATC:L01BA01 | Methotrexate |
| ATC:L01BA03 | Raltitrexed |
| ATC:L01BA04 | Pemetrexed |
| ATC:L01BA05 | Pralatrexate |
| ATC:L01BB | Purineanalogues |
| ATC:L01BB02 | Mercaptopurine |
| ATC:L01BB03 | Tioguanine |
| ATC:L01BB04 | Cladribine |
| ATC:L01BB05 | Fludarabine |
| ATC:L01BB06 | Clofarabine |
| ATC:L01BB07 | Nelarabine |
| ATC:L01BC | Pyrimidineanalogues |
| ATC:L01BC01 | Cytarabine |
| ATC:L01BC02 | Fluorouracil |
| ATC:L01BC03 | Tegafur |
| ATC:L01BC04 | Carmofur |
| ATC:L01BC05 | Gemcitabine |
| ATC:L01BC06 | Capecitabine |
| ATC:L01BC07 | Azacitidine |
| ATC:L01BC08 | Decitabine |
| ATC:L01BC52 | Fluorouracil,combinations |
| ATC:L01BC53 | Tegafur,combinations |
| ATC:L01BC59 | Trifluridine,combinations |
| ATC:L01C | Plant alkaloids and other natural products |
| ATC:L01CA | Vincaalkaloidsandanalogues |
| ATC:L01CA01 | Vinblastine |
| ATC:L01CA02 | Vincristine |
| ATC:L01CA03 | Vindesine |
| ATC:L01CA04 | Vinorelbine |
| ATC:L01CA05 | Vinflunine |
| ATC:L01CA06 | Vintafolide |
| ATC:L01CB | Podophyllotoxinderivatives |
| ATC:L01CB01 | Etoposide |
| ATC:L01CB02 | Teniposide |
| ATC:L01CC | Colchicinederivatives |
| ATC:L01CC01 | Demecolcine |
| ATC:L01CD | Taxanes |
| ATC:L01CD01 | Paclitaxel |
| ATC:L01CD02 | Docetaxel |
| ATC:L01CD03 | Paclitaxelpoliglumex |
| ATC:L01CD04 | Cabazitaxel |
| ATC:L01CX | Otherplantalkaloidsandnaturalproducts |
| ATC:L01CX01 | Trabectedin |
| ATC:L01D | Cytotoxic antibiotics and related substances |
| ATC:L01DA | Actinomycin |
| ATC:L01DA01 | Dactinomycin |
| ATC:L01DB | Anthracyclinesandrelatedsubstances |
| ATC:L01DB01 | Doxorubicin |
| ATC:L01DB02 | Daunorubicin |
| ATC:L01DB03 | Epirubicin |
| ATC:L01DB04 | Aclarubicin |
| ATC:L01DB05 | Zorubicin |
| ATC:L01DB06 | Idarubicin |
| ATC:L01DB07 | Mitoxantrone |
| ATC:L01DB08 | Pirarubicin |
| ATC:L01DB09 | Valrubicin |
| ATC:L01DB10 | Amrubicin |
| ATC:L01DB11 | Pixantrone |
| ATC:L01DC | Othercytotoxicantibiotics |
| ATC:L01DC01 | Bleomycin |
| ATC:L01DC02 | Plicamycin |
| ATC:L01DC03 | Mitomycin |
| ATC:L01DC04 | Ixabepilone |
| ATC:L01X | Other antineoplastic agents |
| ATC:L01XA | Platinumcompounds |
| ATC:L01XA01 | Cisplatin |
| ATC:L01XA02 | Carboplatin |
| ATC:L01XA03 | Oxaliplatin |
| ATC:L01XA04 | Satraplatin |
| ATC:L01XA05 | Polyplatillen |
| ATC:L01XB | Methylhydrazines |
| ATC:L01XB01 | Procarbazine |
| ATC:L01XC | Monoclonalantibodies |
| ATC:L01XC01 | Edrecolomab |
| ATC:L01XC02 | Rituximab |
| ATC:L01XC03 | Trastuzumab |
| ATC:L01XC05 | Gemtuzumab |
| ATC:L01XC06 | Cetuximab |
| ATC:L01XC07 | Bevacizumab |
| ATC:L01XC08 | Panitumumab |
| ATC:L01XC09 | Catumaxomab |
| ATC:L01XC10 | Ofatumumab |
| ATC:L01XC11 | Ipilimumab |
| ATC:L01XC12 | Brentuximabvedotin |
| ATC:L01XC13 | Pertuzumab |
| ATC:L01XC14 | Trastuzumabemtansine |
| ATC:L01XC15 | Obinutuzumab |
| ATC:L01XC16 | Dinutuximab |
| ATC:L01XC17 | Nivolumab |
| ATC:L01XC18 | Pembrolizumab |
| ATC:L01XC19 | Blinatumomab |
| ATC:L01XC21 | Ramucirumab |
| ATC:L01XC22 | Necitumumab |
| ATC:L01XC23 | Elotuzumab |
| ATC:L01XC24 | Daratumumab |
| ATC:L01XC25 | Mogamulizumab |
| ATC:L01XC26 | Inotuzumabozogamicin |
| ATC:L01XD | Sensitizersusedinphotodynamic/radiationtherapy |
| ATC:L01XD01 | Porfimersodium |
| ATC:L01XD03 | Methylaminolevulinate |
| ATC:L01XD04 | Aminolevulinicacid |
| ATC:L01XD05 | Temoporfin |
| ATC:L01XD06 | Efaproxiral |
| ATC:L01XE | Proteinkinaseinhibitors |
| ATC:L01XE01 | Imatinib |
| ATC:L01XE02 | Gefitinib |
| ATC:L01XE03 | Erlotinib |
| ATC:L01XE04 | Sunitinib |
| ATC:L01XE05 | Sorafenib |
| ATC:L01XE06 | Dasatinib |
| ATC:L01XE07 | Lapatinib |
| ATC:L01XE08 | Nilotinib |
| ATC:L01XE09 | Temsirolimus |
| ATC:L01XE10 | Everolimus |
| ATC:L01XE11 | Pazopanib |
| ATC:L01XE12 | Vandetanib |
| ATC:L01XE13 | Afatinib |
| ATC:L01XE14 | Bosutinib |
| ATC:L01XE15 | Vemurafenib |
| ATC:L01XE16 | Crizotinib |
| ATC:L01XE17 | Axitinib |
| ATC:L01XE18 | Ruxolitinib |
| ATC:L01XE19 | Ridaforolimus |
| ATC:L01XE21 | Regorafenib |
| ATC:L01XE22 | Masitinib |
| ATC:L01XE23 | Dabrafenib |
| ATC:L01XE24 | Ponatinib |
| ATC:L01XE25 | Trametinib |
| ATC:L01XE26 | Cabozantinib |
| ATC:L01XE27 | Ibrutinib |
| ATC:L01XE28 | Ceritinib |
| ATC:L01XE29 | Lenvatinib |
| ATC:L01XE31 | Nintedanib |
| ATC:L01XE32 | Cediranib |
| ATC:L01XE33 | Palbociclib |
| ATC:L01XE34 | Tivozanib |
| ATC:L01XE35 | Osimertinib |
| ATC:L01XE36 | Alectinib |
| ATC:L01XE37 | Rociletinib |
| ATC:L01XE38 | Cobimetinib |
| ATC:L01XX | Otherantineoplasticagents |
| ATC:L01XX01 | Amsacrine |
| ATC:L01XX02 | Asparaginase |
| ATC:L01XX03 | Altretamine |
| ATC:L01XX05 | Hydroxycarbamide |
| ATC:L01XX07 | Lonidamine |
| ATC:L01XX08 | Pentostatin |
| ATC:L01XX09 | Miltefosine |
| ATC:L01XX10 | Masoprocol |
| ATC:L01XX11 | Estramustine |
| ATC:L01XX14 | Tretinoin |
| ATC:L01XX16 | Mitoguazone |
| ATC:L01XX17 | Topotecan |
| ATC:L01XX18 | Tiazofurine |
| ATC:L01XX19 | Irinotecan |
| ATC:L01XX22 | Alitretinoin |
| ATC:L01XX23 | Mitotane |
| ATC:L01XX24 | Pegaspargase |
| ATC:L01XX25 | Bexarotene |
| ATC:L01XX27 | Arsenictrioxide |
| ATC:L01XX29 | Denileukindiftitox |
| ATC:L01XX32 | Bortezomib |
| ATC:L01XX33 | Celecoxib |
| ATC:L01XX35 | Anagrelide |
| ATC:L01XX36 | Oblimersen |
| ATC:L01XX37 | Sitimageneceradenovec |
| ATC:L01XX38 | Vorinostat |
| ATC:L01XX39 | Romidepsin |
| ATC:L01XX40 | Omacetaxinemepesuccinate |
| ATC:L01XX41 | Eribulin |
| ATC:L01XX42 | Panobinostat |
| ATC:L01XX43 | Vismodegib |
| ATC:L01XX44 | Aflibercept |
| ATC:L01XX45 | Carfilzomib |
| ATC:L01XX46 | Olaparib |
| ATC:L01XX47 | Idelalisib |
| ATC:L01XX48 | Sonidegib |
| ATC:L01XX49 | Belinostat |
| ATC:L01XX50 | Ixazomib |
| ATC:L01XX51 | Talimogenelaherparepvec |
| ATC:L02 | Endocrine therapy |
| ATC:L02A | Hormones and related agents |
| ATC:L02AA | Estrogens |
| ATC:L02AA01 | Diethylstilbestrol |
| ATC:L02AA02 | Polyestradiolphosphate |
| ATC:L02AA03 | Ethinylestradiol |
| ATC:L02AA04 | Fosfestrol |
| ATC:L02AB | Progestogens |
| ATC:L02AB01 | Megestrol |
| ATC:L02AB02 | Medroxyprogesterone |
| ATC:L02AB03 | Gestonorone |
| ATC:L02AE | Gonadotropin-releasinghormoneanalogues |
| ATC:L02AE01 | Buserelin |
| ATC:L02AE02 | Leuprorelin |
| ATC:L02AE03 | Goserelin |
| ATC:L02AE04 | Triptorelin |
| ATC:L02AE05 | Histrelin |
| ATC:L02B | Hormone antagonists and related agents |
| ATC:L02BA | Anti-estrogens |
| ATC:L02BA01 | Tamoxifen |
| ATC:L02BA02 | Toremifene |
| ATC:L02BA03 | Fulvestrant |
| ATC:L02BB | Anti-androgens |
| ATC:L02BB01 | Flutamide |
| ATC:L02BB02 | Nilutamide |
| ATC:L02BB03 | Bicalutamide |
| ATC:L02BB04 | Enzalutamide |
| ATC:L02BG | Aromataseinhibitors |
| ATC:L02BG01 | Aminogluthetimide |
| ATC:L02BG02 | Formestane |
| ATC:L02BG03 | Anastrozole |
| ATC:L02BG04 | Letrozole |
| ATC:L02BG05 | Vorozole |
| ATC:L02BG06 | Exemestane |
| ATC:L02BX | Otherhormoneantagonistsandrelatedagents |
| ATC:L02BX01 | Abarelix |
| ATC:L02BX02 | Degarelix |
| ATC:L02BX03 | Abiraterone |
| ATC:L03A | Immunostimulants drugs |
| ATC:L03AA | Colony stimulating factors |
| ATC:L03AA02 | Filgrastim |
| ATC:L03AA03 | Molgramostim |
| ATC:L03AA09 | Sargramostim |
| ATC:L03AA10 | Lenograstim |
| ATC:L03AA12 | Ancestim |
| ATC:L03AA13 | Pegfilgrastim |
| ATC:L03AA14 | Lipegfilgrastim |
| ATC:L03AA15 | Balugrastim |
| ATC:L03AA16 | Empegfilgrastim |
| ATC:L03AB | Interferons |
| ATC:L03AB01 | Interferonalfanatural |
| ATC:L03AB02 | Interferonbetanatural |
| ATC:L03AB03 | Interferongamma |
| ATC:L03AB04 | Interferonalfa-2a |
| ATC:L03AB05 | Interferonalfa-2b |
| ATC:L03AB06 | Interferonalfa-n1 |
| ATC:L03AB07 | Interferonbeta-1a |
| ATC:L03AB08 | Interferonbeta-1b |
| ATC:L03AB09 | Interferonalfacon-1 |
| ATC:L03AB10 | Peginterferonalfa-2b |
| ATC:L03AB11 | Peginterferonalfa-2a |
| ATC:L03AB12 | Albinterferonalfa-2b |
| ATC:L03AB13 | Peginterferonbeta-1a |
| ATC:L03AB14 | Cepeginterferonalfa-2b |
| ATC:L03AB60 | Peginterferonalfa-2b,combinations |
| ATC:L03AB61 | Peginterferonalfa-2a,combinations |
| ATC:L03AC | Interleukins |
| ATC:L03AC01 | Aldesleukin |
| ATC:L03AC02 | Oprelvekin |
| ATC:L03AX | Other immunostimulants |
| ATC:L03AX01 | Lentinan |
| ATC:L03AX02 | Roquinimex |
| ATC:L03AX03 | BCGvaccine |
| ATC:L03AX04 | Pegademase |
| ATC:L03AX05 | Pidotimod |
| ATC:L03AX07 | PolyI |
| ATC:L03AX08 | PolyICLC |
| ATC:L03AX09 | Thymopentin |
| ATC:L03AX10 | Immunocyanin |
| ATC:L03AX11 | Tasonermin |
| ATC:L03AX12 | Melanomavaccine |
| ATC:L03AX13 | Glatirameracetate |
| ATC:L03AX14 | Histaminedihydrochloride |
| ATC:L03AX15 | Mifamurtide |
| ATC:L03AX16 | Plerixafor |
| ATC:L03AX17 | Sipuleucel-T |
| ATC:L03AX18 | Cridanimod |
| ATC:L03AX19 | Dasiprotimut-T |
| ATC:L04A | Immunosuppressants drugs |
| ATC:L04AA | Selective immunosuppressants |
| ATC:L04AA02 | Muromonab-CD3 |
| ATC:L04AA03 | Antilymphocyteimmunoglobulin(horse) |
| ATC:L04AA04 | Antithymocyteimmunoglobulin(rabbit) |
| ATC:L04AA06 | Mycophenolicacid |
| ATC:L04AA10 | Sirolimus |
| ATC:L04AA13 | Leflunomide |
| ATC:L04AA15 | Alefacept |
| ATC:L04AA18 | Everolimus |
| ATC:L04AA19 | Gusperimus |
| ATC:L04AA21 | Efalizumab |
| ATC:L04AA22 | Abetimus |
| ATC:L04AA23 | Natalizumab |
| ATC:L04AA24 | Abatacept |
| ATC:L04AA25 | Eculizumab |
| ATC:L04AA26 | Belimumab |
| ATC:L04AA27 | Fingolimod |
| ATC:L04AA28 | Belatacept |
| ATC:L04AA29 | Tofacitinib |
| ATC:L04AA31 | Teriflunomide |
| ATC:L04AA32 | Apremilast |
| ATC:L04AA33 | Vedolizumab |
| ATC:L04AA34 | Alemtuzumab |
| ATC:L04AA35 | Begelomab |
| ATC:L04AB | Tumor necrosis factor alpha (TNF-?) inhibitors |
| ATC:L04AB01 | Etanercept |
| ATC:L04AB02 | Infliximab |
| ATC:L04AB03 | Afelimomab |
| ATC:L04AB04 | Adalimumab |
| ATC:L04AB05 | Certolizumabpegol |
| ATC:L04AB06 | Golimumab |
| ATC:L04AC | Interleukin inhibitors |
| ATC:L04AC01 | Daclizumab |
| ATC:L04AC02 | Basiliximab |
| ATC:L04AC03 | Anakinra |
| ATC:L04AC04 | Rilonacept |
| ATC:L04AC05 | Ustekinumab |
| ATC:L04AC06 | Mepolizumab |
| ATC:L04AC07 | Tocilizumab |
| ATC:L04AC08 | Canakinumab |
| ATC:L04AC09 | Briakinumab |
| ATC:L04AC10 | Secukinumab |
| ATC:L04AC11 | Siltuximab |
| ATC:L04AC12 | Brodalumab |
| ATC:L04AC13 | Ixekizumab |
| ATC:L04AD | Calcineurin inhibitors |
| ATC:L04AD01 | Ciclosporin |
| ATC:L04AD02 | Tacrolimus |
| ATC:L04AD03 | Voclosporin |
| ATC:L04AX | Other immunosuppressants |
| ATC:L04AX01 | Azathioprine |
| ATC:L04AX02 | Thalidomide |
| ATC:L04AX03 | Methotrexate |
| ATC:L04AX04 | Lenalidomide |
| ATC:L04AX05 | Pirfenidone |
| ATC:L04AX06 | Pomalidomide |
| ATC:M01 | Anti-inflammatory and antirheumatic drugs |
| ATC:M01A | Anti-inflammatory and antirheumatic products, non-steroids |
| ATC:M01AA | Butylpyrazolidines |
| ATC:M01AA01 | Phenylbutazone |
| ATC:M01AA02 | Mofebutazone |
| ATC:M01AA03 | Oxyphenbutazone |
| ATC:M01AA05 | Clofezone |
| ATC:M01AA06 | Kebuzone |
| ATC:M01AB | Aceticacidderivativesandrelatedsubstances |
| ATC:M01AB01 | Indometacin |
| ATC:M01AB02 | Sulindac |
| ATC:M01AB03 | Tolmetin |
| ATC:M01AB04 | Zomepirac |
| ATC:M01AB05 | Diclofenac |
| ATC:M01AB06 | Alclofenac |
| ATC:M01AB07 | Bumadizone |
| ATC:M01AB08 | Etodolac |
| ATC:M01AB09 | Lonazolac |
| ATC:M01AB10 | Fentiazac |
| ATC:M01AB11 | Acemetacin |
| ATC:M01AB12 | Difenpiramide |
| ATC:M01AB13 | Oxametacin |
| ATC:M01AB14 | Proglumetacin |
| ATC:M01AB15 | Ketorolac |
| ATC:M01AB16 | Aceclofenac |
| ATC:M01AB17 | Bufexamac |
| ATC:M01AB51 | Indometacin,combinations |
| ATC:M01AB55 | Diclofenac,combinations |
| ATC:M01AC | Oxicams |
| ATC:M01AC01 | Piroxicam |
| ATC:M01AC02 | Tenoxicam |
| ATC:M01AC04 | Droxicam |
| ATC:M01AC05 | Lornoxicam |
| ATC:M01AC06 | Meloxicam |
| ATC:M01AC56 | Meloxicam,combinations |
| ATC:M01AE | Propionicacidderivatives |
| ATC:M01AE01 | Ibuprofen |
| ATC:M01AE02 | Naproxen |
| ATC:M01AE03 | Ketoprofen |
| ATC:M01AE04 | Fenoprofen |
| ATC:M01AE05 | Fenbufen |
| ATC:M01AE06 | Benoxaprofen |
| ATC:M01AE07 | Suprofen |
| ATC:M01AE08 | Pirprofen |
| ATC:M01AE09 | Flurbiprofen |
| ATC:M01AE10 | Indoprofen |
| ATC:M01AE11 | Tiaprofenicacid |
| ATC:M01AE12 | Oxaprozin |
| ATC:M01AE13 | Ibuproxam |
| ATC:M01AE14 | Dexibuprofen |
| ATC:M01AE15 | Flunoxaprofen |
| ATC:M01AE16 | Alminoprofen |
| ATC:M01AE17 | Dexketoprofen |
| ATC:M01AE18 | Naproxcinod |
| ATC:M01AE51 | Ibuprofen,combinations |
| ATC:M01AE52 | Naproxenandesomeprazole |
| ATC:M01AE53 | Ketoprofen,combinations |
| ATC:M01AE56 | Naproxenandmisoprostol |
| ATC:M01AG | FenamateDrugs |
| ATC:M01AG01 | Mefenamicacid |
| ATC:M01AG02 | Tolfenamicacid |
| ATC:M01AG03 | Flufenamicacid |
| ATC:M01AG04 | Meclofenamicacid |
| ATC:M01AH | Coxibs |
| ATC:M01AH01 | Celecoxib |
| ATC:M01AH02 | Rofecoxib |
| ATC:M01AH03 | Valdecoxib |
| ATC:M01AH04 | Parecoxib |
| ATC:M01AH05 | Etoricoxib |
| ATC:M01AH06 | Lumiracoxib |
| ATC:M01AX | Otheranti-inflammatoryandantirheumaticagents,non-steroids |
| ATC:M01AX01 | Nabumetone |
| ATC:M01AX02 | Niflumicacid |
| ATC:M01AX04 | Azapropazone |
| ATC:M01AX05 | Glucosamine |
| ATC:M01AX07 | Benzydamine |
| ATC:M01AX12 | Glucosaminoglycanpolysulfate |
| ATC:M01AX13 | Proquazone |
| ATC:M01AX14 | Orgotein |
| ATC:M01AX17 | Nimesulide |
| ATC:M01AX18 | Feprazone |
| ATC:M01AX21 | Diacerein |
| ATC:M01AX22 | Morniflumate |
| ATC:M01AX23 | Tenidap |
| ATC:M01AX24 | Oxaceprol |
| ATC:M01AX25 | Chondroitinsulfate |
| ATC:M01AX26 | Avocadoandsoyabeanoil,unsaponifiables |
| ATC:M01AX68 | Feprazone,combinations |
| ATC:M01B | Anti-inflammatory/antirheumatic agents in combination |
| ATC:M01BA | Anti-inflammatory/antirheumaticagentsincombinationwithcorticosteroids |
| ATC:M01BA01 | Phenylbutazoneandcorticosteroids |
| ATC:M01BA02 | Dipyrocetylandcorticosteroids |
| ATC:M01BA03 | Acetylsalicylicacidandcorticosteroids |
| ATC:M01C | Specific antirheumatic agents |
| ATC:M01CA | Quinolines |
| ATC:M01CA03 | Oxycinchophen |
| ATC:M01CB | Goldpreparations |
| ATC:M01CB01 | Sodiumaurothiomalate |
| ATC:M01CB02 | Sodiumaurothiosulfate |
| ATC:M01CB03 | Auranofin |
| ATC:M01CB04 | Aurothioglucose |
| ATC:M01CB05 | Aurotioprol |
| ATC:M01CC | Penicillamineandsimilaragents |
| ATC:M01CC01 | Penicillamine |
| ATC:M01CC02 | Bucillamine |
| ATC:M01CX | Otherspecificantirheumaticagents |
| ATC:M02 | Topical products for joint and muscular pain |
| ATC:M02A | Topical products for joint and muscular pain |
| ATC:M02AA | Anti-inflammatorypreparations,non-steroidsfortopicaluse |
| ATC:M02AA01 | Phenylbutazone |
| ATC:M02AA02 | Mofebutazone |
| ATC:M02AA03 | Clofezone |
| ATC:M02AA04 | Oxyphenbutazone |
| ATC:M02AA05 | Benzydamine |
| ATC:M02AA06 | Etofenamate |
| ATC:M02AA07 | Piroxicam |
| ATC:M02AA08 | Felbinac |
| ATC:M02AA09 | Bufexamac |
| ATC:M02AA10 | Ketoprofen |
| ATC:M02AA11 | Bendazac |
| ATC:M02AA12 | Naproxen |
| ATC:M02AA13 | Ibuprofen |
| ATC:M02AA14 | Fentiazac |
| ATC:M02AA15 | Diclofenac |
| ATC:M02AA16 | Feprazone |
| ATC:M02AA17 | Niflumicacid |
| ATC:M02AA18 | Meclofenamicacid |
| ATC:M02AA19 | Flurbiprofen |
| ATC:M02AA21 | Tolmetin |
| ATC:M02AA22 | Suxibuzone |
| ATC:M02AA23 | Indometacin |
| ATC:M02AA24 | Nifenazone |
| ATC:M02AA25 | Aceclofenac |
| ATC:M02AA26 | Nimesulide |
| ATC:M02AA27 | Dexketoprofen |
| ATC:M02AB | Capsaicinandsimilaragents |
| ATC:M02AB01 | Capsaicin |
| ATC:M02AB02 | Zucapsaicin |
| ATC:M02AC | Preparationswithsalicylicacidderivatives |
| ATC:M02AX | Othertopicalproductsforjointandmuscularpain |
| ATC:M02AX02 | Tolazoline |
| ATC:M02AX03 | Dimethylsulfoxide |
| ATC:M02AX05 | Idrocilamide |
| ATC:M02AX06 | Tolperisone |
| ATC:M02AX10 | Various |
| ATC:M03 | Muscle relaxants |
| ATC:M03A | Muscle relaxants, peripherally acting agents |
| ATC:M03AA | Curarealkaloids |
| ATC:M03AA01 | Alcuronium |
| ATC:M03AA02 | Tubocurarine |
| ATC:M03AA04 | Dimethyltubocurarine |
| ATC:M03AB | Cholinederivatives |
| ATC:M03AB01 | Suxamethonium |
| ATC:M03AC | Otherquaternaryammoniumcompounds |
| ATC:M03AC01 | Pancuronium |
| ATC:M03AC02 | Gallamine |
| ATC:M03AC03 | Vecuronium |
| ATC:M03AC04 | Atracurium |
| ATC:M03AC05 | Hexafluronium |
| ATC:M03AC06 | Pipecuroniumbromide |
| ATC:M03AC07 | Doxacuriumchloride |
| ATC:M03AC08 | Fazadiniumbromide |
| ATC:M03AC09 | Rocuroniumbromide |
| ATC:M03AC10 | Mivacuriumchloride |
| ATC:M03AC11 | Cisatracurium |
| ATC:M03AX | Othermusclerelaxants,peripherallyactingagents |
| ATC:M03AX01 | Botulinumtoxin |
| ATC:M03B | Muscle relaxants, centrally acting agents |
| ATC:M03BA | Carbamicacidesters |
| ATC:M03BA01 | Phenprobamate |
| ATC:M03BA02 | Carisoprodol |
| ATC:M03BA03 | Methocarbamol |
| ATC:M03BA04 | Styramate |
| ATC:M03BA05 | Febarbamate |
| ATC:M03BA51 | Phenprobamate,combinationsexcludingpsycholeptics |
| ATC:M03BA52 | Carisoprodol,combinationsexcludingpsycholeptics |
| ATC:M03BA53 | Methocarbamol,combinationsexcludingpsycholeptics |
| ATC:M03BA71 | Phenprobamate,combinationswithpsycholeptics |
| ATC:M03BA72 | Carisoprodol,combinationswithpsycholeptics |
| ATC:M03BA73 | Methocarbamol,combinationswithpsycholeptics |
| ATC:M03BB | Oxazol,thiazine,andtriazinederivatives |
| ATC:M03BB02 | Chlormezanone |
| ATC:M03BB03 | Chlorzoxazone |
| ATC:M03BB52 | Chlormezanone,combinationsexcludingpsycholeptics |
| ATC:M03BB53 | Chlorzoxazone,combinationsexcludingpsycholeptics |
| ATC:M03BB72 | Chlormezanone,combinationswithpsycholeptics |
| ATC:M03BB73 | Chlorzoxazone,combinationswithpsycholeptics |
| ATC:M03BC | Ethers,chemicallyclosetoantihistamines |
| ATC:M03BC01 | Orphenadrine(citrate) |
| ATC:M03BC51 | Orphenadrine,combinations |
| ATC:M03BX | Othercentrallyactingagents |
| ATC:M03BX01 | Baclofen |
| ATC:M03BX02 | Tizanidine |
| ATC:M03BX03 | Pridinol |
| ATC:M03BX04 | Tolperisone |
| ATC:M03BX05 | Thiocolchicoside |
| ATC:M03BX06 | Mephenesin |
| ATC:M03BX07 | Tetrazepam |
| ATC:M03BX08 | Cyclobenzaprine |
| ATC:M03BX09 | Eperisone |
| ATC:M03BX30 | Phenyramidol |
| ATC:M03BX55 | Thiocolchicoside,combinations |
| ATC:M03C | Muscle relaxants, directly acting agents |
| ATC:M03CA | Dantroleneandderivatives |
| ATC:M03CA01 | Dantrolene |
| ATC:M04A | Antigout preparations |
| ATC:M04AA | Preparations inhibiting uric acid production |
| ATC:M04AA01 | Allopurinol |
| ATC:M04AA02 | Tisopurine |
| ATC:M04AA03 | Febuxostat |
| ATC:M04AA51 | Allopurinol,combinations |
| ATC:M04AB | Preparations increasing uric acid excretion |
| ATC:M04AB01 | Probenecid |
| ATC:M04AB02 | Sulfinpyrazone |
| ATC:M04AB03 | Benzbromarone |
| ATC:M04AB04 | Isobromindione |
| ATC:M04AB05 | Lesinurad |
| ATC:M04AC | Preparations with no effect on uric acid metabolism |
| ATC:M04AC01 | Colchicine |
| ATC:M04AC02 | Cinchophen |
| ATC:M04AX | Other antigout preparations |
| ATC:M04AX01 | Urateoxidase |
| ATC:M04AX02 | Pegloticase |
| ATC:M05B | Drugs for treatment of bone diseases |
| ATC:M05BA | Bisphosphonates |
| ATC:M05BA01 | Etidronicacid |
| ATC:M05BA02 | Clodronicacid |
| ATC:M05BA03 | Pamidronicacid |
| ATC:M05BA04 | Alendronicacid |
| ATC:M05BA05 | Tiludronicacid |
| ATC:M05BA06 | Ibandronicacid |
| ATC:M05BA07 | Risedronicacid |
| ATC:M05BA08 | Zoledronicacid |
| ATC:M05BB | Bisphosphonates, combinations |
| ATC:M05BB01 | Etidronicacidandcalcium,sequential |
| ATC:M05BB02 | Risedronicacidandcalcium,sequential |
| ATC:M05BB03 | Alendronicacidandcolecalciferol |
| ATC:M05BB04 | Risedronicacid,calciumandcolecalciferol,sequential |
| ATC:M05BB05 | Alendronicacid,calciumandcolecalciferol,sequential |
| ATC:M05BB06 | Alendronicacidandalfacalcidol,sequential |
| ATC:M05BB07 | Risedronicacidandcolecalciferol |
| ATC:M05BB08 | Zoledronicacid,calciumandcolecalciferol,sequential |
| ATC:M05BC | Bone morphogenetic proteins |
| ATC:M05BC01 | Diboterminalfa |
| ATC:M05BC02 | Eptoterminalfa |
| ATC:M05BX | Other drugs affecting bone structure and mineralization |
| ATC:M05BX01 | Ipriflavone |
| ATC:M05BX02 | Aluminiumchlorohydrate |
| ATC:M05BX03 | Strontiumranelate |
| ATC:M05BX04 | Denosumab |
| ATC:M05BX53 | Strontiumranelateandcolecalciferol |
| ATC:M09A | Other drugs for disorders of the musculoskeletal system |
| ATC:M09AA | Quinine and derivatives |
| ATC:M09AA01 | Hydroquinine |
| ATC:M09AA72 | Quinine,combinationswithpsycholeptics |
| ATC:M09AB | Enzymes |
| ATC:M09AB01 | Chymopapain |
| ATC:M09AB02 | Collagenaseclostridiumhistolyticum |
| ATC:M09AB03 | Bromelains |
| ATC:M09AB52 | Trypsin,combinations |
| ATC:M09AX | Other drugs for disorders of the musculo-skeletal system |
| ATC:M09AX01 | Hyaluronicacid |
| ATC:M09AX02 | Chondrocytes,autologous |
| ATC:M09AX03 | Ataluren |
| ATC:M09AX04 | Drisapersen |
| ATC:M09AX05 | Aceneuramicacid |
| ATC:N01 | Anesthetic drugs |
| ATC:N01A | General anesthetics list |
| ATC:N01AA | Ethers |
| ATC:N01AA01 | Diethylether |
| ATC:N01AA02 | Vinylether |
| ATC:N01AB | Halogenatedhydrocarbons |
| ATC:N01AB01 | Halothane |
| ATC:N01AB02 | Chloroform |
| ATC:N01AB04 | Enflurane |
| ATC:N01AB05 | Trichloroethylene |
| ATC:N01AB06 | Isoflurane |
| ATC:N01AB07 | Desflurane |
| ATC:N01AB08 | Sevoflurane |
| ATC:N01AF | Barbiturates,plain |
| ATC:N01AF01 | Methohexital |
| ATC:N01AF02 | Hexobarbital |
| ATC:N01AF03 | Thiopental |
| ATC:N01AG | Barbituratesincombinationwithotherdrugs |
| ATC:N01AG01 | Narcobarbital |
| ATC:N01AH | Opioidanesthetics |
| ATC:N01AH01 | Fentanyl |
| ATC:N01AH02 | Alfentanil |
| ATC:N01AH03 | Sufentanil |
| ATC:N01AH04 | Phenoperidine |
| ATC:N01AH05 | Anileridine |
| ATC:N01AH06 | Remifentanil |
| ATC:N01AH51 | Fentanylcombinations |
| ATC:N01AX | Othergeneralanesthetics |
| ATC:N01AX03 | Ketamine |
| ATC:N01AX04 | Propanidid |
| ATC:N01AX05 | Alfaxalone |
| ATC:N01AX07 | Etomidate |
| ATC:N01AX10 | Propofol |
| ATC:N01AX11 | Sodiumoxybate |
| ATC:N01AX13 | Nitrousoxide |
| ATC:N01AX14 | Esketamine |
| ATC:N01AX15 | Xenon |
| ATC:N01AX63 | Nitrousoxidecombinations |
| ATC:N01B | Local anesthesia drugs |
| ATC:N01BA | Estersofaminobenzoicacid |
| ATC:N01BA01 | Metabutethamine |
| ATC:N01BA02 | Procaine |
| ATC:N01BA03 | Tetracaine |
| ATC:N01BA04 | Chloroprocaine |
| ATC:N01BA05 | Benzocaine |
| ATC:N01BA52 | Procaine,combinations |
| ATC:N01BB | Amides |
| ATC:N01BB01 | Bupivacaine |
| ATC:N01BB02 | Lidocaine |
| ATC:N01BB03 | Mepivacaine |
| ATC:N01BB04 | Prilocaine |
| ATC:N01BB05 | Butanilicaine |
| ATC:N01BB06 | Cinchocaine |
| ATC:N01BB07 | Etidocaine |
| ATC:N01BB08 | Articaine |
| ATC:N01BB09 | Ropivacaine |
| ATC:N01BB10 | Levobupivacaine |
| ATC:N01BB20 | Combinations |
| ATC:N01BB51 | Bupivacaine,combinations |
| ATC:N01BB52 | Lidocaine,combinations |
| ATC:N01BB53 | Mepivacaine,combinations |
| ATC:N01BB54 | Prilocaine,combinations |
| ATC:N01BB57 | Etidocaine,combinations |
| ATC:N01BB58 | Articaine,combinations |
| ATC:N01BC | Estersofbenzoicacid |
| ATC:N01BC01 | Cocaine |
| ATC:N01BX | Otherlocalanesthesiadrugs |
| ATC:N01BX01 | Ethylchloride |
| ATC:N01BX02 | Dyclonine |
| ATC:N01BX03 | Phenol |
| ATC:N01BX04 | Capsaicin |
| ATC:N02 | Analgesic drugs |
| ATC:N02A | Opioid drugs list |
| ATC:N02AA | Naturalopiumalkaloidslist |
| ATC:N02AA01 | Morphine |
| ATC:N02AA02 | Opium |
| ATC:N02AA03 | Hydromorphone |
| ATC:N02AA04 | Nicomorphine |
| ATC:N02AA05 | Oxycodone |
| ATC:N02AA08 | Dihydrocodeine |
| ATC:N02AA10 | Papaveretum |
| ATC:N02AA51 | Morphine,combinations |
| ATC:N02AA55 | Oxycodone,combinations |
| ATC:N02AA58 | Dihydrocodeine,combinations |
| ATC:N02AA59 | Codeine,combinationsexcludingpsycholeptics |
| ATC:N02AA79 | Codeine,combinationswithpsycholeptics |
| ATC:N02AB | Phenylpiperidinederivatives |
| ATC:N02AB01 | Ketobemidone |
| ATC:N02AB02 | Pethidine |
| ATC:N02AB03 | Fentanyl |
| ATC:N02AB52 | Pethidine,combinationsexcludingpsycholeptics |
| ATC:N02AB72 | Pethidine,combinationswithpsycholeptics |
| ATC:N02AC | Diphenylpropylaminederivatives |
| ATC:N02AC01 | Dextromoramide |
| ATC:N02AC03 | Piritramide |
| ATC:N02AC04 | Dextropropoxyphene |
| ATC:N02AC05 | Bezitramide |
| ATC:N02AC52 | Methadone,combinationsexcludingpsycholeptics |
| ATC:N02AC54 | Dextropropoxyphene,combinationsexcludingpsycholeptics |
| ATC:N02AC74 | Dextropropoxyphene,combinationswithpsycholeptics |
| ATC:N02AD | Benzomorphanderivatives |
| ATC:N02AD01 | Pentazocine |
| ATC:N02AD02 | Phenazocine |
| ATC:N02AE | Oripavinederivatives |
| ATC:N02AE01 | Buprenorphine |
| ATC:N02AF | Morphinanderivatives |
| ATC:N02AF01 | Butorphanol |
| ATC:N02AF02 | Nalbuphine |
| ATC:N02AG | Opioidsincombinationwithantispasmodics |
| ATC:N02AG01 | Morphineandantispasmodics |
| ATC:N02AG02 | Ketobemidoneandantispasmodics |
| ATC:N02AG03 | Pethidineandantispasmodics |
| ATC:N02AG04 | Hydromorphoneandantispasmodics |
| ATC:N02AJ | Opioidsincombinationwithnon-opioidanalgesics |
| ATC:N02AJ14 | TramadolandDexketoprofen |
| ATC:N02AX | Otheropioids |
| ATC:N02AX01 | Tilidine |
| ATC:N02AX02 | Tramadol |
| ATC:N02AX03 | Dezocine |
| ATC:N02AX05 | Meptazinol |
| ATC:N02AX06 | Tapentadol |
| ATC:N02AX52 | Tramadolcombinations |
| ATC:N02B | Other analgesics and antipyretics |
| ATC:N02BA | Salicylicacidandderivatives |
| ATC:N02BA01 | Acetylsalicylicacid |
| ATC:N02BA02 | Aloxiprin |
| ATC:N02BA03 | Cholinesalicylate |
| ATC:N02BA04 | Sodiumsalicylate |
| ATC:N02BA05 | Salicylamide |
| ATC:N02BA06 | Salsalate |
| ATC:N02BA07 | Ethenzamide |
| ATC:N02BA08 | Morpholinesalicylate |
| ATC:N02BA09 | Dipyrocetyl |
| ATC:N02BA10 | Benorilate |
| ATC:N02BA11 | Diflunisal |
| ATC:N02BA12 | Potassiumsalicylate |
| ATC:N02BA14 | Guacetisal |
| ATC:N02BA15 | Carbasalatecalcium |
| ATC:N02BA16 | Imidazolesalicylate |
| ATC:N02BA51 | Acetylsalicylicacid,combinationsexcludingpsycholeptics |
| ATC:N02BA55 | Salicylamide,combinationsexcludingpsycholeptics |
| ATC:N02BA57 | Ethenzamide,combinationsexcludingpsycholeptics |
| ATC:N02BA59 | Dipyrocetyl,combinationsexcludingpsycholeptics |
| ATC:N02BA65 | Carbasalatecalciumcombinationsexcludingpsycholeptics |
| ATC:N02BA71 | Acetylsalicylicacid,combinationswithpsycholeptics |
| ATC:N02BA75 | Salicylamide,combinationswithpsycholeptics |
| ATC:N02BA77 | Ethenzamide,combinationswithpsycholeptics |
| ATC:N02BA79 | Dipyrocetyl,combinationswithpsycholeptics |
| ATC:N02BB | Pyrazolones |
| ATC:N02BB01 | Phenazone |
| ATC:N02BB02 | Metamizole |
| ATC:N02BB03 | Aminophenazone |
| ATC:N02BB04 | Propyphenazone |
| ATC:N02BB05 | Nifenazone |
| ATC:N02BB51 | Phenazone,combinationsexcludingpsycholeptics |
| ATC:N02BB52 | Metamizolesodium,combinationsexcludingpsycholeptics |
| ATC:N02BB53 | Aminophenazone,combinationsexcludingpsycholeptics |
| ATC:N02BB54 | Propyphenazone,combinationsexcludingpsycholeptics |
| ATC:N02BB71 | Phenazone,combinationswithpsycholeptics |
| ATC:N02BB72 | Metamizolesodium,combinationswithpsycholeptics |
| ATC:N02BB73 | Aminophenazone,combinationswithpsycholeptics |
| ATC:N02BB74 | Propyphenazone,combinationswithpsycholeptics |
| ATC:N02BE | Anilides |
| ATC:N02BE01 | Paracetamol |
| ATC:N02BE03 | Phenacetin |
| ATC:N02BE04 | Bucetin |
| ATC:N02BE05 | Propacetamol |
| ATC:N02BE51 | Paracetamol,combinationsexcludingpsycholeptics |
| ATC:N02BE53 | Phenacetin,combinationsexcludingpsycholeptics |
| ATC:N02BE54 | Bucetin,combinationsexcludingpsycholeptics |
| ATC:N02BE71 | Paracetamol,combinationswithpsycholeptics |
| ATC:N02BE73 | Phenacetin,combinationswithpsycholeptics |
| ATC:N02BE74 | Bucetin,combinationswithpsycholeptics |
| ATC:N02BG | Otheranalgesicsandantipyretics |
| ATC:N02BG02 | Rimazolium |
| ATC:N02BG03 | Glafenine |
| ATC:N02BG04 | Floctafenine |
| ATC:N02BG05 | Viminol |
| ATC:N02BG06 | Nefopam |
| ATC:N02BG07 | Flupirtine |
| ATC:N02BG08 | Ziconotide |
| ATC:N02BG09 | Methoxyflurane |
| ATC:N02BG10 | Cannabinoids |
| ATC:N02C | Migraine medication |
| ATC:N02CA | Ergotalkaloids |
| ATC:N02CA01 | Dihydroergotamine |
| ATC:N02CA02 | Ergotamine |
| ATC:N02CA04 | Methysergide |
| ATC:N02CA07 | Lisuride |
| ATC:N02CA51 | Dihydroergotamine,combinations |
| ATC:N02CA52 | Ergotamine,combinationsexcludingpsycholeptics |
| ATC:N02CA72 | Ergotamine,combinationswithpsycholeptics |
| ATC:N02CB | Corticosteroidderivatives |
| ATC:N02CB01 | Flumedroxone |
| ATC:N02CC | Selectiveserotonin(5-HT1)agonists |
| ATC:N02CC01 | Sumatriptan |
| ATC:N02CC02 | Naratriptan |
| ATC:N02CC03 | Zolmitriptan |
| ATC:N02CC04 | Rizatriptan |
| ATC:N02CC05 | Almotriptan |
| ATC:N02CC06 | Eletriptan |
| ATC:N02CC07 | Frovatriptan |
| ATC:N02CX | Othermigrainedrugs |
| ATC:N02CX01 | Pizotifen |
| ATC:N02CX02 | Clonidine |
| ATC:N02CX03 | Iprazochrome |
| ATC:N02CX05 | Dimetotiazine |
| ATC:N02CX06 | Oxetorone |
| ATC:N03A | Antiepileptics |
| ATC:N03AA | Barbiturates and derivatives |
| ATC:N03AA01 | Methylphenobarbital |
| ATC:N03AA02 | Phenobarbital |
| ATC:N03AA03 | Primidone |
| ATC:N03AA04 | Barbexaclone |
| ATC:N03AA30 | Metharbital |
| ATC:N03AB | Hydantoin derivatives |
| ATC:N03AB01 | Ethotoin |
| ATC:N03AB02 | Phenytoin |
| ATC:N03AB03 | Amino(diphenylhydantoin)valericacid |
| ATC:N03AB04 | Mephenytoin |
| ATC:N03AB05 | Fosphenytoin |
| ATC:N03AB52 | Phenytoincombinations |
| ATC:N03AB54 | Mephenytoincombinations |
| ATC:N03AC | Oxazolidine derivatives |
| ATC:N03AC01 | Paramethadione |
| ATC:N03AC02 | Trimethadione |
| ATC:N03AC03 | Ethadione |
| ATC:N03AD | Succinimide derivatives |
| ATC:N03AD01 | Ethosuximide |
| ATC:N03AD02 | Phensuximide |
| ATC:N03AD03 | Mesuximide |
| ATC:N03AD51 | Ethosuximidecombinations |
| ATC:N03AE | Benzodiazepine derivatives |
| ATC:N03AE01 | Clonazepam |
| ATC:N03AF | Carboxamide derivatives |
| ATC:N03AF01 | Carbamazepine |
| ATC:N03AF02 | Oxcarbazepine |
| ATC:N03AF03 | Rufinamide |
| ATC:N03AF04 | Eslicarbazepine |
| ATC:N03AG | Fatty acid derivatives |
| ATC:N03AG01 | Valproicacid |
| ATC:N03AG02 | Valpromide |
| ATC:N03AG03 | Aminobutyricacid |
| ATC:N03AG04 | Vigabatrin |
| ATC:N03AG05 | Progabide |
| ATC:N03AG06 | Tiagabine |
| ATC:N03AX | Other antiepileptics |
| ATC:N03AX03 | Sultiame |
| ATC:N03AX07 | Phenacemide |
| ATC:N03AX09 | Lamotrigine |
| ATC:N03AX10 | Felbamate |
| ATC:N03AX11 | Topiramate |
| ATC:N03AX12 | Gabapentin |
| ATC:N03AX13 | Pheneturide |
| ATC:N03AX14 | Levetiracetam |
| ATC:N03AX15 | Zonisamide |
| ATC:N03AX16 | Pregabalin |
| ATC:N03AX17 | Stiripentol |
| ATC:N03AX18 | Lacosamide |
| ATC:N03AX19 | Carisbamate |
| ATC:N03AX21 | Retigabine |
| ATC:N03AX22 | Perampanel |
| ATC:N03AX23 | Brivaracetam |
| ATC:N03AX30 | Beclamide |
| ATC:N04 | Antiparkinson drugs |
| ATC:N04A | Anticholinergic agents for Parkinson |
| ATC:N04AA | Tertiaryamines |
| ATC:N04AA01 | Trihexyphenidyl |
| ATC:N04AA02 | Biperiden |
| ATC:N04AA03 | Metixene |
| ATC:N04AA04 | Procyclidine |
| ATC:N04AA05 | Profenamine |
| ATC:N04AA08 | Dexetimide |
| ATC:N04AA09 | Phenglutarimide |
| ATC:N04AA10 | Mazaticol |
| ATC:N04AA11 | Bornaprine |
| ATC:N04AA12 | Tropatepine |
| ATC:N04AB | Etherschemicallyclosetoantihistamines |
| ATC:N04AB01 | Etanautine |
| ATC:N04AB02 | Orphenadrine(chloride) |
| ATC:N04AC | Ethersoftropineortropinederivatives |
| ATC:N04AC01 | Benzatropine |
| ATC:N04AC30 | Etybenzatropine |
| ATC:N04B | Dopaminergic agents |
| ATC:N04BA | Dopaanddopaderivatives |
| ATC:N04BA01 | Levodopa |
| ATC:N04BA02 | Levodopaanddecarboxylaseinhibitor |
| ATC:N04BA03 | Levodopa,decarboxylaseinhibitorandCOMTinhibitor |
| ATC:N04BA04 | Melevodopa |
| ATC:N04BA05 | Melevodopaanddecarboxylaseinhibitor |
| ATC:N04BA06 | Etilevodopaanddecarboxylaseinhibitor |
| ATC:N04BB | Adamantanederivatives |
| ATC:N04BB01 | Amantadine |
| ATC:N04BC | Dopamineagonists |
| ATC:N04BC01 | Bromocriptine |
| ATC:N04BC02 | Pergolide |
| ATC:N04BC03 | Dihydroergocryptinemesylate |
| ATC:N04BC04 | Ropinirole |
| ATC:N04BC05 | Pramipexole |
| ATC:N04BC06 | Cabergoline |
| ATC:N04BC07 | Apomorphine |
| ATC:N04BC08 | Piribedil |
| ATC:N04BC09 | Rotigotine |
| ATC:N04BD | MonoamineoxidaseBinhibitors |
| ATC:N04BD01 | Selegiline |
| ATC:N04BD02 | Rasagiline |
| ATC:N04BD03 | Safinamide |
| ATC:N04BX | Otherdopaminergicagents |
| ATC:N04BX01 | Tolcapone |
| ATC:N04BX02 | Entacapone |
| ATC:N04BX03 | Budipine |
| ATC:N05 | Psycholeptics drugs |
| ATC:N05A | Antipsychotic drugs |
| ATC:N05AA | Phenothiazineswithaliphaticside-chain |
| ATC:N05AA01 | Chlorpromazine |
| ATC:N05AA02 | Levomepromazine |
| ATC:N05AA03 | Promazine |
| ATC:N05AA04 | Acepromazine |
| ATC:N05AA05 | Triflupromazine |
| ATC:N05AA06 | Cyamemazine |
| ATC:N05AA07 | Chlorproethazine |
| ATC:N05AB | Phenothiazineswithpiperazinestructure |
| ATC:N05AB01 | Dixyrazine |
| ATC:N05AB02 | Fluphenazine |
| ATC:N05AB03 | Perphenazine |
| ATC:N05AB04 | Prochlorperazine |
| ATC:N05AB05 | Thiopropazate |
| ATC:N05AB06 | Trifluoperazine |
| ATC:N05AB07 | Acetophenazine |
| ATC:N05AB08 | Thioproperazine |
| ATC:N05AB09 | Butaperazine |
| ATC:N05AB10 | Perazine |
| ATC:N05AC | Phenothiazineswithpiperidinestructur |
| ATC:N05AC01 | Periciazine |
| ATC:N05AC02 | Thioridazine |
| ATC:N05AC03 | Mesoridazine |
| ATC:N05AC04 | Pipotiazine |
| ATC:N05AD | Butyrophenonederivatives |
| ATC:N05AD01 | Haloperidol |
| ATC:N05AD02 | Trifluperidol |
| ATC:N05AD03 | Melperone |
| ATC:N05AD04 | Moperone |
| ATC:N05AD05 | Pipamperone |
| ATC:N05AD06 | Bromperidol |
| ATC:N05AD07 | Benperidol |
| ATC:N05AD08 | Droperidol |
| ATC:N05AD09 | Fluanisone |
| ATC:N05AE | Indolederivativesdrugs |
| ATC:N05AE01 | Oxypertine |
| ATC:N05AE02 | Molindone |
| ATC:N05AE03 | Sertindole |
| ATC:N05AE04 | Ziprasidone |
| ATC:N05AE05 | Lurasidone |
| ATC:N05AF | Thioxanthenederivatives |
| ATC:N05AF01 | Flupentixol |
| ATC:N05AF02 | Clopenthixol |
| ATC:N05AF03 | Chlorprothixene |
| ATC:N05AF04 | Thiothixene |
| ATC:N05AF05 | Zuclopenthixol |
| ATC:N05AG | Diphenylbutylpiperidinederivatives |
| ATC:N05AG01 | Fluspirilene |
| ATC:N05AG02 | Pimozide |
| ATC:N05AG03 | Penfluridol |
| ATC:N05AH | Diazepines,oxazepines,thiazepinesandoxepines |
| ATC:N05AH01 | Loxapine |
| ATC:N05AH02 | Clozapine |
| ATC:N05AH03 | Olanzapine |
| ATC:N05AH04 | Quetiapine |
| ATC:N05AH05 | Asenapine |
| ATC:N05AH06 | Clotiapine |
| ATC:N05AL | Benzamideantipsychotics |
| ATC:N05AL01 | Sulpiride |
| ATC:N05AL02 | Sultopride |
| ATC:N05AL03 | Tiapride |
| ATC:N05AL04 | Remoxipride |
| ATC:N05AL05 | Amisulpride |
| ATC:N05AL06 | Veralipride |
| ATC:N05AL07 | Levosulpiride |
| ATC:N05AN | Lithium |
| ATC:N05AN01 | Lithium |
| ATC:N05AX | Otherantipsychotics |
| ATC:N05AX07 | Prothipendyl |
| ATC:N05AX08 | Risperidone |
| ATC:N05AX10 | Mosapramine |
| ATC:N05AX11 | Zotepine |
| ATC:N05AX12 | Aripiprazole |
| ATC:N05AX13 | Paliperidone |
| ATC:N05AX14 | Iloperidone |
| ATC:N05AX15 | Cariprazine |
| ATC:N05AX16 | Brexpiprazole |
| ATC:N05B | Anxiolytic drugs |
| ATC:N05BA | Benzodiazepinederivativesanxiolytics |
| ATC:N05BA01 | Diazepam |
| ATC:N05BA02 | Chlordiazepoxide |
| ATC:N05BA03 | Medazepam |
| ATC:N05BA04 | Oxazepam |
| ATC:N05BA05 | Potassiumclorazepate |
| ATC:N05BA06 | Lorazepam |
| ATC:N05BA07 | Adinazolam |
| ATC:N05BA08 | Bromazepam |
| ATC:N05BA09 | Clobazam |
| ATC:N05BA10 | Ketazolam |
| ATC:N05BA11 | Prazepam |
| ATC:N05BA12 | Alprazolam |
| ATC:N05BA13 | Halazepam |
| ATC:N05BA14 | Pinazepam |
| ATC:N05BA15 | Camazepam |
| ATC:N05BA16 | Nordazepam |
| ATC:N05BA17 | Fludiazepam |
| ATC:N05BA18 | Ethylloflazepate |
| ATC:N05BA19 | Etizolam |
| ATC:N05BA21 | Clotiazepam |
| ATC:N05BA22 | Cloxazolam |
| ATC:N05BA23 | Tofisopam |
| ATC:N05BA56 | Lorazepam,combinations |
| ATC:N05BB | Diphenylmethanederivatives |
| ATC:N05BB01 | Hydroxyzine |
| ATC:N05BB02 | Captodiame |
| ATC:N05BB51 | Hydroxyzine,combinations |
| ATC:N05BC | Carbamates |
| ATC:N05BC01 | Meprobamate |
| ATC:N05BC03 | Emylcamate |
| ATC:N05BC04 | Mebutamate |
| ATC:N05BC51 | Meprobamate,combinations |
| ATC:N05BD | Dibenzo-bicyclo-octadienederivatives |
| ATC:N05BD01 | Benzoctamine |
| ATC:N05BE | Azaspirodecanedionederivatives |
| ATC:N05BE01 | Buspirone |
| ATC:N05BX | Otheranxiolyticdrugs |
| ATC:N05BX01 | Mephenoxalone |
| ATC:N05BX02 | Gedocarnil |
| ATC:N05BX03 | Etifoxine |
| ATC:N05BX04 | Fabomotizole |
| ATC:N05C | Hypnotics and sedatives drugs |
| ATC:N05CA | Barbiturates,plain |
| ATC:N05CA01 | Pentobarbital |
| ATC:N05CA02 | Amobarbital |
| ATC:N05CA03 | Butobarbital |
| ATC:N05CA04 | Barbital |
| ATC:N05CA05 | Aprobarbital |
| ATC:N05CA06 | Secobarbital |
| ATC:N05CA07 | Talbutal |
| ATC:N05CA08 | Vinylbital |
| ATC:N05CA09 | Vinbarbital |
| ATC:N05CA10 | Cyclobarbital |
| ATC:N05CA11 | Heptabarbital |
| ATC:N05CA12 | Reposal |
| ATC:N05CA15 | Methohexital |
| ATC:N05CA16 | Hexobarbital |
| ATC:N05CA19 | Thiopental |
| ATC:N05CA20 | Ethallobarbital |
| ATC:N05CA21 | Allobarbital |
| ATC:N05CA22 | Proxibarbal |
| ATC:N05CB | Barbiturates,combinations |
| ATC:N05CB01 | Combinationsofbarbiturates |
| ATC:N05CB02 | Barbituratesincombinationwithotherdrugs |
| ATC:N05CC | Aldehydesandderivatives |
| ATC:N05CC01 | Chloralhydrate |
| ATC:N05CC02 | Chloralodol |
| ATC:N05CC03 | Acetylglycinamidechloralhydrate |
| ATC:N05CC04 | Dichloralphenazone |
| ATC:N05CC05 | Paraldehyde |
| ATC:N05CD | Benzodiazepinederivatives |
| ATC:N05CD01 | Flurazepam |
| ATC:N05CD02 | Nitrazepam |
| ATC:N05CD03 | Flunitrazepam |
| ATC:N05CD04 | Estazolam |
| ATC:N05CD05 | Triazolam |
| ATC:N05CD06 | Lormetazepam |
| ATC:N05CD07 | Temazepam |
| ATC:N05CD08 | Midazolam |
| ATC:N05CD09 | Brotizolam |
| ATC:N05CD10 | Quazepam |
| ATC:N05CD11 | Loprazolam |
| ATC:N05CD12 | Doxefazepam |
| ATC:N05CD13 | Cinolazepam |
| ATC:N05CE | Piperidinedionedrugs |
| ATC:N05CE01 | Glutethimide |
| ATC:N05CE02 | Methyprylon |
| ATC:N05CE03 | Pyrithyldione |
| ATC:N05CF | Benzodiazepinerelateddrugs |
| ATC:N05CF01 | Zopiclone |
| ATC:N05CF02 | Zolpidem |
| ATC:N05CF03 | Zaleplon |
| ATC:N05CF04 | Eszopiclone |
| ATC:N05CH | Melatoninreceptoragonistdrugs |
| ATC:N05CH01 | Melatonin |
| ATC:N05CH02 | Ramelteon |
| ATC:N05CH03 | Tasimelteon |
| ATC:N05CM | Otherhypnoticandsedativedrugs |
| ATC:N05CM01 | Methaqualone |
| ATC:N05CM02 | Clomethiazole |
| ATC:N05CM03 | Bromisoval |
| ATC:N05CM04 | Carbromal |
| ATC:N05CM05 | Scopolamine |
| ATC:N05CM06 | Propiomazine |
| ATC:N05CM07 | Triclofos |
| ATC:N05CM08 | Ethchlorvynol |
| ATC:N05CM09 | Valerianaeradix |
| ATC:N05CM10 | Hexapropymate |
| ATC:N05CM11 | Bromides |
| ATC:N05CM12 | Apronal |
| ATC:N05CM13 | Valnoctamide |
| ATC:N05CM15 | Methylpentynol |
| ATC:N05CM16 | Niaprazine |
| ATC:N05CM18 | Dexmedetomidine |
| ATC:N05CX | Hypnoticsandsedativesincombination,excludingbarbiturates |
| ATC:N05CX01 | Meprobamatecombinations |
| ATC:N05CX02 | Methaqualonecombinations |
| ATC:N05CX03 | Methylpentynolcombinations |
| ATC:N05CX04 | Clomethiazolecombinations |
| ATC:N05CX05 | Emeproniumcombinations |
| ATC:N05CX06 | Dipiperonylaminoethanolcombinations |
| ATC:N06 | Psychoanaleptics |
| ATC:N06A | Antidepressant drugs |
| ATC:N06AA | Non-selectivemonoaminereuptakeinhibitors |
| ATC:N06AA01 | Desipramine |
| ATC:N06AA02 | Imipramine |
| ATC:N06AA03 | Imipramineoxide |
| ATC:N06AA04 | Clomipramine |
| ATC:N06AA05 | Opipramol |
| ATC:N06AA06 | Trimipramine |
| ATC:N06AA07 | Lofepramine |
| ATC:N06AA08 | Dibenzepin |
| ATC:N06AA09 | Amitriptyline |
| ATC:N06AA10 | Nortriptyline |
| ATC:N06AA11 | Protriptyline |
| ATC:N06AA12 | Doxepin |
| ATC:N06AA13 | Iprindole |
| ATC:N06AA14 | Melitracen |
| ATC:N06AA15 | Butriptyline |
| ATC:N06AA16 | Dosulepin |
| ATC:N06AA17 | Amoxapine |
| ATC:N06AA18 | Dimetacrine |
| ATC:N06AA19 | Amineptine |
| ATC:N06AA21 | Maprotiline |
| ATC:N06AA23 | Quinupramine |
| ATC:N06AB | SelectiveSerotoninReuptakeInhibitors |
| ATC:N06AB02 | Zimelidine |
| ATC:N06AB03 | Fluoxetine |
| ATC:N06AB04 | Citalopram |
| ATC:N06AB05 | Paroxetine |
| ATC:N06AB06 | Sertraline |
| ATC:N06AB07 | Alaproclate |
| ATC:N06AB08 | Fluvoxamine |
| ATC:N06AB09 | Etoperidone |
| ATC:N06AB10 | Escitalopram |
| ATC:N06AF | Monoamineoxidaseinhibitors,non-selective |
| ATC:N06AF01 | Isocarboxazid |
| ATC:N06AF02 | Nialamide |
| ATC:N06AF03 | Phenelzine |
| ATC:N06AF04 | Tranylcypromine |
| ATC:N06AF05 | Iproniazide |
| ATC:N06AF06 | Iproclozide |
| ATC:N06AG | MonoamineoxidaseAinhibitors |
| ATC:N06AG02 | Moclobemide |
| ATC:N06AG03 | Toloxatone |
| ATC:N06AX | Otherantidepressantdrugs |
| ATC:N06AX01 | Oxitriptan |
| ATC:N06AX02 | Tryptophan |
| ATC:N06AX03 | Mianserin |
| ATC:N06AX04 | Nomifensine |
| ATC:N06AX05 | Trazodone |
| ATC:N06AX06 | Nefazodone |
| ATC:N06AX07 | Minaprine |
| ATC:N06AX08 | Bifemelane |
| ATC:N06AX09 | Viloxazine |
| ATC:N06AX10 | Oxaflozane |
| ATC:N06AX11 | Mirtazapine |
| ATC:N06AX12 | Bupropion |
| ATC:N06AX13 | Medifoxamine |
| ATC:N06AX14 | Tianeptine |
| ATC:N06AX15 | Pivagabine |
| ATC:N06AX16 | Venlafaxine |
| ATC:N06AX17 | Milnacipran |
| ATC:N06AX18 | Reboxetine |
| ATC:N06AX19 | Gepirone |
| ATC:N06AX21 | Duloxetine |
| ATC:N06AX22 | Agomelatine |
| ATC:N06AX23 | Desvenlafaxine |
| ATC:N06AX24 | Vilazodone |
| ATC:N06AX25 | Hypericiherba |
| ATC:N06AX26 | Vortioxetine |
| ATC:N06B | Psychostimulants, agents used for ADHD and nootropics |
| ATC:N06BA | Centrallyactingsympathomimetics |
| ATC:N06BA01 | Amphetamine |
| ATC:N06BA02 | Dexamphetamine |
| ATC:N06BA03 | Dextromethamphetamine |
| ATC:N06BA04 | Methylphenidate |
| ATC:N06BA05 | Pemoline |
| ATC:N06BA06 | Fencamfamin |
| ATC:N06BA07 | Modafinil |
| ATC:N06BA08 | Fenozolone |
| ATC:N06BA09 | Atomoxetine |
| ATC:N06BA10 | Fenetylline |
| ATC:N06BA11 | Dexmethylphenidate |
| ATC:N06BA12 | Lisdexamfetamine |
| ATC:N06BA13 | Armodafinil |
| ATC:N06BC | Xanthinederivatives |
| ATC:N06BC01 | Caffeine |
| ATC:N06BC02 | Propentofylline |
| ATC:N06BX | Otherpsychostimulantsandnootropics |
| ATC:N06BX01 | Meclofenoxate |
| ATC:N06BX02 | Pyritinol |
| ATC:N06BX03 | Piracetam |
| ATC:N06BX04 | Deanol |
| ATC:N06BX05 | Fipexide |
| ATC:N06BX06 | Citicoline |
| ATC:N06BX07 | Oxiracetam |
| ATC:N06BX08 | Pirisudanol |
| ATC:N06BX09 | Linopirdine |
| ATC:N06BX10 | Nizofenone |
| ATC:N06BX11 | Aniracetam |
| ATC:N06BX12 | Acetylcarnitine |
| ATC:N06BX13 | Idebenone |
| ATC:N06BX14 | Prolintane |
| ATC:N06BX15 | Pipradrol |
| ATC:N06BX16 | Pramiracetam |
| ATC:N06BX17 | Adrafinil |
| ATC:N06BX18 | Vinpocetine |
| ATC:N06BX21 | Mebicar |
| ATC:N06BX22 | Phenibut |
| ATC:N06C | Psycholeptics and psychoanaleptics in combination |
| ATC:N06CA | Antidepressantsincombinationwithpsycholeptics |
| ATC:N06CA01 | Amitriptylineandpsycholeptics |
| ATC:N06CA02 | Melitracenandpsycholeptics |
| ATC:N06CA03 | Fluoxetineandpsycholeptics |
| ATC:N06D | Dementia drugs |
| ATC:N06DA | Anticholinesterasedrugs |
| ATC:N06DA01 | Tacrine |
| ATC:N06DA02 | Donepezil |
| ATC:N06DA03 | Rivastigmine |
| ATC:N06DA04 | Galantamine |
| ATC:N06DA05 | Ipidacrine |
| ATC:N06DA52 | Donepezilandmemantine |
| ATC:N06DA53 | Donepezil,memantineandGinkgofolium |
| ATC:N06DX | Otheranti-dementiadrugs |
| ATC:N06DX01 | Memantine |
| ATC:N06DX02 | Ginkgofolium |
| ATC:N06DX30 | Combinations |
| ATC:N07 | Other nervous system drugs |
| ATC:N07A | Parasympathomimetic drugs |
| ATC:N07AA | Anticholinesterasedrugs |
| ATC:N07AA01 | Neostigmine |
| ATC:N07AA02 | Pyridostigmine |
| ATC:N07AA03 | Distigmine |
| ATC:N07AA30 | Ambenonium |
| ATC:N07AA51 | Neostigmine,combinations |
| ATC:N07AB | Cholineesters |
| ATC:N07AB01 | Carbachol |
| ATC:N07AB02 | Bethanechol |
| ATC:N07AX | Otherparasympathomimetics |
| ATC:N07AX01 | Pilocarpine |
| ATC:N07AX02 | Cholinealfoscerate |
| ATC:N07AX03 | Cevimeline |
| ATC:N07B | Drugs used in addictive disorders |
| ATC:N07BA | Drugsusedinnicotinedependence |
| ATC:N07BA01 | Nicotine |
| ATC:N07BA03 | Varenicline |
| ATC:N07BB | Drugsusedinalcoholdependence |
| ATC:N07BB01 | Disulfiram |
| ATC:N07BB02 | Calciumcarbimide |
| ATC:N07BB03 | Acamprosate |
| ATC:N07BB04 | Naltrexone |
| ATC:N07BB05 | Nalmefene |
| ATC:N07BC | Drugsusedinopioiddependence |
| ATC:N07BC01 | Buprenorphine |
| ATC:N07BC02 | Methadone |
| ATC:N07BC03 | Levacetylmethadol |
| ATC:N07BC04 | Lofexidine |
| ATC:N07BC05 | Levomethadone |
| ATC:N07BC06 | Diamorphine |
| ATC:N07BC51 | Buprenorphinecombinations |
| ATC:N07C | Antivertigo preparations |
| ATC:N07CA | Antivertigodrugs |
| ATC:N07CA01 | Betahistine |
| ATC:N07CA02 | Cinnarizine |
| ATC:N07CA03 | Flunarizine |
| ATC:N07CA04 | Acetylleucine |
| ATC:N07CA52 | Cinnarizinecombinations |
| ATC:N07XX | Other nervous system drugs |
| ATC:N07XX01 | Tirilazad |
| ATC:N07XX02 | Riluzole |
| ATC:N07XX03 | Xaliproden |
| ATC:N07XX04 | Sodiumoxybate |
| ATC:N07XX05 | Amifampridine |
| ATC:N07XX06 | Tetrabenazine |
| ATC:N07XX07 | Fampridine |
| ATC:N07XX08 | Tafamidis |
| ATC:N07XX09 | Dimethylfumarate |
| ATC:N07XX10 | Laquinimod |
| ATC:N07XX11 | Pitolisant |
| ATC:N07XX59 | Dextromethorphancombinations |
| ATC:P01 | Antiprotozoal drugs |
| ATC:P01A | Agents against amoebiasis and other protozoal diseases |
| ATC:P01AA | Hydroxyquinolinederivatives |
| ATC:P01AA01 | Broxyquinoline |
| ATC:P01AA02 | Clioquinol |
| ATC:P01AA04 | Chlorquinaldol |
| ATC:P01AA05 | Tilbroquinol |
| ATC:P01AA52 | Clioquinol,combinations |
| ATC:P01AB | Nitroimidazolederivatives |
| ATC:P01AB01 | Metronidazole |
| ATC:P01AB02 | Tinidazole |
| ATC:P01AB03 | Ornidazole |
| ATC:P01AB04 | Azanidazole |
| ATC:P01AB05 | Propenidazole |
| ATC:P01AB06 | Nimorazole |
| ATC:P01AB07 | Secnidazole |
| ATC:P01AB51 | Metronidazole,combinations |
| ATC:P01AC | Dichloroacetamidederivatives |
| ATC:P01AC01 | Diloxanide |
| ATC:P01AC02 | Clefamide |
| ATC:P01AC03 | Etofamide |
| ATC:P01AC04 | Teclozan |
| ATC:P01AR | Arseniccompounds |
| ATC:P01AR01 | Arsthinol |
| ATC:P01AR02 | Difetarsone |
| ATC:P01AR03 | Glycobiarsol |
| ATC:P01AR53 | Glycobiarsol,combinations |
| ATC:P01AX | Otheragentsagainstamoebiasisandotherprotozoaldiseases |
| ATC:P01AX01 | Chiniofon |
| ATC:P01AX02 | Emetine |
| ATC:P01AX04 | Phanquinone |
| ATC:P01AX05 | Mepacrine |
| ATC:P01AX06 | Atovaquone |
| ATC:P01AX07 | Trimetrexate |
| ATC:P01AX08 | Tenonitrozole |
| ATC:P01AX09 | Dehydroemetine |
| ATC:P01AX10 | Fumagillin |
| ATC:P01AX11 | Nitazoxanide |
| ATC:P01AX52 | Emetine,combinations |
| ATC:P01B | Antimalarials |
| ATC:P01BA | Aminoquinolines |
| ATC:P01BA01 | Chloroquine |
| ATC:P01BA02 | Hydroxychloroquine |
| ATC:P01BA03 | Primaquine |
| ATC:P01BA06 | Amodiaquine |
| ATC:P01BB | Biguanides |
| ATC:P01BB01 | Proguanil |
| ATC:P01BB02 | Cycloguanilembonate |
| ATC:P01BB51 | Proguanil,combinations |
| ATC:P01BC | Methanolquinolines |
| ATC:P01BC01 | Quinine |
| ATC:P01BC02 | Mefloquine |
| ATC:P01BD | Diaminopyrimidines |
| ATC:P01BD01 | Pyrimethamine |
| ATC:P01BD51 | Pyrimethamine,combinations |
| ATC:P01BE | Artemisininandderivatives,plain |
| ATC:P01BE01 | Artemisinin |
| ATC:P01BE02 | Artemether |
| ATC:P01BE03 | Artesunate |
| ATC:P01BE04 | Artemotil |
| ATC:P01BE05 | Artenimol |
| ATC:P01BF | Artemisininandderivatives,combinations |
| ATC:P01BF01 | Artemetherandlumefantrine |
| ATC:P01BF02 | Artesunateandmefloquine |
| ATC:P01BF03 | Artesunateandamodiaquine |
| ATC:P01BF04 | Artesunate,sulphamethopyrazineandpyrimethamine |
| ATC:P01BF05 | Artenimolandpiperaquine |
| ATC:P01BF06 | Artesunateandpyronaridine |
| ATC:P01BX | Otherantimalarials |
| ATC:P01BX01 | Halofantrine |
| ATC:P01BX02 | ArterolaneandPiperaquine |
| ATC:P01C | Agents against leishmaniasis and trypanosomiasis |
| ATC:P01CA | Nitroimidazolederivatives |
| ATC:P01CA02 | Benznidazole |
| ATC:P01CB | Antimonycompounds |
| ATC:P01CB01 | Meglumineantimonate |
| ATC:P01CB02 | Sodiumstibogluconate |
| ATC:P01CC | Nitrofuranderivatives |
| ATC:P01CC01 | Nifurtimox |
| ATC:P01CC02 | Nitrofural |
| ATC:P01CD | Arseniccompounds |
| ATC:P01CD01 | Melarsoprol |
| ATC:P01CD02 | Acetarsol |
| ATC:P01CX | Otheragentsagainstleishmaniasisandtrypanosomiasis |
| ATC:P01CX01 | Pentamidineisethionate |
| ATC:P01CX02 | Suraminsodium |
| ATC:P01CX03 | Eflornithine |
| ATC:P02 | Anthelmintic drugs |
| ATC:P02B | Antitrematodals |
| ATC:P02BA | Quinolinederivativesandrelatedsubstances |
| ATC:P02BA01 | Praziquantel |
| ATC:P02BA02 | Oxamniquine |
| ATC:P02BB | Organophosphorouscompounds |
| ATC:P02BB01 | Metrifonate |
| ATC:P02BX | Otherantitrematodalagents |
| ATC:P02BX01 | Bithionol |
| ATC:P02BX02 | Niridazole |
| ATC:P02BX03 | Stibophen |
| ATC:P02BX04 | Triclabendazole |
| ATC:P02C | Antinematodal agents |
| ATC:P02CA | Benzimidazolederivatives |
| ATC:P02CA01 | Mebendazole |
| ATC:P02CA02 | Tiabendazole |
| ATC:P02CA03 | Albendazole |
| ATC:P02CA04 | Ciclobendazole |
| ATC:P02CA05 | Flubendazole |
| ATC:P02CA06 | Fenbendazole |
| ATC:P02CA51 | Mebendazole,combinations |
| ATC:P02CB | Piperazineandderivatives |
| ATC:P02CB01 | Piperazine |
| ATC:P02CB02 | Diethylcarbamazine |
| ATC:P02CC | Tetrahydropyrimidinederivatives |
| ATC:P02CC01 | Pyrantel |
| ATC:P02CC02 | Oxantel |
| ATC:P02CE | Imidazothiazolederivatives |
| ATC:P02CE01 | Levamisole |
| ATC:P02CF | Avermectines |
| ATC:P02CF01 | Ivermectin |
| ATC:P02CX | Otherantinematodals |
| ATC:P02CX01 | Pyrvinium |
| ATC:P02CX02 | Bephenium |
| ATC:P02D | Anticestodals |
| ATC:P02DA | Salicylicacidderivatives |
| ATC:P02DA01 | Niclosamide |
| ATC:P02DX | Otheranticestodals |
| ATC:P02DX01 | Desaspidin |
| ATC:P02DX02 | Dichlorophen |
| ATC:P03 | Ectoparasiticides, including scabicides, insecticides and repellents |
| ATC:P03A | Ectoparasiticides, including scabicides |
| ATC:P03AA | Sulfurcontainingproducts |
| ATC:P03AA01 | Dixanthogen |
| ATC:P03AA02 | Potassiumpolysulfide |
| ATC:P03AA03 | Mesulfen |
| ATC:P03AA04 | Disulfiram |
| ATC:P03AA05 | Thiram |
| ATC:P03AA54 | Disulfiram,combinations |
| ATC:P03AB | Chlorinecontainingproducts |
| ATC:P03AB01 | Clofenotane |
| ATC:P03AB02 | Lindane |
| ATC:P03AB51 | Clofenotane,combinations |
| ATC:P03AC | Pyrethrines,includingsyntheticcompounds |
| ATC:P03AC01 | Pyrethrum |
| ATC:P03AC02 | Bioallethrin |
| ATC:P03AC03 | Phenothrin |
| ATC:P03AC04 | Permethrin |
| ATC:P03AC51 | Pyrethrum,combinations |
| ATC:P03AC52 | Bioallethrin,combinations |
| ATC:P03AC53 | Phenothrin,combinations |
| ATC:P03AC54 | Permethrin,combinations |
| ATC:P03AX | Otherectoparasiticides,includingscabicides |
| ATC:P03AX01 | Benzylbenzoate |
| ATC:P03AX02 | Copperoleinate |
| ATC:P03AX03 | Malathion |
| ATC:P03AX04 | Quassia |
| ATC:P03AX05 | Dimeticone |
| ATC:P03AX06 | Benzylalcohol |
| ATC:P03B | Insecticides and repellents |
| ATC:P03BA | Pyrethrines |
| ATC:P03BA01 | Cyfluthrin |
| ATC:P03BA02 | Cypermethrin |
| ATC:P03BA03 | Decamethrin |
| ATC:P03BA04 | Tetramethrin |
| ATC:P03BX | Otherinsecticidesandrepellents |
| ATC:P03BX01 | Diethyltoluamide |
| ATC:P03BX02 | Dimethylphthalate |
| ATC:P03BX03 | Dibutylphthalate |
| ATC:P03BX04 | Dibutylsuccinate |
| ATC:P03BX05 | Dimethylcarbate |
| ATC:P03BX06 | Etohexadiol |
| ATC:R01 | Nasal preparations |
| ATC:R01A | Decongestants and other nasal preparations for topical use |
| ATC:R01AA | Sympathomimetics,plain |
| ATC:R01AA02 | Cyclopentamine |
| ATC:R01AA03 | Ephedrine |
| ATC:R01AA04 | Phenylephrine |
| ATC:R01AA05 | Oxymetazoline |
| ATC:R01AA06 | Tetryzoline |
| ATC:R01AA07 | Xylometazoline |
| ATC:R01AA08 | Naphazoline |
| ATC:R01AA09 | Tramazoline |
| ATC:R01AA10 | Metizoline |
| ATC:R01AA11 | Tuaminoheptane |
| ATC:R01AA12 | Fenoxazoline |
| ATC:R01AA13 | Tymazoline |
| ATC:R01AA14 | Epinephrine |
| ATC:R01AA15 | Indanazoline |
| ATC:R01AB | Sympathomimetics,combinationsexcludingcorticosteroids |
| ATC:R01AB01 | Phenylephrine |
| ATC:R01AB02 | Naphazoline |
| ATC:R01AB03 | Tetryzoline |
| ATC:R01AB05 | Ephedrine |
| ATC:R01AB06 | Xylometazoline |
| ATC:R01AB07 | Oxymetazoline |
| ATC:R01AB08 | Tuaminoheptane |
| ATC:R01AC | Antiallergicagents,excludingcorticosteroids |
| ATC:R01AC01 | Cromoglicicacid |
| ATC:R01AC02 | Levocabastine |
| ATC:R01AC03 | Azelastine |
| ATC:R01AC04 | Antazoline |
| ATC:R01AC05 | Spaglumicacid |
| ATC:R01AC06 | Thonzylamine |
| ATC:R01AC07 | Nedocromil |
| ATC:R01AC08 | Olopatadine |
| ATC:R01AC51 | Cromoglicicacid,combinations |
| ATC:R01AD | Corticosteroids |
| ATC:R01AD01 | Beclometasone |
| ATC:R01AD02 | Prednisolone |
| ATC:R01AD03 | Dexamethasone |
| ATC:R01AD04 | Flunisolide |
| ATC:R01AD05 | Budesonide |
| ATC:R01AD06 | Betamethasone |
| ATC:R01AD07 | Tixocortol |
| ATC:R01AD08 | Fluticasone |
| ATC:R01AD09 | Mometasonefuroate |
| ATC:R01AD11 | Triamcinolone |
| ATC:R01AD12 | Fluticasonefuroate |
| ATC:R01AD13 | Ciclesonide |
| ATC:R01AD52 | Prednisolone,combinations |
| ATC:R01AD53 | Dexamethasone,combinations |
| ATC:R01AD57 | Tixocortol,combinations |
| ATC:R01AD58 | Fluticasone,combinations |
| ATC:R01AD60 | Hydrocortisone,combinations |
| ATC:R01AX | Othernasalpreparations |
| ATC:R01AX01 | Calciumhexaminethiocyanate |
| ATC:R01AX02 | Retinol |
| ATC:R01AX03 | Ipratropiumbromide |
| ATC:R01AX05 | Ritiometan |
| ATC:R01AX06 | Mupirocin |
| ATC:R01AX07 | Hexamidine |
| ATC:R01AX08 | Framycetin |
| ATC:R01AX09 | Hyaluronicacid |
| ATC:R01AX10 | Various |
| ATC:R01AX30 | Combinations |
| ATC:R01BA | Nasal decongestants for systemic use |
| ATC:R01BA01 | Phenylpropanolamine |
| ATC:R01BA02 | Pseudoephedrine |
| ATC:R01BA03 | Phenylephrine |
| ATC:R01BA51 | Phenylpropanolamine,combinations |
| ATC:R01BA52 | Pseudoephedrine,combinations |
| ATC:R01BA53 | Phenylephrine,combinations |
| ATC:R02A | Throat drugs |
| ATC:R02AA | Throat antiseptics |
| ATC:R02AA01 | Ambazone |
| ATC:R02AA02 | Dequalinium |
| ATC:R02AA03 | Dichlorobenzylalcohol |
| ATC:R02AA05 | Chlorhexidine |
| ATC:R02AA06 | Cetylpyridinium |
| ATC:R02AA09 | Benzethonium |
| ATC:R02AA10 | Myristyl-benzalkonium |
| ATC:R02AA11 | Chlorquinaldol |
| ATC:R02AA12 | Hexylresorcinol |
| ATC:R02AA13 | Acriflaviniumchloride |
| ATC:R02AA14 | Oxyquinoline |
| ATC:R02AA15 | Povidone-iodine |
| ATC:R02AA16 | Benzalkonium |
| ATC:R02AA17 | Cetrimonium |
| ATC:R02AA18 | Hexamidine |
| ATC:R02AA19 | Phenol |
| ATC:R02AA20 | Various |
| ATC:R02AA21 | Octenidine |
| ATC:R02AB | Throat antibiotics |
| ATC:R02AB01 | Neomycin |
| ATC:R02AB02 | Tyrothricin |
| ATC:R02AB03 | Fusafungine |
| ATC:R02AB04 | Bacitracin |
| ATC:R02AB30 | Gramicidin |
| ATC:R02AD | Anesthetics, local |
| ATC:R02AD01 | Benzocaine |
| ATC:R02AD02 | Lidocaine |
| ATC:R02AD03 | Cocaine |
| ATC:R02AD04 | Dyclonine |
| ATC:R02AX | Other throat preparations |
| ATC:R02AX01 | Flurbiprofen |
| ATC:R02AX02 | Ibuprofen |
| ATC:R03 | Drugs for obstructive airway diseases |
| ATC:R03A | Adrenergics, inhalants |
| ATC:R03AA | Alphaandbetaadrenoreceptoragonists |
| ATC:R03AA01 | Epinephrine |
| ATC:R03AB | Non-selectivebeta-adrenoreceptoragonists |
| ATC:R03AB02 | Isoprenaline |
| ATC:R03AB03 | Orciprenaline |
| ATC:R03AC | Selectivebeta-2-adrenoreceptoragonists |
| ATC:R03AC02 | Salbutamol |
| ATC:R03AC03 | Terbutaline |
| ATC:R03AC04 | Fenoterol |
| ATC:R03AC05 | Rimiterol |
| ATC:R03AC06 | Hexoprenaline |
| ATC:R03AC07 | Isoetarine |
| ATC:R03AC08 | Pirbuterol |
| ATC:R03AC09 | Tretoquinol |
| ATC:R03AC10 | Carbuterol |
| ATC:R03AC11 | Tulobuterol |
| ATC:R03AC12 | Salmeterol |
| ATC:R03AC13 | Formoterol |
| ATC:R03AC14 | Clenbuterol |
| ATC:R03AC15 | Reproterol |
| ATC:R03AC16 | Procaterol |
| ATC:R03AC17 | Bitolterol |
| ATC:R03AC18 | Indacaterol |
| ATC:R03AC19 | Olodaterol |
| ATC:R03AH | Combinationsofadrenergics |
| ATC:R03AK | Adrenergicsincombinationwithcorticosteroidsorotherdrugs,excl.anticholinergics |
| ATC:R03AK01 | Epinephrineandotherdrugsforobstructiveairwaydiseases |
| ATC:R03AK02 | Isoprenalineandotherdrugsforobstructiveairwaydiseases |
| ATC:R03AK04 | Salbutamolandsodiumcromoglicate |
| ATC:R03AK05 | Reproterolandsodiumcromoglicate |
| ATC:R03AK06 | Salmeterolandfluticasone |
| ATC:R03AK07 | Formoterolandbudesonide |
| ATC:R03AK08 | Formoterolandbeclometasone |
| ATC:R03AK09 | Formoterolandmometasone |
| ATC:R03AK10 | Vilanterolandfluticasonefuroate |
| ATC:R03AK11 | Formoterolandfluticasone |
| ATC:R03AK12 | Salmeterolandbudesonide |
| ATC:R03AK13 | SalbutamolandBeclometasone |
| ATC:R03AL | Adrenergicsincombinationwithanticholinergics |
| ATC:R03AL01 | Fenoterolandipratropiumbromide |
| ATC:R03AL02 | Salbutamolandipratropiumbromide |
| ATC:R03AL03 | Vilanterolandumeclidiniumbromide |
| ATC:R03AL04 | Indacaterolandglycopyrroniumbromide |
| ATC:R03AL05 | Formoterolandaclidiniumbromide |
| ATC:R03AL06 | Olodaterolandtiotropiumbromide |
| ATC:R03B | Other drugs for obstructive airway diseases, inhalants |
| ATC:R03BA | Glucocorticoids |
| ATC:R03BA01 | Beclometasone |
| ATC:R03BA02 | Budesonide |
| ATC:R03BA03 | Flunisolide |
| ATC:R03BA04 | Betamethasone |
| ATC:R03BA05 | Fluticasone |
| ATC:R03BA06 | Triamcinolone |
| ATC:R03BA07 | Mometasone |
| ATC:R03BA08 | Ciclesonide |
| ATC:R03BA09 | Fluticasonefuroate |
| ATC:R03BB | Anticholinergics |
| ATC:R03BB01 | Ipratropiumbromide |
| ATC:R03BB02 | Oxitropiumbromide |
| ATC:R03BB03 | Stramonipreparations |
| ATC:R03BB04 | Tiotropiumbromide |
| ATC:R03BB05 | Aclidiniumbromide |
| ATC:R03BB06 | Glycopyrroniumbromide |
| ATC:R03BB07 | Umeclidiniumbromide |
| ATC:R03BB54 | Tiotropiumbromide,combinations |
| ATC:R03BC | Antiallergicagents,excludingcorticosteroids |
| ATC:R03BC01 | Cromoglicicacid |
| ATC:R03BC03 | Nedocromil |
| ATC:R03BX | Otherdrugsforobstructiveairwaydiseases,inhalants |
| ATC:R03BX01 | Fenspiride |
| ATC:R03C | Adrenergics for systemic use |
| ATC:R03CA | Alpha-andbeta-adrenoreceptoragonists |
| ATC:R03CA02 | Ephedrine |
| ATC:R03CB | Non-selectivebeta-adrenoreceptoragonists |
| ATC:R03CB01 | Isoprenaline |
| ATC:R03CB02 | Methoxyphenamine |
| ATC:R03CB03 | Orciprenaline |
- Patient
- Consent
- RelatedPathology
- FamilyCancerHistory
- TumorPathologyEvent
- TNM
- Analysis
- ResponseEvaluation
- Biomarker
- Treatment
- AdverseEvent
- Drug
- BiologicalSample
- Technology
- Panel
- AnalysisProcess
- OmicAnalysis
- AlterationOnSample
- Validation
- Alteration
- GenomeEntity
- Fusion
- CNV
- Variant
- Annotation
- VariantInSample
- GeneExpression